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This PhD project represents the end point of my first 10-year journey in the world 
of physiotherapy. During the first decade of clinical practice the central questions that 
have continued to motivate my work were: “Why does the patient sometimes improve, 
independently of the specificity of my treatment?”, “Why does the patient sometimes 
get worse even if the evidence-based guidelines have been followed?”, “Why does the 
patient choose a specific clinician instead of another clinician?”. 
The healthcare context provides answers to these professional doubts. The 
features of patient and clinician, the patient-clinician relationship, the feature of the 
treatment and healthcare setting, represent the context. It pervades all clinical actions: 
its positive use can trigger placebo effects, while its negative use can generate nocebo 
effects, thus directly influencing the therapeutic outcome. 
The research performed during these last three years has provided insights into the 
role of the healthcare context as a trigger of placebo and nocebo effects, which 
contributed to improving my clinical reasoning and expertise. Moreover, the results of 
the project leave the door open for future studies and didactic activities concerning 
placebo, nocebo and contextual factors effects. 
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  GENERAL INTRODUCTION 
	  
A brief overview on placebo and nocebo effects 
Placebo and nocebo effects represent one of the most fascinating topics in the 
healthcare field. They represent complex and distinct psychoneurobiological 
phenomena where behavioural and neurophysiological changes occur during an 
interaction between the patient and the healthcare context (1). Placebo effects (Latin “I 
shall please”) are produced by a psychosocial context that is capable of positively 
affecting the patient's brain and therapeutic outcomes (2-4). On the contrary, nocebo 
effects (Latin “I shall harm”) are consequences of the negative perception of the ritual 
and therapeutic act on the patient's mind and body, so much so that it generates 
unwanted effects and side effects (5-7). 
Throughout the history of medicine, placebo and nocebo have been traditionally 
viewed as bothersome variables to check for in a clinical trial. In the last four decades, 
in light of some significant clinical and laboratory findings, they have become a source 
of research interest. Indeed, placebo and nocebo have been adopted as a conceptual 
model to examine the body-mind interaction and the human body systems, exploring 
their connection with different systems, mechanisms, diseases and therapeutic 
interventions (8, 9). In particular, placebo and nocebo effects have been studied in mood 
(10), cardiovascular, respiratory (11), gastrointestinal (12, 13), motor (14), immune and 
endocrine (15), and pain systems (16-18). 
Clinically, not all improvement or aggravation of patients’ symptoms is due to 
placebo and nocebo effects. It is necessary to rule out the patients’ modifications 
created by placebo and nocebo effects from the changes of outcomes related to other 
	  confounding elements. The elements which could create misinterpretations of the 
patients’ clinical picture are: the spontaneous remission of the disease and symptom 
fluctuation (also called the natural history), the regression to the mean (a statistical 
phenomenon caused by selection biases), the patient’s and clinician’s biases during the 
reports of clinical conditions, and unidentified effects of concomitant co-interventions 
(8, 9). 
Different psychoneurobiological findings allowed the scientific community to 
begin to understand the underlying mechanisms of placebo and nocebo effects. From a 
theoretical perspective, two main psychological subjective constructs have been 
suggested to explain how placebo or nocebo effects act: the expectation and the 
conditioning. The social learning, reward, anxiety reduction, desire, motivation, 
memory, somatic focus, genetic and personality traits also represent alternative theories 
(19-25). “Alternative” however does not mean that these psychological mechanisms are 
mutually exclusive: they can interact simultaneously (26). 
Regarding the actual findings, placebo and nocebo interact with the brain 
modulatory systems at a neurochemical level, through the release of specific 
neurotransmitters. For instance, considering pain outcome as a model, the endogenous 
opioids, dopamine, cannabinoids, oxytocin and vasopressin are involved in placebo 
analgesia, while cholecystokinin, dopamine, opioid deactivation and cyclooxygenase-
prostaglandins activation are implicated in nocebo hyperalgesia (27-29).  
Furthermore, recent advances in neuroimaging techniques, such as functional 
magnetic resonance imaging (fMRI) and positron emission tomography (PET), suggest 
an involvement of specific neural correlates during placebo and nocebo effects, mainly 
the pain one. In fact, placebo and nocebo are able to activate or deactivate the four key 
	  brain regions commonly associated with the descending pain processing pathway: the 
dorsolateral prefrontal cortex, the rostral anterior cingulate cortex, the periaqueductal 
gray and the dorsal horn of spine (16). Nevertheless, they represent only a part of brain 
areas showing a change in their activity during placebo or nocebo (30-32). 
Therefore, the previously described evidence suggests that placebo and nocebo 
effects are concrete and genuine phenomena, triggered by different contexts, and 
capable of impacting the patients’ brain. It is necessary to define what the context is, 
and why its parts are important from a clinical perspective (33). 
 
The healthcare context as a trigger of placebo and nocebo effects 
In 1955 Balint described the context as the “whole atmosphere around the 
therapy” (34). The context is not a vacuum, but it embodies a healing space composed 
by internal, external and relational elements capable of interacting with the patient’s 
disease (35). The internal elements consist of memories, emotions, expectations and 
psychological characteristics of the patient. The external elements include the physical 
aspects of therapy, such as the kind of treatment (pharmacological or manual) and the 
place in which the treatment is delivered. Relational elements are represented by all the 
social cues that characterize the patient-clinician relationship, such as the verbal 
information that the clinicians give to the patient, the communication style or the body 
language (36).  
In 2001, Di Blasi et al. defined these elements as “contextual factors”. These 
factors have been grouped, from a clinical practice point of view, in five categories: a) 
clinician features, b) patient features, c) patient-clinician relationship, d) intervention 
features, and e) healthcare setting features (37). As a whole, contextual factors 
	  constitute the therapeutic ritual and healing symbols surrounding the patient-clinician 
encounter, capable of producing changes in the patient at perceptual, neurophysiological 
and cognitive levels (38). Indeed, contextual factors convey a hidden meaning, actively 
detected and analysed by the patient, which is essential for the perception of care and 
the interpretation of the therapeutic intervention (39, 40). When these contextual stimuli 
and cues are filtered by the patient’s perspective and mind-set (41), they are translated 
into a complex cascade of psycho-neuroimmunoendocrine events, thus triggering 
placebo and nocebo effects and influencing the course of illness (42, 43). 
From a clinical perspective, the contextual factors pervade every healthcare action 
(history taking, physical examination, therapy and prognosis) and directly affect the 
quality of the health-related outcome (44-46). A positive context, that is characterized 
by the presence of positive contextual factors, can improve therapeutic outcome by 
producing placebo effects, while a negative context, characterized by the presence of 
negative contextual factors, can aggravate therapeutic outcome by creating nocebo 
effects(47, 48). For example, during the same treatment delivery (e.g. painkillers), the 
use of positive verbal suggestion (e.g. “This therapy will help you and it will decrease 
pain”) can improve musculoskeletal pain, while the adoption of verbal suggestion of 
uncertainty (e.g. “This therapy could help you and sometimes it decrease pain”) can 
aggravate patient’s pain (49). 
The presented studies offer a starting point for reflection about the role of the 
contextual factors surrounding the administration of a healthcare treatment: they can be 
a source of improvement of the efficacy of the therapy or implicated in the 
manifestation of adverse effects. The logical consequence is to wonder whether context, 
	  placebo and nocebo effects have been taken into consideration in a specific healthcare 
field, such as physical therapy. 
 
The link between placebo, nocebo effects and physical therapy 
Throughout the history of physical therapy and rehabilitation, placebo and nocebo 
effects have been considered as problematic phenomena for two main reasons. From a 
research point of view, they have represented confounding factors capable of limiting 
the internal validity of the study design and reducing the external validity of the 
findings (50). From a clinical point of view, they have embodied troublesome and non-
specific variables able to attenuate the therapeutic role of specific therapies such as 
massage, joint mobilization and therapeutic exercise (51, 52). As a consequence, for 
many years the role of placebo and nocebo effects was debated worldwide by clinicians 
and researchers (53-55).  
At the end of the first decade of the twenty-first century the scientific community 
began to investigate the mechanisms of action of joint, soft tissue and neural therapeutic 
intervention, consequently revaluing the role of placebo and nocebo effects in 
physiotherapy (56). Recent studies have suggested a mechanical and neurophysiological 
mechanism (peripheral, spinal and supraspinal) linked to the therapeutic strategies 
adopted by physical therapists (57). Among the supraspinal mechanisms, the placebo 
and nocebo effects have assumed an important top-down role in inducing changes in 
patient’s symptoms (58), thus becoming elements that clinicians should adopt in clinical 
practice (59). 
Recently, also the context in which interventions are delivered has been suggested 
as a moderator of clinical effects (60). A new line of research has indicated the context 
	  as responsible for a larger non-specific component of treatment efficacy in physical 
therapy (61). Despite these promising advances, the following issues remain 
unexplored:  
1) What are the contextual factors?  
2) How can the contextual factors trigger placebo and nocebo effects?  
3) Which therapeutic outcomes can be influenced by the contextual factors? 
4) Are the physical therapists aware of the use of contextual factors in clinical 
practice? 
5) What is the role of contextual factors in research? 
 
General organization of the research project 
The main goal of this PhD research project is to investigate the relevance of the 
contextual factors as triggers of placebo/nocebo effects and their impact on therapeutic 
outcomes in physiotherapy. Different studies were conducted during the 3-year period 
of PhD training (2015-2018). The results, relative discussions and implications are 
reported in the chapters of the present dissertation as follows: 
• Chapter I: a conceptual model regarding the role of the contextual factors as 
triggers of placebo, nocebo responses and influencers of physical therapy outcomes; 
• Chapter II: the model of contextual factors regarding musculoskeletal pain, which 
is a common outcome encountered by physical therapists; 
• Chapter III: the link between the determinants of patient satisfaction in outpatient 
musculoskeletal physiotherapy clinics and the contextual factors;  
• Chapter IV: the knowledge, attitude and behaviour of Italian physiotherapists 
specialized in manual therapy towards contextual factors;  
	  • Chapter V: the translational value of contextual factors and their relevance for 
physical therapy research. 
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Introduction: Placebo and nocebo represent complex and distinct 
psychoneurobiological phenomena in which behavioural and neurophysiological 
modifications occur together with the application of a treatment. Despite a better 
understanding of this topic in the medical field, little is known about their role in 
physiotherapy. 
Purpose: The aim of this review is: a) to elucidate the neurobiology behind placebo and 
nocebo effects, b) to describe the role of the contextual factors as modulators of the 
clinical outcomes in rehabilitation and c) to provide clinical and research guidelines on 
their uses. 
Implications: The physiotherapist’s features, the patient’s features, the patient-
physiotherapist relationship, the characteristics of the treatment and the overall 
healthcare setting are all contextual factors influencing clinical outcomes. Since every 
physiotherapy treatment determines a specific and a contextual effect, physiotherapists 
should manage the contextual factors as boosting elements of any manual therapy to 
improve placebo effects and avoid detrimental nocebo effects. 
	  Introduction 
 Every day physiotherapists (PTs) use different tools, such as manual techniques 
and exercises, to achieve their main professional goals: the improvement of pain, 
disability and patient’s self-perceived health condition. The management of placebo and 
avoidance of nocebo responses have recently been suggested as promising additional 
clinical strategies (1), generating a wide debate in manual therapy research (2-4).  
 Placebo and nocebo represent complex and distinct psychoneurobiological 
phenomena in which behavioural and neurophysiological modifications occur following 
application of a treatment. The placebo (Latin “I shall please”) is created by the positive 
psychosocial context that is capable of influencing the patient’s brain (5). Instead, the 
nocebo (Latin “I shall harm”) is the result of the negative ritual and therapeutic act on 
the patient’s mind and body (6-8).  
 From a psychobiological perspective (Figure 1), conscious expectation and the 
unconscious classical conditioning, reward-learning, observational and social learning, 
modulation of anxiety, desire, motivation, memory and prior experience, somatic focus, 
personality traits and genetics work as facilitators of placebo or nocebo (9-11) and 
modulate different responses across several diseases, illnesses, and treatment methods 
(12-14). 
 Although some attempts to identify (15) and to measure (16) the placebo response 
induced by sham techniques have been reported, to date the role of placebo response 
seems to be poorly recognized and applied by PTs in clinical setting (17) and nocebo is 
still scarcely considered as a possible variable negatively influencing rehabilitation 
outcome. 
	   Agreeing that the conscious reinforcement of placebo strategies could represent an 
additional opportunity for every PT to improve their clinical outcomes, the present 
article aims to: 
a) Synthesize the neurobiological mechanisms underlying the placebo and nocebo 
responses; 
b) Describe the contextual factors as modulators of the clinical outcomes in 
musculoskeletal rehabilitation; 
c) Provide guidance for the clinical implementation of placebo enhancement and/or 
nocebo avoidance; 
d) Identify possible new lines of investigation in manual therapy research. 
 
The neurobiological mechanisms behind placebo and nocebo responses 
 Pain and motor performance are the most frequently used models to describe the 
neural network involved during the placebo and nocebo responses (18-21). 
 
Pain 
 Placebo and nocebo engage distinct top-down modulatory systems using different 
key neurotransmitters. Endogenous opioids, dopamine, cannabinoids, oxytocin and 
vasopressin are involved in placebo while cholecystokinin, dopamine, opioid 
deactivation and cyclooxygenase-prostaglandins activation interact with nocebo (22-
24). Placebo analgesia and nocebo hyperalgesia largely involve, with opposite 
activation, numerous brain areas (Table 1).  
 Among them, placebo analgesia is mostly associated with an increased functional 
coupling of the dorsolateral prefrontal cortex, the anterior cingulate cortex, the 
	  hypothalamus, the amygdala, the periaqueductal grey and a decreased activity in pain 
processing area such as the thalamus, insula and the somatosensory cortex (10, 25-27). 
On the contrary, negative expectations of pain increase the activation of affective-
cognitive pain regions like the anterior cingulate cortex, the prefrontal cortex, the insula 
and the hippocampus. Furthermore, placebo and nocebo are capable of modulating pain 




 Placebo and nocebo influence the activity of the motor system and the consequent 
motor performance (28-31). It has been shown that placebo induces an increase of 
dopamine in the striatum and a change of neural activity in the basal ganglia and in 
limbic areas of the brain in patients affected by Parkinson disease (32, 33). Enhanced 
corticospinal system excitability (34) and reduced fatigue by modulating readiness 
potential during the anticipatory phase of movement (35) were displayed in healthy 
subjects. Similarly, a nocebo procedure in which the induced expectation decreases 
force production modulated the corticospinal circuits influencing motor performance 
(36). 
 
The contextual factors optimize the rehabilitation outcomes 
 The psychosocial context and the therapeutic ritual around the patient can also 
influence the patient’s brain activity and the therapeutic outcome such as satisfaction 
and perceived effect (5, 37, 38). As reported in Figure 3, the physiotherapist’s and 
patient’s features, the patient-physiotherapist relationship, the characteristics of the 
	  treatment and the overall healthcare setting are the most relevant categories of 
contextual factors involved in placebo or nocebo effects (39).  
 
Physiotherapist’s features 
 A “physiotherapist’s effect” is present and influences the outcome of treatment in 
patients with musculoskeletal disorders (40). 
 
Professional reputation and appearance  
The perception of expertise, professionalism, qualification, reputation and the 
level of training of the PTs are important elements for the patient and can contribute to 
modify the clinical outcome in musculoskeletal disorders (41-43). Moreover the way a 
therapist dresses is able to influence the patient’s perception of care (44). Recently the 
results of a study by Mercer, Mackay-Lyons (45) reported that lab coat and tailored 
clothing were ranked respectively most professional and preferred, by patients with low 
back pain (LBP). By contrast, patients were less satisfied if the professional appearance 
was poor and if PTs used jeans during clinical practice (42, 45). 
 
Beliefs and behaviours 
 Enthusiastic practitioners and their optimism or pessimism regarding the nature of 
a treatment have an active effect on the outcome (46-48). This is a self-fulfilling 
prophecy whereby the convincement of a practitioner about the patient’s outcome leads 
to an improvement (“Pygmalion effect” – “Rosenthal effect”) or a worsening (“Golem 
effect”) of the outcome itself (49). Recent evidence linked the attitudes and beliefs of 
patients with LBP with the attitudes and beliefs of the health care professional (included 
	  PTs) they have consulted (50). Patients appreciate PT’s aptitude to encourage questions 
and to answer the patient’s requests, to explore disease and illness experience and to 
trust their opinion. The PT’s ability to deliver positive feedback, to give clear prognostic 
information and explanation about the patient’s condition and the treatment can 
positively interact with the results of therapy (41, 42, 51-54). On the other hand, PTs 
should avoid to show nervousness, to be uncooperative or in a hurry, to spend too much 
time reading patient charts and to use too technical words with the patient during the 
clinical encounter (41, 52). 
 
Patient’s feature 
 The patient’s perception and direct experience of care are central elements 
capable of influencing the placebo analgesia (55).  
  
Expectation, preferences and previous experience 
 The expectation of a treatment can shape the patient’s pain experience (21, 56-
58). It was recently demonstrated that the general expectations for pain relief strategies 
had an important influence on pain and disability, in patients with LBP (59) and neck 
pain (60). Moreover, expectation is a significant prognostic factor in musculoskeletal 
pain and is often underestimated by PTs (61-63). Also the patient’s prior experience of 
care is another factor that can affect the outcome of a therapy (64). Indeed, patient’s 
preferences and previous experiences about a physiotherapy treatment are able to tune 
the magnitude of the therapeutic response in musculoskeletal rehabilitation just because 
of the way they are paired with prior positive or negative results (42). By contrary, 
	  avoiding or ignoring the patient’s preferences, expectations and previous experiences 
can negatively influence the therapeutic outcome (41). 
 
Musculoskeletal condition, gender and age 
 The phases of the course of the musculoskeletal disorder can influence the 
outcomes of care such as the satisfaction of the patient (65). Indeed, acute patients 
reported higher satisfaction with physical therapy care and were more sensitive to a 
number of PT’s features such as expertise, reputation, level of training and professional 
behaviour than those with chronic conditions who perceived the organization of care as 
the most significant element (42). Moreover, the perception of the quality of 
physiotherapy care is affected differently in males and females as well as in patients of 
different age (66). In particular, the main predictors of satisfaction for male patients 
were the therapist and treatment outcome, whereas for female patients the most 
important elements were organization and the communication component of care. Older 
patients seem to be more sensitive to particular aspects of physical therapy care such as 
access to services and the effectiveness of communication (42).  
 
The patient-provider relationship 
 A good patient-PT relationship positively influences outcomes like pain, 
disability, satisfaction and strengths of the therapeutic alliance (51, 67). The clinical 
encounter is modulated by different factors such as verbal and non-verbal skills (68). 
 
Verbal communication 
	   An appropriate verbal communication is a prerequisite of a good therapeutic 
relationship (69). PTs spent approximately twice the time passed hands-on talking with 
the patient (70, 71). Active listening and verbal expressions of support and 
encouragement, humour and sympathy, empathetic and communicative talk, partnership 
statements, paraphrasing and requests for patient’s opinion and the language reciprocity 
correlated with patients’ satisfaction can significantly influence the outcome of the 
treatment. (41, 42, 52, 53). PTs should avoid negative communication, verbal 
expressions of anxiety, closed questions to gather information and use of social niceties 
(52). Patients were dissatisfied when they were interrupted and could not tell their story 
and when PT lacked empathy, friendliness, was too confident or behaved arrogantly 
(41). Furthermore, the use of positive messages associated with treatment for pain relief 
(e.g. “this treatment is a powerful pain killer”) produces a large placebo analgesia effect 
in medicine (72, 73). In manual therapy, conversely, associating hands on techniques 
with positive verbal instructions changed positive expectation and patients’ satisfaction, 
without affecting pain or disability (74-76). Moreover, the use of negative information 
during the leg flexion test (e.g. “this procedure could lead to a slight increase in pain”) 
determined an aggravation of pain and poor performance during the test in patients with 
chronic LBP (77). 
 
Non-verbal communication 
 Facial expression and eye contact represent important elements in therapeutic 
interaction (53) from which patients deduce meaning (5). The expression on the face is 
capable of influencing pain processing (78) and enhance the placebo analgesia (79). In 
clinical context, PTs use non-verbal behaviour such as eye contact, smiling (70), caring 
	  expressions of support and interest, potentially contributing to affect therapy outcome 
(52). Also gestures, postures and physical contact along with speech form an integrated 
message full of meaning during clinical interaction (41, 80). By observing these 
elements a patient can infer the therapist’s intention and adapt his own behaviour 
unconsciously with modification of neurohormonal substrate of oxytocin system (5, 81, 
82). PTs regularly use affirmative head nodding, touch, forward leaning and body 
orientation to facilitate and involve patients to improve satisfaction of consultation (52, 
70). Additionally, the therapist’s ability to interpret patients’ nonverbal body language 
expressions is an important element of satisfaction during the clinical encounter (52). 
Thus, PTs should avoid an inquisitive eye contact, a slanting position (45° or 90° 
towards the patients), asymmetrical arm postures, crossed legs, backward leaning and 
neck relaxation (52, 53). 
 
Treatment feature 
 Different variables of a treatment can influence the outcome perceived by the 
patient (83). 
 
Clear diagnosis, overt therapy and observational learning 
 A diagnosis, which gives meaning to the patient’s illness, is a form of treatment 
per se (84). Delivering an exhaustive diagnosis and explanation of musculoskeletal 
disorders is appreciated by the patients and can influence their satisfaction about the 
care during the first visit (42, 53, 85). Moreover, showing and telling patients that a 
treatment is being applied is important for the creation of the placebo response and 
modulation of therapeutic outcome (86). In a postoperative analgesia study, covert 
	  administration of analgesic resulted in slower onset of pain relief than when patients 
knew when morphine was administered, implying that the initial rapid relief is largely 
effected through a placebo response (87). Also in physiotherapy, the administering of an 
overt treatment by a mirror feedback was proposed as an effective strategy in chronic 
LBP (88). Indeed, patients that looked at their back when moving during exercises 
reported less increase in pain and faster resolution of dysfunction (89, 90). Finally, 
endorsing the positive effects of a therapy in a therapeutic context in which patients 
could talk to other patients who successfully received the same treatment, or watching 
videos of other patients, can influence placebo analgesia and avoid nocebo (9). In 
musculoskeletal rehabilitation, the use of action observation of others’ movement 
improves pain and disability of patients after total knee replacement (91, 92). 
 
Patient-centred approach and global process of care 
 Personalizing treatment, taking patient’s opinions into account and use of a 
patient-centred care seem to influence the result of the treatment (41, 42, 52, 53, 93). 
Moreover, organisational and procedural aspects of physiotherapy such as therapy 
delivered by the same PT, cleanliness, adequate length of consultation, punctuality, 
flexibility with patient appointments, timely and efficient treatment, adequate 
frequency, duration and follow-up of therapy affect the patient’s satisfaction and 
therapeutic outcome (41, 42, 52). Instead, the use of a therapist-centred or biomedical 
approach, a lack of privacy, an expensive treatment, a too long waiting list, a reduction 
of patient-PT time, being treated by different PTs or an hastened treatment negatively 
influence the outcome of therapy (41, 42, 52). 
 
	  Therapeutic touch  
 In clinical context, PTs apply different form of touch such as assistive touch, 
touch used to prepare the patient, touch to provide information, caring touch, touch to 
provide a therapeutic intervention, and touch used to perceive information (94, 95). 
Touch is a fundamental element of interpersonal interaction (96) that regulates the 
social bonding in humans. This kind of touch information is conducted by a class of 
cutaneous unmyelinated, low threshold mechanosensitive nerves, called c-tactile 
afferents, that process affiliative tactile stimuli (97, 98). Moreover touch in therapeutic 
setting acts as a useful strategy to relieve musculoskeletal pain (99, 100). When 
moderate and light pressure massage were compared, only moderate pressure 
contributed to enhance pain, depression and anxiety (101). Furthermore, moderate 
pressure massage was capable of modifying neurophysiological parameters such as 
heart rate, improved vagal activity, decreased cortisol levels, enhanced serotonin and 
dopamine levels, influence cortical and spinal excitability and inhibit nociceptive 
responses at a subcortical and cortical level (101-105). 
 
Healthcare setting feature 
 The healing environment and the use of combined positive distractors in a 
therapeutic context can influence the patient’s outcomes such as pain, stress and anxiety 
(106).   
 
Environment 
 Different sensory elements of the environment can modulate the patient’s 
outcome. Environments with natural lighting, monitored low noise levels, with relaxing 
	  and soft music are more desirable (107-114). Moreover, the use of pleasing aromas and 




 Structural aspects of the healthcare environment can influence the patient’s 
perception of care and pain perception (115). Environments that integrate windows and 
skylights in the workplace, comfortable and private therapeutic settings are more 
appreciated by patients (107, 108, 111-113). Furthermore, it is advisable the use of 
supportive indications such as highly visible and easy to read signs, parking 
information, accessible entrances, clear and consistent verbal or written directions, 
information desks, and accessible electronic information (108). Indeed, a good access to 
services, particularly convenient clinic hours, location, parking, and an available and 
approachable support staff are perceived as important elements for the patient (42). 
 
Interior design  
Decorations and ornaments can impact the health status of the patient. Nature 
artworks that include green vegetation, flowers, water and a setting with a view of 
nature that integrates plants or garden ornaments have a calming effect (107-113). Also 
colour schemes based on soothing shades seem to modulate the patient’s experience of 
care (107). However, the meaning of colour differs among persons and should be 
culturally suitable for the patient population it is intended to serve (108, 112). 
 
Implications for clinicians: maximise placebo, minimize nocebo 
	   In therapeutic settings, placebo and nocebo effects are commonly detected. 
Various systematic reviews observed placebo when continuous subjective measures of 
disease are adopted, and not when binary subjective or objective measures are applied 
(116-118). This advocates that placebo does not influence the disease but affects the 
illness as subjective perceptions of patient experience (119, 120). Indeed placebo and 
nocebo can positively and negatively impact impairments and disabilities such as pain 
(72, 73, 121), motor performance (28-31) and satisfaction in musculoskeletal disorder 
therapy (42). Therefore, PTs should consider it in clinical practice and be aware to 
maximize placebo and eliminate nocebo (13, 122). Table 2 provides guidelines on the 
application of placebo. 
 From a clinical point of view, placebo and nocebo elements are always present 
during therapeutic intervention. Every healthcare intervention is formed by two factors: 
a specific/active biological component and a contextual/psycho-social one (5). These 
contextual elements interact with the specific effect of the therapy by either increasing 
or decreasing the global effect of treatment (37, 38). Also manual therapy presents a 
specific biomechanical and neurophysiological mechanism that could be modulated by 
the context (17, 123-125). For PTs it is essential to transfer this knowledge in clinical 
practice to improve therapy application and outcome (1, 126). Figure 4 shows the 
relevance of adding different contextual factors on the specific effect of a treatment. 
 PTs should remember that patient satisfaction is determined more by interactions 
with the PT and the process of care instead of the outcome of treatment (Hush, 
Cameron, 2011). Therefore, it is useful to strengthen the therapeutic relationship, the 
healing rituals and treatment setting during the clinical encounter (127-129). In the 
therapeutic arena multiple signs and cues convey a hidden meaning that is essential for 
	  the perception and interpretation of care and that may be just as important as the 
specific effect of the treatment (130-133). 
 Beside placebo and nocebo, other conditions such as the natural history of the 
disease, the regression to the mean, biases by clinicians and patients, unidentified co-
interventions or adverse side effects in the placebo group in a randomized controlled 
clinical trial (RCT) can modify the outcomes of therapy and can disguise recovery or 
aggravations, (8, 12). Figure 5 provides a graphical synopsis about the different 
elements that influence the global therapeutic outcome. 
 While placebo is a real and powerful phenomenon with a supportive evidence of 
action, it must be clear that the placebo intervention should not be based on unethical 
principles or deception and should not be a substitute for other more effective 
treatments (120). It is ethical to use it as a boosting strategy combined with the best 
available therapy to improve clinical outcomes of patient and avoid nocebo (134, 135). 
 
Implications for research: design placebo and nocebo trials 
 The creation of an adequate trial design remains a challenge in placebo and 
nocebo research (136, 137). Researchers should be aware of the fact that the 
management of the contextual factors is linked to their goals. Limiting the therapeutic 
relationship and the ritual around the treatment favours emersion of the specific effect 
of the therapy. (138-140). On the other hand, the administering of an active therapy 
increasing the therapeutic alliance and healthcare interaction can help to reveal the role 
of the context in the modulation of the patient’s outcome (141, 142). Much of the 
information presented in this paper does not result from RCT assessing the effectiveness 
of individual contextual factors, but it is extrapolated from qualitative research and 
	  patient interviews. Therefore, there is a strong need for a translational research with a 
significant clinical impact (143). Several lines of investigation are a priority such as: the 
effect of the single and combined contextual factors on the therapeutic outcome, the 
PTs’ knowledge and expertise about placebo and nocebo effect, the patient’s point of 
view about the role of the contextual elements in influencing the outcome, the 
identification of psychological and genetic traits of placebo responders.  
 
Conclusion 
 The difference of clinical success between two different PTs, both practicing 
respectful of the scientific evidence and applying the clinical guidelines lies in the 
different level of implementation of the “art” component of the profession. This is 
probably mostly due to behaviours that have relevant effects on the clinical outcome 
through placebo or nocebo phenomenon. The possibility of adopting knowledgeable, 
expert and ethical strategies to enhance placebo and avoid nocebo is a great opportunity 
for every PT to enrich their therapeutic toolbox.   
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  Table 1. Description of brain areas involved in placebo analgesia and nocebo 
hyperalgesia 
Placebo Analgesia Nocebo Hyperalgesia  
rostral anterior cingulate cortex, 
hypothalamus,  
amygdala, 
periaqueductal gray,  
rostral ventro-medial medulla, 
lateral orbitofrontal cortex, 
nucleus accumbens, 
dorsolateral prefrontal cortex, 
ventrolateral prefrontal cortex, 
dorsal horn of spinal cord, 
thalamus,  
anterior insular cortex,  





supramarginal gyrus,  
left inferior parietal lobule. 
the parabrachial nuclei 
hippocampus, 
dorsal horn of spinal cord, 
nucleus accumbens, 
thalamus,  
second somatosensory cortex,  
posterior insular cortex , 
caudal anterior cingulate cortex,  
head of the caudate,  
cerebellum,  
contralateral nucleus cuneiformis, 
parietal operculum, 
bilateral dorsal anterior cingulate cortex,  
left frontal and parietal operculum,  
orbitofrontal cortex, 




Table 2. Strategies to enhance placebo in physiotherapy 
Key points 
Physiotherapist’s and patient’s feature 
• Improve professionalism, reputation, training and expertise; 
• Use a lab coat or tailored clothing;  
	  • Be optimistic during the consultation and regarding the dysfunction; 
• Deliver clear diagnosis, prognosis and explanation of the patient’s problem; 
• Explore the patient’s disease and illness, request and trust the patient’s opinion; 
• Encourage questions, answer requests by the patient, deliver positive feedback; 
• Investigate expectation, preferences and previous experience of the patient; 
• Consider the phase of the musculoskeletal conditions, gender and age of the patient; 
 
Patient-physiotherapist relationship  
• Be warm, confident, friendly, relaxed and open during the clinical encounter 
• Use verbal expressions of empathy, support, sympathy, language reciprocity;  
• Adopt psychosocial talk, partnership statements and paraphrase;  
• Use positive messages associated with treatment for pain relief; 
• Use eye contact, smiling, caring expressions of support and interest; 
• Use affirmative head nodding, forward leaning and open body posture; 
• Interpret patient’s nonverbal body language expressions; 
 
Treatment feature 
• Use open treatment, show and tell the patient that a therapy is applied; 
• Boost the patient’s willingness to talk to other patients who undergo the same 
treatment with positive results; 
• Use patient-centred care, personalize the treatment; 
• Deliver the treatment by the same physiotherapist in a clean and private 
environment,   
• Set appointments with adequate length, punctuality, frequency, follow-up; 
• Use touch to assist, prepare, inform, care of, perceive and treat patients; 
 
Healthcare setting feature 
• Combine positive distractors as light, music, temperature and aromas,  
• Adopt supportive indications to facilitate access to physiotherapy service; 
• Decorate the therapeutic environment with artworks and ornaments; 










!Figure 2. Brain areas most involved in placebo analgesia (a) and nocebo 
hyperalgesia (b).  
 
For complete listing see Table 1 In grey area activated, in black area deactivated. DLPC: dorsolateral 
prefrontal cortex, ACC: anterior cingulate cortex; S1: primary somatosensory cortex; Hypo: 
hypothalamus; Amy: amigdala; PAG: periaqueductal gray; S2: secondary somatosensory cortex; PC: 
prefrontal cortex. 
!Figure 3. The contextual factors as modulators of therapeutic outcome.
 
!Figure 4. The modulation of the specific effect of therapy by positive and negative context.
 
!Figure 5. Different determinant of global therapeutic outcome.
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  Clinical relevance of contextual factors as triggers of placebo and 
nocebo effects in musculoskeletal pain 	  
Abstract 
Placebo and nocebo effects are embodied psycho-neurobiological responses capable 
of modulating pain and producing changes at different neurobiological, body at 
perceptual and cognitive levels. These modifications are triggered by different 
contextual factors (CFs) presented in the therapeutic encounter between patient and 
healthcare providers, such as healing rituals and signs. The CFs directly impact on the 
quality of the therapeutic outcome: a positive context, that is a context characterized 
by the presence of positive CFs, can reduce pain by producing placebo effects, while a 
negative context, characterized by the presence of negative CFs, can aggravate pain 
by creating nocebo effects. Despite the increasing interest about this topic; the 
detailed study of CFs as triggers of placebo and nocebo effects is still lacked in the 
management of musculoskeletal pain.  
Increasing evidence suggest a relevant role of CFs in musculoskeletal pain 
management. CFs are a complex sets of internal, external or relational elements 
encompassing: patient’s expectation, history, baseline characteristics; clinician’s 
behavior, belief, verbal suggestions and therapeutic touch; positive therapeutic 
encounter, patient-centered approach and social learning; overt therapy, posology of 
intervention, modality of treatment administration; marketing features of treatment 
and health care setting. Different explanatory models such as classical conditioning 
and expectancy can explain how CFs trigger placebo and nocebo effects. CFs act 
through specific neural networks and neurotransmitters that were described as 
mediators of placebo and nocebo effects. 
	  Available findings suggest a relevant clinical role and impact of CFs. They should be 
integrated in the clinical reasoning to increase the number of treatment solutions, 
boosts their efficacy and improve the quality of the decision-making. From a clinical 
perspective, the mindful manipulation of CFs represents a useful opportunity to enrich 
a well-established therapy in therapeutic setting within the ethical border. From a 
translational perspective, there is a strong need of research studies on CFs close to 
routine and real-world clinical practice in order to underline the uncertainty of therapy 



















Pain represents a “distressing experience associated with actual or potential 
tissue damage with sensory, emotional, cognitive and social components” (1). Among 
the different pain conditions, musculoskeletal pain is ubiquitous and multifaceted: it 
can be the consequence of everyday activities that repeatedly or unusually stress the 
system, or it can be due to either acute traumatic events or to musculoskeletal diseases 
(2). It is the most disabling symptom in musculoskeletal disorders, causing a high 
number of requests for healthcare treatments and rising social costs (3). Moreover, 
especially in chronic conditions when pain persists beyond the normal healing time, it 
is influenced by different physical, psychological and social factors (4-6) defined as 
“contextual factors” (CFs).  
The multidimensionality that characterizes pain in musculoskeletal complaints 
requires an integrative and personalized approach for its treatment. For this reason, 
the study of the CFs and their conscious use and integration in the clinical practice 
could represent a novel approach in the management of this complex experience (7-
16). 
By definition, CFs are physical, psychological and social elements that 
characterize the therapeutic encounter with the patient (17, 18). CFs are actively 
interpreted by the patient and are capable of eliciting expectations, memories and 
emotions that in turn can influence the health-related outcome, producing placebo or 
nocebo effects (19). In other words, the CFs represent the context that accompany any 
healthcare treatment: the exposure of a patient to a positive context (positive CFs) 
very often produces a placebo effect that is the occurrence of symptoms improvement 
(e.g. analgesia), whereas a negative context (negative CFs) can generate a nocebo 
effect, with a worsening of the pain condition (e.g. hyperalgesia) (20, 21). In the 
	  following review, we use the term CFs instead of placebo, avoiding the misleading 
interpretation of placebo as inert treatment given to comfort or please the patient and 
following the recent conceptualization of the placebo as the psychosocial context that 
accompanies any medical intervention, be it active or sham (22-31).  
As extensively demonstrated by the placebo and nocebo effect literature, the 
CFs can affect the outcome of a treatment with different mechanisms and in different 
systems, medical conditions, and therapeutic interventions (32). From a clinical 
perspective, the study of CFs as triggers of placebo and nocebo effects, is crucial for 
the management of musculoskeletal pain for several reasons (33). First, even if CFs 
are embodied in every complex therapeutic interventions in musculoskeletal 
complaints, they are often considered as incidental factors capable to affect outcomes. 
For this reason they are not always identified and used intentionally by clinicians (34). 
Second, CFs can produce a therapeutic effect through the involvement of the same 
central pathways of pain modulation activated by several hands-on (e.g. manual 
therapy, therapeutic exercises, acupuncture, injections) and hands-off solutions (e.g. 
pain neuroscience education) commonly applied in clinical practice (35-37). Third, 
CFs serve as additional tools for the interpretation of the clinical picture and guide 
clinicians in managing the complexity behind the patient’s musculoskeletal pain (38). 
Taking into consideration CFs as active influencer of the therapeutic outcomes, can 
help to explain some unexpected outcomes and variability of symptoms experience 
(39).  
Moving from this vision, the present debate is proposed to all the health 
professionals (physiotherapists, chiropractors, osteopaths, nurses, occupational 
therapists, rheumatologists, orthopedics etc.) that work with musculoskeletal pain. In 
order to support a better and more conscientious therapeutic use of the CFs in 
	  musculoskeletal field, the purposes of this debate are to: 1) briefly define the CFs, 
how they work and act from a neurophysiological perspective; 2) underline their 
clinical relevance in pain management; 3) consider their role in clinical reasoning, 
within the ethical border and 4) suggest how to take them into account in the research 
field.  
 
Contextual factors  
What do the contextual factors represent? 
A treatment is never administered in a neutral situation, but rather in a complex 
set of CFs, that Balint called the “atmosphere around the treatment” (40) and Miller 
and Kaptchuk called “contextual healing” (41). Following these definitions, it is clear 
that the CFs can act “independently” by the nature of the treatment: since they 
represent the context of any medical treatment, they have a role when a sham 
treatment is administered but also when an active treatment is administered. 
CFs were introduced in 2001 by Di Blasi et al. (17) in medical community and 
recently exploited by Testa & Rossettini in physiotherapy field (33). CFs can be 
internal, external or relational. The internal factors consist of memories, emotions, 
expectations and psychological characteristics of the patient; the external factors 
include the physical aspects of therapy, such as the kind of treatment 
(pharmacological or manual) and the place in which the treatment is delivered. 
Relational factors are represented by all the social cues that characterizes the patient-
physiotherapist relationship, such as the verbal information that the physiotherapist 
gives to the patient, the communication style or the body language (19). 
A clear identification of the CFs is crucial in clinical practice, in order to 
enhance the treatment efficacy. In a work targeted to physiotherapy field, CFs have 
	  been grouped in 5 different categories on the base of their sensory and social features 
(33): physiotherapist characteristics (professional reputation, appearance, beliefs, 
behaviours); patient characteristics (expectation, preferences, previous experience, 
musculoskeletal condition, gender, age); patient-physiotherapist relationship (verbal 
communication, non-verbal communication), treatment (clear diagnosis, overt 
therapy, observational learning, patient-centered approach, global process of care, 
therapeutic touch), healthcare setting (environment, architecture, interior design).  
During any clinical phase (e.g. consultation, examination and treatment) the CFs 
“inform” the patient that a healthcare procedure has been delivered and they could 
positively or negatively affect symptom perception, experience and meaning (20, 21).  
The identification of the CFs and the attention to healthcare context is crucial 
for at least two reasons. First, a treatment delivered in a positive context (positive 
CFs) produces better outcomes than a treatment delivered in a neutral condition or 
negative context (negative CFs). The open-hidden approach is one of the best 
evidence of decreased effectiveness of a medical treatment when a meaningful 
context is eliminated (42). In the “open” condition, that mimics the routine medical 
practice, a treatment is delivered in full view of the patient: it means that the patient is 
aware of receiving a medical treatment and know when the medical treatment is 
delivered. In the “hidden” condition, the treatment is administered unbeknownst to the 
patient. Different studies have reported that open treatments are more effective than 
hidden treatments, because in the hidden condition the surrounding context (healing 
rituals, therapist-patient interaction, etc.) is absent, thus losing its positive meaning 
(43-46). 
Second, the psychosocial context can influence the patients in different ways 
since the responsiveness to the context seems to be not a stable trait but a situational 
	  trait (47), and the same patient can sometimes positively respond to the context and 
sometimes not. Thus, if a patient is not influenced by the therapeutic context (the so 
called “placebo non-responders”) he/she needs more medical attention because the 
lower the placebo responsiveness, the lower the treatment responsiveness (48). 
Indeed, if the total treatment effect is conceptualized as the sum of the CFs effect plus 
the active treatment effect plus the interaction of the CFs and active treatment effects 
(49), a patient that is not sensible to the positive influence of the CFs will show a 
lower treatment response (50). 
 
How do the contextual factors trigger placebo and nocebo effects? 
If we aim to implement an aware use of CFs along the clinical routine, the 
understanding of how they work has a capital importance. The CFs shape placebo and 
nocebo effects through different sources. Historically, the most important models 
include classical conditioning and expectation processes. 
Following the classical conditioning, different external CFs represent an 
example of conditioned stimuli that evoke a conditioned response (51). In general, as 
proposed by this model, the repeated contingency between a salient unconditioned 
stimulus (e.g., sight of food) with a neutral conditioned stimulus (e.g., a bell ringing) 
can induce the same conditioned response (i.e., salivation) even if the neutral stimulus 
is presented alone. In the specific contest of healthcare, different aspects of the 
healthcare setting or physical features of the medical treatment can act as external 
conditioned stimuli, eliciting a therapeutic response in the absence of an active 
principle, just because they have been previously associated with it. Recently, other 
learning mechanisms has been documented, such social learning. In particular, 
	  beyond direct first-hand experience to specific external CFs, it is possible to learn a 
conditioned response by observing other people that respond to specific CFs (9). 
Following the expectation model, different external, internal and relational CFs 
can activate the expectancy of pain relief, triggering neurobiological changes and 
symptoms’ amelioration (52). Verbal suggestions are typical external CFs that trigger 
positive or negative responses. For example, the administration of an analgesic 
treatment along with the expectations of pain relief can lead to a positive analgesic 
response, whereas the administration of an analgesic treatment without specific 
expectations or with expectations or pain exacerbation can result in a negative 
response and in the perpetration of pain (53). 
Following the Colloca and Miller integrative model (54), conditioning and 
expectations are not mutually exclusive and can be integrated in a more general 
learning model, whereby various types of CFs trigger expectancies, memories and 
emotions that in turn generate behavioral and clinical outcome changes, through the 
activation of the central nervous system (Fig. 1) (7, 9, 20, 21). In other words, the 
presence of external CFs, combined with specific internal and relational CFs, is 
interpreted by the patient and converted into neural input events and behavioral 
changes (54). This model represents a good conceptualization of the role of the 
therapeutic context, useful also at the clinical practice level. Indeed, it opens up to the 
possibility to study the effects and the impacts of every single CF on the outcome of a 
medical treatment. 
 
How do the contextual factors work at the neurobiological level? 
A robust body of knowledge, especially acquired in the field of pain, has 
identified the neural networks activated by the CFs. Indeed, a crucial question that 
	  catch the attention of neuroscientists and clinicians is whether the subjective changes 
in the outcome after the exposure to a specific therapeutic context are associated with 
specific neurobiological activities (10). Pharmacological studies, as well as 
neuroimaging studies, have address this question using different experimental 
approaches based on classical conditioning and modulation of expectations. Taken 
together, these studies demonstrated that different changes in the pain processing 
network occurs when positive or negative CFs trigger placebo or nocebo effects, 
respectively. In particular, pain reduction is associated with decreased activity in the 
classical pain-matrix areas, such as the thalamus, insula, somatosensory cortex, and 
mid-cingulate regions (55-60). Interestingly, positron emission tomography (PET) 
studies showed that the analgesic effect induced by the administration of a real mu-
agonist, such as remifentanil, and the analgesic effect triggered by verbal suggestions 
determined similar activation of different brain regions, such as rostral anterior 
cingulate cortex and the orbital cortex (61, 62). Separating the pain anticipation phase 
and the pain perception phase, a meta- analysis of brain imaging data using the 
activation likelihood estimation method, identified the involvement of different brain 
regions: during expectation, areas of activation are found in the anterior cingulate, 
precentral and lateral prefrontal cortex, and in the periaqueductal gray, whereas 
during pain inhibition, deactivations are found in the mid- and posterior cingulate 
cortex, superior temporal and precentral gyri, in the anterior and posterior insula, in 
the claustrum and putamen, and in the thalamus and caudate body (63). On the other 
hand, pain increase is associated with signal increases in several regions including 
anterior cingulate cortex, insula, left frontal and parietal operculum (64-67). Also, 
high temporal resolution techniques, such as electroencephalography (EEG), have 
confirmed that the amplitude of specific evoked potentials, both related to pain 
	  anticipation and to pain perception, are affected by the CFs (68-71). Thus, both early 
and late sensory components of pain processing are affected by the exposure to 
positive and negative CFs. 
Different studies have also characterized the neurotransmitter systems activated 
the CFs. Using a classical conditioning approach, it has been demonstrated that when 
an opioid drug, such as morphine, is delivered for different days and then it is 
replaced by a placebo unbeknownst to the patient a placebo analgesic effect occurs 
(72). This effect can be blocked by the mu opioid antagonist, naloxone, thus 
indicating that the opioid system plays an important role (57, 73, 74). An indirect 
evidence of the involvement of the opioid system comes from the study of the anti-
opioid action of the cholecystokinin (CCK) system. The proglumide, that is a CCK 
antagonist, enhances placebo analgesia (75, 76), whereas the activation of the CCK 
type-2 receptors with the agonist pentagastrin disrupts it (77). These pharmacological 
data have been confirmed by a neuroimaging study, in which the authors proved that 
naloxone blocked the placebo analgesic response in dorsolateral prefrontal cortex 
(DLPFC), rostral anterior cingulate cortex (rACC), hypothalamus, periaqueductal 
gray (PAG), and	   rostral ventromedial medulla (RVM), and abolished placebo-
enhanced coupling between rACC and PAG (57).	   Using a the same conditioning 
protocol, it has been demonstrated that also the cannabinoid system is activated by the 
positive therapeutic context: when non-opioid drugs, like ketorolac, are administered 
for two days in a row and then replaced with a placebo on the third day, the analgesic 
effect is not reversed by naloxone, whereas the CB1 cannabinoid receptor antagonist, 
rimonabant, blocks this placebo analgesia completely (78). Also studies in which 
expectations were manipulated by positive verbal suggestions, showed an activation 
	  of µ-opioid neurotransmission in the dorsolateral prefrontal cortex, the anterior 
cingulate cortex, the insula, and the nucleus accumbens (79, 80). 
A different system activated by the therapeutic context is the dopaminergic 
system: indeed, the positive effect due to the presence of positive CFs seems to be 
related to the activation of dopamine in the nucleus accumbens. as assessed using in 
vivo receptor binding PET with raclopride. Moreover, when expectations of pain 
reduction were induced, the analgesic effect of the context was associated with 
activation of opioid neurotransmission in the anterior cingulate, orbitofrontal and 
insular cortices, nucleus accumbens, amygdala, and periaqueductal gray matter. 
Dopaminergic activation was observed in the ventral basal ganglia, including the 
nucleus accumbens. Both dopaminergic and opioid activity were associated with both 
anticipation and perceived effectiveness of the positive verbal suggestions (81, 82). 
Recently, oxytocin (83) and vasopressin (84) have been identified CFs enhancer 
as they potentiate the analgesic effect due to the presence of positive verbal 
suggestions. Moreover it has been documented that negative expectations about 
headache pain led to the enhancement of the cyclooxygenase-prostaglandins pathway, 
which, in turn, induced pain worsening (85). 
 
Clinical relevance of the contextual factors 
What is the magnitude of placebo and nocebo effects induced by CFs in 
musculoskeletal pain? 
The impact of CFs as trigger of placebo and nocebo effects on pain outcome has 
been quantified in different ways and has been reported in a wide range of 
musculoskeletal conditions such as low back pain (86-108), neck pain (95, 99, 109-
	  111), shoulder pain (95, 112, 113), osteoarthritis (38, 91, 99, 100, 114-125), 
rheumatoid arthritis (126), and fibromyalgia (97, 127-132). 
Different studies have measured the magnitude of placebo and nocebo effects 
induced by CFs in different musculoskeletal pain conditions commonly encounter in 
daily setting (117, 133). Indeed the clinical effectiveness of placebo analgesia was 
demonstrated in specific complaints such as fibromyalgia (128) and osteoarthritis 
(118) with an effect size (ES) over 0.5. Also, nocebo hyperalgesia measured as 
dropout rate due to adverse event were present in fibromyalgia (9.6%) (134) and 
osteoarthritis (4.8%) (135). Concerning osteoarthritis, the ES decreased consistently 
from hand, to knee, to combined hip and knee and then to hip (118, 136). 
Moreover, considering the overall treatment efficacy as the sum of the specific 
component related to the active treatment plus the unspecific component due to the 
CFs, the impact of the CFs was measured in different conditions and interventions 
(137). Zou and colleagues showed that 75% of the overall treatment effect in 
osteoarthritis is attributable to contextual effects rather than the specific effect of 
treatments (116). In fibromyalgia, the 45% of the response of the active drug is 
attributable to contextual effect (129) and a relevant contextual effects was shown 
also in aspecific low back pain (138). Moreover, a recent meta-analysis on spinal 
manual therapies showed that in acute pain and chronic pain, respectively 81% and 
66% of the pain variance were ascribed to CFs (139). 
 
Which kind of CFs influence musculoskeletal pain conditions? 
Considering the patient’s perspective, expectations toward the therapy, patient’s 
treatment history and baseline pain severity are elements capable to predict the 
outcomes of different musculoskeletal pain treatments. 
	  Expectations of symptoms improvement can be activated by different CFs: for 
example, the simple act of administering a treatment, the exposure to a clinical 
setting, the verbal or non-verbal interaction with the physician are capable of 
triggering patient’s expectations. As demonstrated by different studies, boosting 
patient’s expectations toward the therapy significantly increased the chance of pain 
relief more than delivering a treatment without the expectation of any benefit (86, 90-
98, 109, 111, 112, 126, 140).  
Patient’s treatment history, that is the patient’s history of past positive or negative 
medical treatments, can influence the future response of the patient to new medical 
treatments. Previous positive experiences obtained by a specific therapy increase the 
likelihood of future positive experiences with the same therapy, while precedent 
negative outcomes associated to a particular intervention increase the probability of 
negative outcomes (99, 141).  
Higher pain intensity at baseline (99, 100, 118, 128, 129) and the presence of 
concomitant diseases and psychosocial elements such as depressions (99, 130) are 
associated with an augmented placebo analgesia and reduced nocebo hyperalgesia. 
Long-term dysfunction seems to respond less to placebo analgesia indicating that 
duration of complaints influence placebo analgesia (128, 132). 
From the provider’s perspective, clinician’s behavior, belief, verbal suggestions 
and therapeutic touch can strongly influence patients’ pain perception.  
A provider acting as competent, experienced, educated, professional, trustworthy, 
capable to indicate a diagnosis and prognosis, and to monitor patient with follow up, 
can moderate pain with his behavior (38, 114, 115, 120, 142). Aligning his/her beliefs 
with patient’s beliefs, a clinician could modulate pain. Indeed, it was demonstrated 
that the healthcare provider’s point of view concerning the clinical pathway, the 
	  therapy and the prognosis influence patient’s pain (38, 101-103, 107, 114, 115, 143, 
144).  Informing the patient that a potent treatment has been delivered enhanced the 
analgesic effect of the treatment, conversely verbal suggestion concerning the 
threatening effect of the therapy can compromise the effectiveness of the treatment 
creating nocebo hyperalgesic effects (108, 121, 122, 141, 145, 146). Non-verbal 
communication has powerful effects as well. For example, the use of therapeutic 
touch can positively influence patient’s pain (105, 123, 124, 131, 147, 148). 
Finally, considering the patient-physician relationship, it appears that a positive 
therapeutic encounter between patient and clinicians can lead to additional clinical 
benefits. Indeed, an enhanced empathetic interaction comprehensive of therapeutic 
alliance, active listening, extra time spent with patient, more face-to-face visit, 
warmth, attention, care, encouragement and support significantly reduced pain more 
than the same therapy performed with neutral therapeutic interaction	   (87, 88, 100, 
104, 145, 149, 150). Moreover, a patient-centered approach can increase the 
effectiveness of the therapy. Indeed, the patient’s involvement in the global process of 
care has been shown to modulate pain (106, 125). The strategy to favor the social 
learning between patients by the observation of other’s pain improvement or 
reduction is capable to affect the observers’ symptomatology (151, 152). 
Also the way by which the therapy is administered can influence pain 
perception. The adoption of an overt paradigm that enhances patient’s knowledge of 
being treated modulates the therapeutic outcome (110): a significant pain reduction 
was observed after the execution of an exercise in an environment that allowed 
patients to visualize their body (89). Also the posology of intervention has an effect as 
CFs: the placebo effect is higher when therapies are more frequent and repeated a 
therapy is delivered (e.g. two or more times vs one time) (118). The choice of the 
	  modality of treatment administration can be crucial to modulate patient’s pain. In 
general, the higher is the invasiveness of treatment (e.g. acupuncture, dry needling, 
injection, surgery), the better is the reduction of pain (116, 118, 119, 153, 154). 
Moreover, parenteral or subcutaneous administrations (e.g. topical) are more efficient 
than oral administrations (115, 116, 119).  
Even the marketing features of treatment should be taken into account. Branded 
therapy seems to be more effective than unbranded therapy (114, 115). High prize 
medication produced better pain relief then discounted medication, therapy considered 
as “new” improved pain more than “usual” therapy (114, 115). The more complex is 
the procedure including therapeutic rituals, mysterious powers, high technology the 
larger the placebo effect (114, 115).  
Lastly, the health care setting, in terms of environment, architecture and interior 
design should not be overlooked. The use of facilities where evidence-based design 
such as furnishing, colors, artwork, light, outside views, temperature, soothing sound 
and music were adopted, positively impacts on patient’s pain creating a proper 
healing setting (127, 155-157). 
  
Clinical applications and translational research  
Is it time to implement CFs in our clinical reasoning? 
The clinical reasoning adopted by clinicians in musculoskeletal conditions 
represents a complex procedure that encompasses different dimensions of pain 
experience in a bio-psycho-social framework (158). Indeed, this multi-factorials 
thinking process considered biomedical (e.g. tissue pathology, disease), psychological 
and social elements (e.g. experience of disability, patient’s belief, values and 
perspective) to obtain more complete analyses of the patient’s dysfunction (159). The 
	  role and the impact of CFs should be integrated in the clinical reasoning to increase 
the number of treatment solutions, boosts their efficacy and improve the quality of the 
decision-making (33). Based on the evidence available, some considerations can be 
drawn to guide a more conscious use of CFs as activators of placebo analgesia and 
avoiders of nocebo hyperalgesia. 
Considering the global process of care, clinicians should be aware that the 
overall therapeutic outcome is determined by the suitability of the therapy adopted 
(“what we do”) and by how it is delivered (“how we do”) (33). In this perspective, 
every musculoskeletal pain treatment is composed by a specific component and by a 
contextual component (34). These components represent the two faces of the same 
coin and are capable of influencing pain at multiple levels of the central nervous 
system (160). The use of the best evidence-based therapy is unquestionable, but 
clinicians should not forget the role of the CFs, as the context surrounding the specific 
treatment is capable of generating placebo or nocebo responses and modifying the 
therapeutic trajectory towards a positive or a negative direction (42). 
Because it is a fact that placebo (161-163) and nocebo (164) effects are always 
present in routine clinical practice and can be triggered by CFs (33), clinicians should 
be able to use them to optimize the results and reduce failures. Indeed, there are clear 
evidence that, when placebo was purposely searched as a mechanism, the effect size 
was about five times greater (Cohen’s d ranging from 0.95 to 1.14) (161-163) than 
when placebo was used as a control condition (Cohen’s d ranging from 0.15 to 0.27) 
(165-167). Moreover, clinicians should combine at the same time different CFs to 
obtain a larger placebo effect and minimize the nocebo effects. Some studies 
demonstrated that a lower effect size is present when using verbal suggestions alone 
(placebo - Cohen’s d = 0.85; nocebo - Cohen’s d = 0.65), while a higher effect size 
	  was observed adopting a combination of verbal suggestions and conditioning 
procedures (placebo - Cohen’s d = 1.45; nocebo - Cohen’s d = 1.07) (161, 164). 
Since placebo effects are learning phenomenon (9), during the history taking, 
clinicians should assess the patient’s previous experience, expectations and beliefs 
giving the patient adequate time to tell his/her story (50, 168, 169) (Fig. 2).  
Previous successful and unsuccessful experiences of a specific treatment are capable 
to influence the therapeutic outcome (170). In order to plan a therapeutic intervention, 
it’s important to question about past memories of analgesic and hyperalgesic 
responses concerning a treatment; reinforcing the positive experiences and 
devaluating the negative ones (7, 169, 171-173). For example, if a patient had a 
previous negative experience with a specific treatment, clinician should avoid 
adopting it. On the contrary, if a patient experienced a positive outcome with a 
treatment, the use of the very same treatment is recommended in order to “activate” 
the patient’s positive memory of the previous treatment.  
Since patients’ expectations about the therapeutic benefit influence the 
effectiveness of the treatment, a clear assessment of patients’ expectations toward the 
therapy is crucial. In particular, it is crucial to identify patients with low expectations 
in order to work with them with the aim of improving their belief (174). Different 
scale and semi-standardized questionnaires have been proposed to assess patient’s 
expectations. For example, Younger et al. developed a tool for measuring patient 
outcome expectancy. The authors found that the final six-item scales, made of two 
subscales (positive expectancy and negative expectancy), predicted a significant 
amount of outcome variance in patients receiving surgical and pain intervention (175). 
Moreover, clinicians should monitor patient’s belief concerning musculoskeletal 
conditions, therapeutic action, prognosis and ask questions about the meaning they 
	  attribute to symptoms (169, 172, 176-178). In these times of important expansion of 
healthcare information delivering by Internet, social media and television it is crucial 
to avoid the misinformation (7). The discussion with the patients can help the 
clinician to guide them to evidence-based information and avoid that they refer to 
unproven or fake information (176). Also, asking systematically the patients to 
summarize the information provided can prevent negative misunderstandings about 
their complaints (169, 173, 176, 178). 
In the waiting, examination, therapeutic and follow-up phases, the social 
interaction between patients (179, 180), the therapeutic ritual (181, 182) and the 
awareness of the ongoing procedure (42, 43) are fundamental elements to consider. 
While waiting for healthcare encounter, a pleasant and peaceful environment, 
employing professional, friendly and helpful support staff can help patients to feel 
comfortable (169). In waiting rooms, clinicians should reduce the social contagion of 
negative emotions preventing the patient’s interaction and/or observation of another 
patient experiencing a negative outcome (e.g. increased pain) (7, 183). Instead, they 
should promote the social interaction favoring observation of the positive effects of 
the therapy (e.g reduction of pain) also using video clips showing patients coping well 
with painful condition (50, 176, 179, 180) (Fig. 3). 
Before starting the treatment clinicians should read records, thoroughly examine 
the patients, provide a confident diagnosis and propose, when available, different 
treatment options encouraging the patient’s involvement in the choice of therapy and 
treatment goals (169, 171, 184-186).  
During treatment it is useful to avoid unintentional “hidden administration” of 
therapy (173). Thus, it is crucial to focus the patient’s attention to all the salient 
sensory elements presented in the therapeutic arena in order to increase the contextual 
	  power of the therapy (169). These elements are: the healthcare environment (e.g. 
light, color, design of the room), the physical features of the therapy (e.g. shape, size, 
colour, smell and taste) and the technological features of the device (e.g. novelty, 
price, invasiveness) (50, 169-173, 187) (Fig. 4). 
After the treatment, it is valuable to assess the therapeutic outcome and give to 
patient a feedback on the clinical course in order to maximize the treatment 
adherence, encouraging the self-managing of the condition (50, 169). 
The clinician’s not-verbal and verbal communication represent important 
element of the overall clinical interaction (33). Clinicians should prepare themselves 
mentally and physically for the clinical encounter (38), acting as experts in their field 
(169, 172). It is crucial to effectively inform about the efficacy of a specific treatment 
(169, 172), considering that beliefs and behaviors could influence patients’ attitudes 
in a positive or negative way (7, 169). It is suitable to individualize consultation style 
according to the patient’s preference opting for a personal interaction and seeking for 
a warm, authentic and empathic style, limiting technical contacts to the minimum 
(169, 171, 172, 176, 188-190). 
Also, the content of the message (what), the modality of delivering (how) and 
the time of communication (when) represent a great clinical enigma (191) and should 
be taken into account. It is recommended to enhance the positive expectation toward 
the treatment and limit the emphasis on contraindications, tell patients about side 
effects, but associated with positive clinical outcome. Side effects of treatment should 
be presented in form of probability instead of a mere list and during the informed 
consent process positive and negative information should be balanced (7, 50, 169, 
172, 173, 176, 180, 183, 191, 192).  
 
	  What is the concern about ethics? 
The adoption of placebo strategies seems to be common practice in clinical 
routine among healthcare providers (193). In musculoskeletal field, orthopedics 
surgeon, rheumatology physicians and nurses thought that placebo effects are real, 
have therapeutic benefits, and are permissible within the ethical borders (194-196). 
Patients with chronic musculoskeletal pain and rheumatologic complaints know what 
placebo effects are, consider placebo treatments acceptable when adopted as 
complementary/adjunct treatments and when no other established treatments are 
available. However, they present a lack of understanding of nocebo effects (196-198). 
Scientific community is still focusing the debate on the possibility of a transparent 
disclosure to patients of placebo treatments (199-202). The current researches suggest 
the possibility to openly prescribe sham medication or sham physical treatments with 
advanced prior consent (169). Thus, when available the choice of the best evidence-
based therapy is mandatory and a patient must be informed about the use of a placebo 
intervention with an amount of disclosure sufficient to avoid deception (201, 203, 
204). Although it is common thought that revealing the use of a placebo inhibits its 
effect, different studies point out the efficacy of placebo interventions also in “open 
label” conditions where the use of a placebo was disclosed in patients with chronic 
low back pain (205, 206). From a clinical perspective, the mindful manipulation of 
CFs represents a useful opportunity to enrich a well-established therapy that have 
different ethical implication in comparison with the replacement of real treatment 
with a potentially ineffective treatment (200).   
 
Is there a place for a translational research on CFs? 
	  There is a strong need of research studies on CFs close to routine and real-world 
clinical practice (49, 207) in order to underline the uncertainty of therapy action (208) 
and help clinicians to implement knowledge in daily practice. 
The research community should investigate the effect of the different CFs on 
therapeutic outcome, instead of minimizing or labeling them exclusively as 
confounders (209, 210). The search for a good placebo control in musculoskeletal 
pain field (e.g. physical therapy) represents an unresolved challenge (211, 212).  
Indeed, medical treatments are generally more complex than the mere administration 
of a drug, involving multiple treatment components that interact with each other and 
that are difficult to separate (e.g. verbal instruction and education, patient-therapist 
contact, physical action by the patient or therapist, and sensory feedback) leading to 
biased estimates of treatment effect (213). 
In clinical trial there is a urge to measure patient’s expectation before, during, 
and after the treatment (214) evaluating by standardized and validated scale all the 
dimensions of expectation (optimism, pain catastrophizing, hope, trust, worry and 
neuroticism) (215, 216). Also measuring the impact of CFs from the patient’s 
perspective represents a desirable outcome to be implemented in the future researches. 
Recently, a new item banks (Healing Encounters and Attitudes Lists - HEAL) was 
proposed as suitable for measuring CFs of the treatment and present promising 
evidence of predictive and concurrent validity (217). 
Despite CFs play a key role in pain (20, 21), there is a still paucity of 
knowledge on their effects in different musculoskeletal diseases, in young and old 
participants (218-220), in acute and chronic conditions (141), in different pain 
mechanism such as nociceptive, neuropathic, central sensitization (221). It is of 
paramount importance to try to identify psychological, neuroendocrine or genetic 
	  elements that predict the responsiveness to specific CFs (50). Finally, the use of meta- 
analysis may help to estimate the effects of the CFs (222). 
 
Limitations 
This debate presents some limitations. The framework adopted (17, 33) for 
reviewing the role of the CFs was not preliminarily validated for its specific 
consistency in the musculoskeletal field and some factors are not related exclusively 
to musculoskeletal pain literature but refer to pain in general. Examples of primary 
studies and data offered to sustain each factors of the model were not selected by 
adopting a systematic review approach and not criticized in depth, given that the main 
goal was to propose a short synopsis. CFs have been categorized into a conceptual 
framework by describing each factor involved, therefore interpretations about the 
relationships between factors and placebo/nocebo effects need additional critical 
analysis and discussion. 
 
Conclusion 
This debate points to a conscious use of the CFs, as supplementary therapeutic 
strategy for pain management capable to improve analgesia and prevent hyperalgesia. 
The good news is that pain perception can be positively influenced by an honest and 
aware use of CFs. The bad news is related to the complexity of the phenomenon, to a 
certain degree of uncertainty in the individual response and to a risk of patient’s 
deception associated with their use. Nevertheless, clinicians have already enough 
comprehensive scientific information that allows them to choose the correct behavior 
wisely and adjust the CFs of the therapeutic setting in an evidence-based and ethically 
respectful perspective. We think that time has come for clinicians to manage 
	  conscientiously and ethically the CFs to enhance the placebo and avoid nocebo effects 
for the benefit of their patients. 
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!Figure 1. Psycho-neurobiological mechanism of CFs. 
 
The image displays how CFs are capable to influence the brain networks, neurochemistry and 
therapeutic outcome. The principal neural areas and neurotransmitters involved in placebo and nocebo 
effects are reported. 
Abbreviation: rACC = Rostral Anterior Cingulate Cortex; DLPFC = Dorsolateral prefrontal cortex; 






!Figure 2. Influencers of decision-making process. 
 
The image presents: a) the clinical situation in which meeting patient’s expectation, previous 
experience and beliefs creates positive therapeutic outcomes; b) the clinical situation in which ignoring 
patient’s expectation, previous experience and beliefs creates negative therapeutic outcomes  
 
 
Figure 3. Social interaction and learning. 
The image displays: a) a positive social interaction between patients in waiting room capable to produce positive therapeutic outcome; b) a negative social interaction 
between patients in waiting room capable to produce negative therapeutic outcome. 
Figure 4. Therapeutic rituals and overt therapeutic administration. 
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The determinants of patients’ satisfaction in outpatient 
musculoskeletal physiotherapy: a systematic review with a 
metasummary and metasynthesis 
Abstract 
Purpose: To identify and synthesize patient-identified factors that influence satisfaction 
with outpatient musculoskeletal physiotherapy (O-MSK). 
Methods: A systematic literature search was conducted using six electronic databases: 
CINAHL, Embase, MEDLINE, Scopus, Web of Science, Wiley Online Library from 
inception to March 2017. Additional articles were identified using a “berry-picking” 
method. Search limits were: primary studies; English language, human subject. 
Qualitative peer reviewed articles describing patient satisfaction in O-MSK were 
selected for inclusion. After a process of exclusion, 11 publications were included in the 
synthesis. Two reviewers critically appraised studies independently using the Critical 
Appraisal of Skills Program (CASP) tool for qualitative studies. All text identified in 
the findings sections of the selected studies were extracted verbatim for analysis using a 
purpose-designed form.  
Results: Extracted data were synthesized using the metasummary and metasynthesis 
approach. Factors influencing patient satisfaction were grouped into six broad themes: 
1) clinical outcome; 2) physiotherapist features; 3) patient features; 4) physiotherapist-
patient relationship; 5) treatment features and 6) healthcare setting features. 
Conclusions: These findings suggest that patient satisfaction towards O-MSK is a 
multidimensional construct influenced by individual patient/provider, clinical and 





Within healthcare, there is an increased emphasis on identifying and 
understanding patient-reported outcomes (PRO) (1). PRO are important because they 
offer constructs capable of depicting the patient’s health status (2). In order to identify 
PRO, and then subsequently deliver patient-centered care, it is essential to gather 
information directly from patients or the users of health care services. The inclusion of 
patient perspectives is aimed at better understanding structures, processes and outcomes 
of care based upon their personal experiences within the system (3). Within this process 
of identifying PRO, patient satisfaction has been considered a milestone to be examined 
due to its adequateness of measure the quality of care (4). 
Patient satisfaction represents a complex, implicit, subjective and 
multidimensional construct (5). It involves cognitive, affective and emotional processes 
(5) through which the patient evaluates the congruence between the actual healthcare 
experience and his/her needs, values, desires and expectations (6). The higher the 
congruence between the actual experience and the patient’s expectations, the greater 
reported level of patient satisfaction (7). Overall, various factors contribute to patient 
satisfaction including technical and interpersonal care, the physical environment, the 
access of care, organizational features, the continuity of care and the clinical outcomes 
(8-12).  
At multiple levels, stakeholders, organizations and governments have adopted 
patient satisfaction as a proxy of care appropriateness, efficacy, quality and feasibility 
(1, 13). This proxy helps to identify problems, to improve quality of healthcare services, 
to ameliorate health professionals’ behaviors, to define appropriate policies and to 
allocate resources (4, 14). Satisfaction enhances also the attractiveness of a healthcare 
	  	  
service, guiding the patient to choose, return and recommend it and to improve the 
compliance towards treatment and follow-up (15, 16).  
Patient satisfaction (17) and their perceptions of their health care experiences (18, 
19) have been identified as a health service research priority (20) among inpatient and 
outpatient rehabilitation settings (21). Specifically, the outpatient musculoskeletal 
physiotherapy (O-MSK) represents an ideal setting for patient satisfaction research (6). 
O-MSK is an increasingly used service capable of responding faster to the patient’s 
health needs thus reducing costs within the public health system (22). O-MSK differs 
from inpatient physiotherapy among a variety of constructs including the 
musculoskeletal disorders addressed, patients’ expectations, recovery times and 
treatment goals (23). Generally O-MSK patients are exclusively managed by a 
physiotherapist and, therefore, their evaluations of the received care can directly be 
attributable to the physiotherapy instead of to other healthcare interventions (6).  
A systematic review with meta-analysis revealed that the level of satisfaction with 
O-MSK was high with a pooled estimate of 4.44 (95% confidence interval = 4.41– 
4.46) on a scale of 1 (very dissatisfied) to 5 (very satisfied) (17). This review is a decade 
old, included only studies until 2009 by searching three databases; although some 
qualitative findings were reported by identifying the physiotherapist’s interpersonal 
attributes and the process of care as key determinants of patient satisfaction, these were 
not synthetized through a declared method of analysis. Therefore, there is a need to 
advance the synthesis of the knowledge available in the field and more comprehensively 
understand the concept of patient satisfaction in O-MSK focussing only on data 
collected through qualitative methods, such as in-depth, semi-structured interviews. 
This type of qualitative data allows for a holistic understanding of specific patient 
	  	  
perceptions and experiences that is not typically expressed when satisfaction is 
measured with surveys based upon quantitative methods (24, 25). 
Therefore, the aim of qualitative metasummary and metasynthesis is to identify 
the determinants of patient satisfaction with O-MSK. This approach is commonly used 
to understand experiences of healthcare and has been documented of being used to 
specifically explore services to address musculoskeletal issues (26, 27). It represents an 
adequate design for the interpretation of findings across multiple studies enhancing our 
understanding of the phenomenon of interest (28), it provides a mechanism to 
understand from the service user’s perspective the factors that contribute to patient 
satisfaction (21), and findings from metasynthesis are then better positioned to inform 
policies that offer direction for clinical practice (29).  
 
Materials and methods 
Design 
A systematic, qualitative metasummary and metasynthesis was performed using 
the methods outlined by Sandelowsky and Barroso (30) which include: 1) developing 
the research question, 2) searching and extracting systematically studies to be analyzed, 
3) appraising the quality of the studies retrieved, 4) classifying the studies that emerged 
and 5) synthesizing data into metasummary and metasynthesis (30). A metasummary 
refers to the quantitative summation of qualitative research findings, while a 
metasynthesis involves the integration of the qualitative results through a new 
interpretation of findings (31). This systematic qualitative synthesis was registered in 
the Prospero database (CRD42016049124) in November 2016 and it is reported here in 
accordance with the Preferred Reporting Items for Systematic Reviews and Meta-
	  	  
Analyses (PRISMA) statement (32) and with the Enhancing transparency in reporting 
the synthesis of qualitative research (ENTREQ) (33). 
 
Research question and systematic search 
The research question established was: “What are the determinants of patient 
satisfaction towards O-MSK?” A pre-planned search was performed in six electronic 
databases (CINAHL, Embase, MEDLINE -via PUBMED-, Scopus, Web of Science, 
Wiley Online Library) from inception until March 2017. Study limitations applied to the 
search included searching only for studies published in the English language, included 
human subjects and primary studies. The search strategies adopted are reported in 
Appendix 1. The keywords used were: patient satisfaction, outpatient setting, and 
physiotherapy treatment. A combination of free text terms and thesaurus or subject 
headings was adopted due to challenges with methodological indexing of qualitative 
research (34). As suggested by Sandelowsky and Barroso (35), a “berry-picking” 
method was used to ensure a comprehensive search and location of published 
qualitative studies that met our inclusion criteria including: footnote chasing, citation 
searching, hand searching, journal run, author searching and fugitive literature (e.g 
Master’s theses and doctoral dissertations). A medical library health information 
specialist was consulted throughout the systematic search of the databases (36).  
 
Eligibility criteria and study selection 
The eligibility criteria for study inclusion in the synthesis included: 1) study used 
a qualitative design or a mixed methods design where the qualitative and quantitative 
data analyses were conducted and presented separately; 2) included study participants 
>18 years of age, 3) presenting with musculoskeletal complaints, 3) who received 
	  	  
physiotherapy treatment in an outpatient service; and 4) where the authors examined 
factors related to patient satisfaction. Studies were excluded if they were: 1) quantitative 
in nature or a mixed-method study that did not separate the qualitative and quantitative 
data analysis; 2) included patients with a specific diagnosis of pain not attributed to 
musculoskeletal complaints; 3) performed a treatment not delivered by a 
physiotherapist, and 4) treated in an inpatient service setting. Two authors (TL, SG) 
independently reviewed the articles. Titles, abstracts and then the full text of all articles 
(manuscript, figures and tables) were screened using Sandelowsky and Barroso’s 
reading guide (37). When both reviewers individually agreed, a study was included. In 
case of uncertain eligibility, any disagreement was resolved through a discussion with 
the research group. 
 
Critical appraisal 
Despite debate (38-40) around the value and need to critically appraise qualitative 
studies included in a metasynthesis, and the lack of recommendations around the most 
appropriate tools for appraising qualitative studies, our research team made the decision 
to appraise all included studies with a goal to provide commentary on the overall quality 
of the qualitative evidence conducted in this field. However, overall quality of the 
individual studies was not used as a criteria for inclusion or exclusion within this review 
(36). The Critical Appraisal Screening Programme (CASP) tool for appraising 
qualitative research was used (41), due to its extensive adoption in other systematic 
reviews in musculoskeletal field (26, 42). The CASP is a 10-question tool useful to 
examine: the aim of research, the appropriateness of qualitative methodology, the 
research design, the recruitment strategy, the data collection, the researcher and 
participant relationship, the research ethics, the data analysis, the findings, and the 
	  	  
contribution to knowledge. Each item was scored as “yes” (Y) or “no” (N), depending 
on whether the topic was described sufficiently. An additional score of “Unclear” (U) 
was added to differentiate between sufficiently and insufficiently (43). This resulted in 3 
options: 1, 1/2, and 0 (43). The higher the total score, the better the methodological 
quality was, with a maximum score of 10. Because the CASP does not offer a scoring 
matrix for the overall method rating, we decided a priori to identify cut-off point for 
low (CASP 0-5), medium (CASP 6-8) and high levels of quality (CASP 9-10). Two 
authors (GR, SJ) determined the quality of the studies independently, with any 
disagreements resolved by consensus and consultation with a research group.  
 
Data extraction and study classification 
Data extraction was performed by using a purpose-designed form by one author 
(DR); the form was populated and cross-checked by another author (MT) (26, 27). 
Extracted data included: description of the setting, study population, sample size, 
gender and age, aims of the study, methods of data collection and analysis and key 
findings about patient satisfaction. The research group overcame any disagreement 
between the two researchers. Moreover, we classified the findings of the included 
studies based upon the degree of researcher transformation of the raw data, thus to guide 
the subsequent analysis and synthesis of findings (36). The classification system 
included: thematic surveys (e.g. latent pattern of themes discerned from data), 
conceptual/thematic descriptions (e.g. concepts or themes developed in situ), or 
interpretive explanations (e.g. fully integrated explanations of phenomenon) (44).  
 
Data analysis and synthesis 
	  	  
Three independent authors (TL, GR, AP), through an inductive approach 
performed the analysis of the included studies, following these steps simultaneously 
rather than subsequently (30): 1) the articles were read multiple times, line-by-line to 
obtain an idea of the topics; 2) the target findings of each report were extracted from the 
“Result” section and separated from not-relevant data; then copied and pasted into a 
Microsoft Word (Microsoft Corp, Redmond, Washington) document; 3) the findings 
were edited to make them as accessible as possible to any reader and to ensure that the 
original wording was captured and to preserve the authors’ original intentions; 4) 
similar findings were grouped according to their topical similarity to determine, when 
compared, if findings across studies confirm, extend, or refute findings with the dataset; 
5) the grouped findings were abstracted by elimination of redundancies, refinement of 
statements and preservation of contradictions and ambiguities; 6) the final findings were 
coded through a highly iterative and collaborative process and reduced into categories 
and themes, then findings were evaluated for similarities and differences within and 
between studies and synthetizes using a constant target comparison; 7) the manifest 
inter-study frequency effect sizes (e.g. prevalence rate of findings) and intra-study 
intensity effect sizes (e.g. concentration of findings in each report) were then calculated 
(45).  
 
Validity, rigor and trustworthiness of metasynthesis 
The validity, rigor and trustworthiness of this metasynthesis was ensured by 
several strategies (30). A multidisciplinary panel of experts were involved. Authors 
were clinicians and academic researchers with a range of different professional 
backgrounds and experiences evaluating qualitative research (physiotherapy, nursing 
and marketing). This strategy helps to continually scrutinize and criticize the study 
	  	  
procedures and outcomes (30). Moreover, an audit trail was adopted to document every 
phase of the project, the rationale behind the choice, adoption, creation or leaving of 
specific strategies (46). This solution helped to enhance the transparency of reporting 
and reflexivity process of the panel (47). Finally, a debriefing session and a negotiated 
process to achieve consensual validity was performed (48). Authors discussed their 
methodological choices, data analysis, procedures and interpretations by using a “think 





The search resulted in 21,972 records. After the removal of duplicates, 20,068 
records remained. Once the study inclusion and exclusion criteria were applied to a 
reading of titles of abstracts, 19,537 studies were eliminated. Out of the remaining 531-
screened articles, 69 were considered potentially relevant and the full texts were 
retrieved. Then, 58 studies were excluded as reported in appendix 2. Finally, 11 articles 
(50-60) describing findings from 9 unique studies were included in the qualitative 
metasynthesis. Two of the studies each produced two unique articles (53, 54, 56, 57), 
presenting findings on the same samples yet for different study objectives. The selection 
process is shown in figure 1.  
 
Characteristic of the studies 
A total of 362 participants (169 males; 193 females) were included in the studies 
ranging from 10 (60) to 57 (52, 56, 57) per study, with a range of age between 18 (51) 
and 82 (53, 54, 60) years. Globally, patients presented non-specific low back pain (50, 
	  	  
51, 55, 59), or not specified musculoskeletal complaints (52-54, 56-58, 60). Two studies 
analyzed acute and chronically ill patients (53, 54), two investigated chronic conditions 
(51, 59), two focused on post-acute care (52, 57), one on a non-acute condition (60), 
and the remaining studies did  not clarify the condition type (50, 55, 56, 58).  
The included studies were informed by a range of qualitative designs which 
included thematic surveys (54, 58, 60), conceptual/thematic description (50, 52, 55-57) 
and interpretive explanations (51, 53, 59). The data collection methods reported in the 
included papers were focus groups (52-54, 56, 59), semi-structured interviews (51, 55), 
focus groups and semi-structured interviews (50, 57, 60), and the nominal group 
technique (58). Clinical outpatient settings were located in Spain (52, 56, 57), Australia 
(58-60), England (53-55), Scotland (51) and Egypt (50). A summary of the data is 
reported in table 1.  
 
Quality appraisal 
Using the CASP tool for the appraisal of qualitative studies, all of the included 
studies (50-60) were satisfactory with regards to the items: 1 (Clear research statement), 
2 (Qualitative methodology), 7 (Ethical considerations), 9 (Clear statement of findings) 
and 10 (Value of the research). Globally, item 3 (Research question appropriate) was 
considered as “Unclear” in all the studies. The assessment “No” was presented in nine 
studies (51-59) for item 6 (Relationship researcher-participants described adequately) 
and in one study (50) for item 5 (Data collection). Three studies (53, 54, 59) considered 
the item 8 (Data analysis) as “Unclear”. Item 4 (Recruitment strategy) was appraised as 
“No” in two studies (55, 59) and as “Unclear” in one study (58). The overall quality 
appraisal (table 2) ranged from 7 to 9.5 with a mean of 8.2. Only one study (60) was 




The metasummary and metasynthesis processes of included studies (appendix 3) 
resulted in 123 statements, 66 codes, which were condensed in 13 categories and lastly 
systematized into 6 themes: 1) clinical outcome; 2) physiotherapist features; 3) patient 
features; 4) physiotherapist-patient relationship; 5) treatment features and 6) healthcare 
setting features (figure 2).  
The most frequent categories were: organization of care (82%), education (82%) 
and attitude of the physiotherapist (73%). The studies of Ali & May (69%) (50), Cooper 
et al. (69%) (51) and Hills & Kitchen (64%) (53, 54) reported the highest level of 
intensity, while Del Baño-Aledo et al. (52) and Medina-Mirapeix et al. (57) revealed the 
lowest (23%) (table 3).  
 
Theme 1: Clinical outcome 
Result of treatment 
For some patients the desired outcomes were complete recovery and the control of 
pain (50, 53). For others, it was important to develop and learn helpful coping strategies 
for the self-management of the problem over the long-term (50, 54, 55). In general, 
patients were satisfied by any effective therapy capable of achieving their desired 
outcome(s) (50, 54). Moreover, the presenting clinical conditions were reported to 
influence the desired outcome (53). Patients with an acute injury identified the 
following as factors influencing satisfaction: the continuity of treatment and the 
progressive improvement of daily activities between physiotherapy sessions, compared 
to patients with a chronic complaint/injury who were satisfied from an improvement in 
range of motion or pain relief (54).  
	  	  
 
Theme 2: Physiotherapist features 
Attitude 
In general, patients described high levels of satisfaction in working with 
physiotherapists who had the following aptitudes: friendly, respectful, confident, clean, 
and capable of creating a pleasant and welcoming environment in clinical practice (50-
53, 55, 58). Moreover, patients appreciated an empathetic, good listener, as well as a 
physiotherapist who expressed a genuine interest in the patient’s concerns and disease 
(50-52, 54, 55, 58, 60). They valued engaging with physiotherapists who were non-
judgmental, not egoistical, and who provided emotional support during the 
rehabilitation process (52, 58). Within two of the studies, participants also identified 
valuing physiotherapists who demonstrated sensitivity to patients’ functional and 
emotional status changes, who were capable of identifying patient-specific 
modifications and then who could quickly revise the plan of care to adopt new 
therapeutic strategies tailored to patient needs (52, 55).  
 
Professionalism 
Overall, patients appreciated competent and skilled physiotherapists who were 
knowledgeable on the most effective treatment, aware of current best practices and 
capable of prioritizing the patient’s needs and identifying the most appropriate therapies 
for each individual patient (50-52, 55, 58). Furthermore, patients desired a 
physiotherapist who used detailed notes, who was reliable, punctual and who 
demonstrated strong organizational abilities (58). They further appreciated 
physiotherapists who demonstrated the capacity to work as a part of a larger inter-
disciplinary health care team, those who were able to establish and maintain 
	  	  
professional-client boundaries during the rehabilitation sessions and those who treated 
the patient as an individual (50, 58). Moreover, patients were satisfied with 
physiotherapists who were passionate about their work, honest and aware of their limits 
(50, 58).  
 
Gender 
Physiotherapist’s gender was reported as impacting patient satisfaction only in 
Egyptian patients (50). These patients felt comfortable with physiotherapists of the 
same gender, but if there was the opportunity to be treated by an expert physiotherapist, 
they preferred a more competent provider from the opposite gender rather than a less 
experienced colleague of the same gender (50). 
 
Theme 3: Patient features 
Expectations 
The assessment of patients’ expectations represented a key factor of satisfaction 
towards O-MSK (51). These expectations were frequently established based upon the 
nature of the information shared by the referring physician (60), patients’ previous 
positive or negative experiences with physiotherapy and their presenting clinical 
condition (53). Indeed, patient satisfaction arose when physiotherapists were able to 
meet patients’ expectations formed by the referring physician (60). The symptom relief, 
the adequate education on management and prognosis of patients’ disorder, and 
previous positive treatment experiences, were all elements capable of modifying 
patients’ expectations, especially when they were unrealistic to more realistic ones (54). 
Acute patients usually were naïve of physiotherapy and optimistic about a positive 
resolution of their problem, while chronic patients were not always optimistic because 
	  	  
they had previous experience with physiotherapy, and they were interested in the 
amount of problem reduction they could obtain (54). In general, patients were satisfied 
when their expectations to be helped were met or exceeded by the treatment (53). 
Sometimes patients’ expectations of recovery were excessive, but they could be 
modified during the course of treatment, thus influencing the outcome, through a careful 
explanation to the patients of their conditions and how to cope with the problem (50, 
54).  
 
Theme 4: Physiotherapist-patient relationship 
Communication 
Patients considered tailored communication that addressed specific, individual 
needs and feelings as an important dimension of satisfaction (51, 53, 54, 60). Effective 
communication requires adequate time spent with a patient, specific interpersonal 
communication skills including the ability to actively listen and be receptive to patient’s 
input, and being respectful of the patient’s point of view (51, 58, 59). Patients also 
appreciated non-verbal communication elements that contributed to the establishment of 
trust between the provider and the patient, including: open body language, direct eye 
contact and orientation of the provider’s body and face towards the patient (58). 
Moreover, they appreciated the use of verbal communication that provided adequate 
explanations, that included the use of language that accurately reflected the health 
condition, that was understandable to a lay person, as well as the encouragement of the 
patient’s participation in the communication process from both parties, and the use of 
simple and clear questions (51, 58, 60). 
 
Partnership of care 
	  	  
From the perception of the patients, one of the most important elements was the 
establishment of a therapeutic alliance with the physiotherapist, where the patient felt 
that the physiotherapist was genuinely engaged and viewed the patient as a partner in 
the care provision (56, 59). Specifically, patients appreciated when physiotherapists 
took the time to holistically learn about their patient, including the individual’s values, 
preferences and lifestyle and consider the patients’ experiences, abilities and life 
circumstances in developing a plan of care (51, 59). Ultimately, patients wanted to be 
respected as individuals (60). They expressed a need for mutuality and appreciated the 
development of symmetrical and consultative relationships that enhanced the patients’ 
sense of connection with care, their efforts in the care plan and the trust in their 
physiotherapist (51, 54, 56, 59, 60). 
 
Theme 5: Treatment features 
Education  
Education was considered as an influencer of satisfaction (50-52, 55, 59). 
Education was not a passive transmission of knowledge from physiotherapist to 
patients, but it represented an active process through which patients obtained a deeper 
understanding and reassurance about their dysfunction, thus influencing their mindset 
and increasing their self-management, motivation and responsibility in the long-term 
(50, 54, 55). Patients appreciated information received in the beginning of the treatment 
(52, 54), in form of accurate, understandable, free of jargon-free explanations (59) or 
charts, drawings, written information and models (55, 58, 59). They desired to know the 
cause of their problem (50, 52-54, 58, 59), and they appreciated getting anatomical and 
biomechanical explanations (50, 55). Patients were satisfied with specific advice on 
movement, position, ergonomics, activities of daily living to follow or avoid, and 
	  	  
information about the treatment plan, its rationale, positive effects and side-effects (50, 
53-56, 58). Moreover, they appreciated information regarding patients’ active role in the 
management of the dysfunction as well as regarding the prognosis of the condition, the 
long-term consequences and the limitations (50, 53, 55, 56). 
 
Organization of care 
Patients most appreciated a positive service organization that was conveniently 
located with easy access for injured or disabled individuals, flexible payment plans, 
precision in data management and the ability to schedule appointments through a simple 
booking system (50, 51, 53-55, 58). Also, patient satisfaction with the care delivery 
organization was increased when treatment session were scheduled so they started on 
time, when there was a short waiting list to access services, when they could directly 
access an appointment to manage a “flare-up,” a wait time not longer than 5-10 minutes, 
and the consistent offer of an appointment to follow up or contact to the service again if 
problems occurred (50, 51, 53-55, 57, 58, 60). Moreover, patients were pleased to be 
treated by the same physiotherapist in one-to-one individualized sessions and to be re-
evaluated by experienced physiotherapists (50, 51). A proper clinical contact time with 
a physiotherapist, an adequate amount of time spent with the physiotherapist and a 
reasonable frequency of sessions were elements identified to influence patient 
satisfaction (50, 51, 55, 57, 60). Moreover the absence of interruption, to be guided and 
supervised during manual therapy and exercises contributed to overall patient 
satisfaction (57). Also, when treatments were provided as a part of a multi-professional 
rehabilitation team, the consistency of information and care among providers, enhanced 




Patients appreciated a treatment derived from an adequate clinical evaluation and 
imaging view (51, 54). Some patients did not have a specific preference between 
passive (e.g. manual therapy, physical therapy modalities) or active (e.g. therapeutic 
exercises) treatment strategies (53), others gave great emphasis to exercise (51, 59). 
Exercise was considered an element of active self-help management and involvement 
(58), through which patients improved their feeling of empowerment, their knowledge 
of their body’s functioning and their response to pain and activities (59). To increase 
compliance with a prescribed treatment plan, patients appreciated receiving exercises 
tailored to their preferences and lifestyle (51, 58). Moreover, a physiotherapist’s 
flexibility in adapting treatment to patients’ functional needs (56), and the creation of an 
individual strategy of care seem to be important elements that ultimately increase 
patient satisfaction in O-MSK (51).  
 
Decision-making 
An individualized approach to decision-making about treatment represented the 
best strategy to increase patient satisfaction (51). Patients desired to be listened to, and 
asked about, their involvement in the plan of care through a democratic-participatory 
rather than a prescriptive process (50, 55, 56). Some patients expressed the desire to 
participate in the plan of treatment after the physiotherapist’s explanation about the 
importance of their input to develop a customized therapy for their needs (50). Others 
preferred that their physiotherapist did not seek collaboration or explicitly request it 
(56), thus it is important to consider and explore the patient’s expectations about his/her 
level of involvement in decision-making (51). Several patients preferred to not 
	  	  
participate or to delegate the choice to the expert physiotherapists, but every decision 
had to be explained and justified to patients during the process (50, 51).  
 
Theme 6: Healthcare setting 
Physical environment 
The physical environment where the treatment was provided was important for 
patient comfort and safety. Patients valued being treated in a facility where the office 
design and ambient conditions created a healing environment (50). It is essential to 
provide single or private rooms both for changing clothes and for the receipt of therapy 
(57). Moreover, the control of nonvisual aspects such as the temperature and the smell 
represented additional important elements related to overall satisfaction (57). 
 
Social context 
A social environment that facilitated positive interactions with other patients, 
especially during group therapy, increased patient satisfaction (57). This positive 
environment was perceived as motivational because patients could support each other in 
their efforts and share similar stories concerning their disability (57). 
 
Discussion 
Summary of evidence 
This metasummary and metasynthesis informed by 11 reports informed by 9 
primary qualitative studies offers a thorough understanding of patient-identified factors 
that influence satisfaction in O- MSK. The clinical outcome, patient and physiotherapist 
features, the treatment features, the patient and physiotherapist relationship, and the 
	  	  
healthcare setting were identified as overall determinants of patient satisfaction in O-
MSK.  
According to the contextual factors theory (61), findings from this review 
emphasize the multidimensionality of the phenomenon of patient satisfaction in 
physiotherapy and how clinical and contextual determinants both, inseparably, influence 
its manifestation. Indeed, improving the clinical outcome (e.g. range of motion) only 
(10, 11, 17) or meeting a singular contextual factor (51, 52, 55, 57) (e.g. healthcare 
setting) represents a useful condition, but it is not sufficient to completely reach patient 
satisfaction, thus indicating that the global outcome of therapeutic intervention is 
strongly linked to the interdependence between the different determinants of patient 
satisfaction (5). From a translational perspective, our review suggests to 
physiotherapists a conscious adoption of contextual factors during the administration of 
specific evidence-based physiotherapy treatment to improve the overall patient 
satisfaction in O-MSK (61). 
According to the findings, the active role of the patient in the process of care at 
multiple levels is strengthened as influencing the patient satisfaction (17). Indeed, 
considering the expectations of patients about what should occur during physiotherapy 
sessions is an important element of the clinical assessment in order to orient the 
treatment (62) and to meet patient satisfaction (9, 17). During the decision-making 
process, patients desired to be questioned to choose freely their direct involvement or 
delegation in the healthcare decision, thus highlighting the importance of a patient-
centered approach in O-MSK (10, 11, 63, 64). 
This systematic metasynthesis eta also confirmed the role of physiotherapist as a 
moderator of patient satisfaction (17). Patients were satisfied by different 
physiotherapist’s traits such as personality, leadership, competence, flexibility and 
	  	  
critical thinking, thus supporting the key role of the provider’s interpersonal (8-12) and 
technical care (8, 10, 11) in influencing patient satisfaction. Moreover, patient 
appreciated physiotherapist’s education and information (9, 10, 17, 63) as strategies for 
a better understanding of pain experience and modification of misleading behaviors 
(65).  
Our findings further corroborate the function of effective, efficient, well organized 
and coordinated O-MSK services as mediators of patient satisfaction (17). In 
accordance with previous systematic reviews (8-12), different elements of caring 
process such as continuity, accessibility, availability and affordability of the services 
were positively associated with patient satisfaction and contribute to increase their 
attractiveness and magnetism in the contemporary competitive healthcare context. 
Moving away from a previous systematic review in O-MSK (17), this qualitative 
metasummary and metasynthesis adds innovative findings. In only one study (50), we 
have found that physiotherapist’s gender can put the patient at ease differently, thus 
influencing patient satisfaction and patient’s engagement directly during the plan of care 
(66, 67). Moreover, our findings highlights the importance of the therapeutic alliance 
and the partnership of care (68, 69), the verbal and non-verbal elements of 
communication (8, 10, 70, 71) as determinants of patient satisfaction capable to affect 
the quality of interaction between physiotherapist and patient.  
Another interesting novel findings concerns patients’ desires to acquire coping 
strategies and self-treatment tools (e.g. therapeutic exercises) (72) to better manage their 
problems in daily life, thus strengthening their resilience and affecting their well-being 
(73). Moreover, this qualitative metasynthesis emphasizes the relevance of a pleasant 
atmosphere, room comfort, noise level, temperature and lighting as physical 
environmental determinants capable of influencing overall patient satisfaction (10). 
	  	  
Patients also valued the social context as a space that enhances supportive relationships 
between patients, offers an opportunity for reflection and increases the sharing of 
individual experiences (74). 
 
Strength and limitations 
To our knowledge, this is the first metasummary and metasynthesis that 
summarizes the determinants of patient satisfaction with O-MSK (30), thus responding 
to a recent call to action concerning the need for health service research in rehabilitation 
(20). Despite we have performed an extensive search in six databases using the “berry-
picking” method to improve the investigation (35), some relevant studies could be 
missed and publication bias could be occurred. This review obtained studies regarding 
patient satisfaction only in O-MSK reported in English, performed prevalently in 
Europe, therefore our findings cannot be generalized across patients with other health 
problems, in different settings (inpatient), in other continents with different cultural and 
language references (29). Moreover, the interpretation of findings may have been 
influenced by some of the authors’ experiences as physiotherapists. However, the 
methodological approach combining a multidisciplinary team of experts served to 
reduce this potential bias (30). Finally, during the critical appraisal process, we used the 
CASP tool (43) with a scoring matrix to classify the overall quality of the included 
papers. This a priori decision was made because no cut-off point systems were 
presented in the literature for the categorization of methodological quality of the studies 
(42). Overall the included papers reported a critical appraisal ranged from medium to 
high quality. We have also commented on all of the included CASP items thus 
identifying any possible weaknesses in the included study, including: the 
appropriateness of the research question; the description of the relationship between 
	  	  




This qualitative metasummary and metasynthesis contributes to extend the 
knowledge concerning patient satisfaction in O-MSK and identified this proxy as 
composed both by clinical and contextual factors. Policies of healthcare services should 
take in account patient satisfaction as a fundamental indicator of quality care, thus 
stimulating its assessment and analysis in clinical settings. Future qualitative research 
should investigate the relationships between the determinants of patient satisfaction and 
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Item 1. Was there a clear statement of the aims of the 
research? 
Y Y Y Y Y Y Y Y Y Y Y 
Item 2. Is a qualitative methodology appropriate? Y Y Y Y Y Y Y Y Y Y Y 
Item 3. Was the research design appropriate to address 
the aims of the research? 
U U U U U U U U U U U 
Item 4. Was the recruitment strategy appropriate to the 
aims of the research? 
Y Y Y Y Y N Y Y U N Y 
Item 5. Was the data collected in a way that addressed 
the research issue? 
N Y Y Y Y Y Y Y Y Y Y 
	  	  
Item 6. Has the relationship between researcher and 
participants been adequately considered? 
Y N N N N N N N N N Y 
Item 7. Have ethical issues been taken into 
consideration? 
Y Y Y Y Y Y Y Y Y Y Y 
Item 8. Was the data analysis sufficiently rigorous? Y Y Y U U Y Y Y Y U Y 
Item 9. Is there a clear statement of findings? Y Y Y Y Y Y Y Y Y Y Y 
Item 10. How valuable is the research? Y Y Y Y Y Y Y Y Y Y Y 
Overall score 8.5 8.5 8.5 8 8 7.5 8.5 8.5 8 7 9.5 
Legend: 
Y = yes; N = No; U = Unclear.
	  	  
Table 3. Metasummary. 




























































































































































Attitude  X X X X X X   X  X 73% 
Professionalism X X X X  X   X   54% 














Communication  X  X X    X X X 54% 
Partnership of 
care 
 X   X  X   X X 45% 
 
TREATMENT FEATURE 
       
Education X X X X X X X  X X  82% 
Organization of 
care 
X X  X X X X X X  X 82% 
Typology  X  X X  X  X X  54% 
Decision 
making 












X       X    18% 







23% 62% 62% 46% 38% 23% 46% 31% 38% 
 
Interstudy Frequency = (number of study containing a finding / total number of study) * 100  
Intrastudy Intensity    = (number of findings in the study / total number of findings) * 100
!
!
Figure 1. Preferred Reporting Items for Systematic Reviews and Meta-Analyses 




Figure 2. The determinants of patient satisfaction towards O-MSK
 
	  	  
Appendix 1. Search strategy for different database. 




("Patient Satisfaction"[Mesh] OR “patient satisfaction” OR "Consumer Behavior"[Mesh] OR “consumer satisfaction” OR “client 
satisfaction” OR “patient experience” OR “client experience”) AND (“physiotherapy” OR “physical therapy” OR "Physical Therapy 
Modalities"[Mesh] OR "Musculoskeletal Manipulations"[Mesh] OR “allied health” OR “outpatient”) 
LIMITS:  English, humans, full text 
CINAHL (“patient satisfaction” OR “consumer satisfaction” OR “client satisfaction” OR “patient experience” OR “client experience” OR 
“customer experience” OR “consumer experience” OR “patient behavior” OR “client behavior” OR “consumer behaviour” OR 
“customer behavior” ) AND (“physiotherapy” OR “physical therapy” OR “physical therapy modality” OR  “physical therapy 
modalities” OR “physical therapy technique" OR “physical therapy techniques” OR “musculoskeletal manipulations" OR “manual 
therapy” OR “manual therapies” OR “manipulation therapy” OR “manipulation therapies” OR “manipulative therapy” OR 
“manipulative therapies” OR “allied health” OR “outpatient”) 
LIMITS:  English, humans, full text 
SCOPUS TITLE-ABS-KEY(("patient satisfaction" OR "consumer satisfaction" OR "client satisfaction" OR "patient experience" OR "client 
experience" OR "customer experience" OR "consumer experience" OR "patient behavior" OR "client behavior" OR "consumer 
behaviour" OR "customer behavior" ) AND ("physiotherapy" OR "physical therapy" OR "physical therapy modality" OR "physical 
therapy technique" OR "musculoskeletal manipulations" OR "manual therapy" OR "manipulation therapy" OR “manipulative therapy” 
OR  "allied health" OR "outpatient")) AND ( LIMIT-TO(DOCTYPE,"ar" ) ) AND ( LIMIT-TO(LANGUAGE,"English" ) ) AND ( 
LIMIT-TO(SRCTYPE,"j" ) ) AND ( LIMIT-TO(SUBJAREA,"HEAL" ) ) 
LIMITS: English, type of document (article), area (professional health), source (documents from journal sources) 
Web of 
science 
(“patient satisfaction” OR “consumer satisfaction” OR “client satisfaction” OR “patient experience” OR “client experience” OR 




“customer behavior” ) AND (“physiotherapy” OR “physical therapy” OR “physical therapy modality” OR  “physical therapy 
modalities” OR “physical therapy technique" OR “physical therapy techniques” OR “musculoskeletal manipulations" OR “manual 
therapy” OR “manual therapies” OR “manipulation therapy” OR “manipulation therapies” OR “manipulative therapy” OR 
“manipulative therapies” OR “allied health” OR “outpatient”) 
LIMITS: English, type of document (article) 
Wiley Online 
library 
(“patient satisfaction” OR “consumer satisfaction” OR “client satisfaction” OR “patient experience” OR “client experience” OR 
“customer experience” OR “consumer experience” OR “patient behavior” OR “client behavior” OR “consumer behaviour” OR 
“customer behavior” ) AND (“physiotherapy” OR “physical therapy” OR “physical therapy modality” OR “physical therapy 
technique" OR “musculoskeletal manipulations" OR “manual therapy” OR “manipulation therapy” OR “manipulative therapy” OR 
“allied health” OR “outpatient”) 
LIMITS: type of source (journal), entry terms present in abstract 
EMBASE (‘patient satisfaction’/exp OR ‘patient satisfaction’ OR ‘consumer experience’/exp OR ‘consumer satisfaction’ OR ‘client satisfaction’ 
OR ‘patient experience’/exp OR ‘patient experience’ OR ‘client experience’ OR ‘customer experience’ OR ‘consumer experience’ OR 
‘patient behavior’/exp OR ‘patient behavior’ OR ‘client behavior’ OR ‘consumer behavior’/exp OR ‘consumer behavior’ OR 
‘customer behavior’ ) AND (‘physiotherapy’/exp OR ‘physiotherapy’ OR ‘physical therapy’/exp OR ‘physical therapy’ OR ‘physical 
therapy modality’ OR ‘physical therapy modalities’/exp OR ‘physical therapy modalities’ OR ‘physical therapy technique’ OR 
‘physical therapy techniques’/exp OR ‘physical therapy techniques’ OR ‘musculoskeletal manipulations’/exp OR ‘musculoskeletal 
manipulations’ OR ‘manual therapy’/exp OR ‘manual therapy’ OR ‘manual therapies’ OR ‘manipulation therapy’/exp OR 
‘manipulation therapy’ OR ‘manipulation therapies’ OR ‘manipulative therapy’/exp OR ‘manipulative therapy’ OR ‘manipulative 
therapies’ OR ‘allied health’ OR ‘outpatient’/exp OR ‘’outpatient’ 
LIMITS: English, type of document (primary studies), human subjects 
	  	  
Appendix 2. Excluded studies with motivations. 
References Motivations 
Carlesso LC, MacDermid JC, Santaguida PL, Thabane L. A survey of patient's perceptions of what is adverse in 
manual physiotherapy and predicting who is likely to say so. J Clin Epidemiol. 2013 Oct;66(10):1184-91. 
Quantitative method 
Abtahi AM, Presson AP, Zhang Z, Saltzman CL, Tyser AR. Association Between Orthopaedic Outpatient 
Satisfaction and Non-Modifiable Patient Factors. J Bone Joint Surg Am. 2015 Jul 1;97(13):1041-8. 
Quantitative method 
McKinnon AL. Client Satisfaction with Physical Therapy Services does age make a difference. Physical and 
Occupational Therapy in Geriatrics 2001 19:2 (23-37) 
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Appendix 3. The metasynthesis process. 
EXAMPLE OF ILLUSTRATIVE QUOTES CODES CATEGORIES THEMES 
After physiotherapy some patients perceived that 
the outcome was to develop coping strategies. 
Patients appreciated any effective therapy, which 
could help them achieve the desired/expected 
outcome. 
Most participants considered complete recovery an 
important determinant of satisfaction, immediately 
or over time. (50) 
Outcome, result of treatment, 
recovery 
Result of treatment CLINICAL 
OUTCOME 
Patients were satisfied by physiotherapist’s 
personal manner such as: friendliness and bedside 
manner; sensitivity to patients’ needs; friendliness 
and empathy.  
Generally, the respondents liked the 
physiotherapists’ friendly attitude, their ability to 
put people at ease, and their helpfulness.  
The characteristic of empathy involved a range of 
skills, which allowed patients to feel they were 
being dealt with in a sympathetic and respectful 
Interpersonal manners, attitude, 
empathy, support, physiotherapist’s 
personality, personal and 
professional manner, professional 
behaviour, organisational ability, 







way. Listening to the patients’ concerns and being 
understanding of their situation. (55) 
Physiotherapists’ technical expertise impacted 
patients’ perceptions.  
The impact was based on patients’ feeling about 
physiotherapists’ ability to provide good 
assessments and early improvement of functioning. 
These feelings were reported based on comparing 
outcomes or qualifications of knowledge among 
physiotherapists. (52) 
Technical expertise, competence Professionalism 
Most patients felt comfortable with therapist of the 
same sex, but working with an expert form the 
opposite gender was some time favoured over less 
experienced therapist of the same gender. (50) 
Gender Gender 
Patients with acute problems did not know what to 
expect, expect specific treatment modality, and 
expect to make a full recovery, expect a good 
recovery, not expect full recovery, and expect 
treatment to be painful. 
Patients with chronic problems expect symptomatic 
Patient’s wishes, expectation about 
physiotherapy, treatment, recovery 
 Patient expectation PATIENT FEATURE 
	  	  
relief, specific treatment modality, and resolution of 
the problem “cure”, expect no treatment to help. 
Subjects with positive expectations of being helped 
tended to report a positive outcome to the encounter 
if the treatment met or exceeded their expectations. 
(53) 
Patients were appreciative explanations they were 
given about their problem and what improvements 
they were likely to make with treatment.  
Patients in the acute group needed reassurance that 
by the time they came for treatment their fracture 
had healed. An explanation that there is no danger 
in moving the limb will reduce apprehension and 
facilitate more effective treatment.  
Devising home exercise regimens that incorporate 
functional activities rather than those which may 
appear divorced from everyday life is a way of 
improving compliance and ensuring continued 
improvement. (54) 
Interpersonal skills, communication, 




Listening, understanding and getting to know the Partnership with practitioner, Partnership of care 
	  	  
patient and allowing the patient to explain their 
problem and to question the physiotherapist were 
recurrently cited in relation to this dimension. (51) 
 
 
engagement with the health care 
process, individual care, trust, 
relatedness, relationship with the 
therapist, knowledge of patients’ 
disability experience  
All the patients reported a strong motivation to 
understand and explain their situation and to be 
given educational materials and resources. 
They reported that explanations should be accurate, 
understandable and free of jargon, they agreed that 
this facilitated positive therapeutic experiences. 
(59) 
Patient education, teaching, 




Patients were satisfied by different elements of the 
treatment process such as: the clinic waiting time, 
the patient awareness of clinic efficiency as a factor 
influencing waiting times and the clinical contact 
time. Patient awareness of time spent within clinic 
was also acknowledge by front desk reception staff. 
(60)  
Organization, time, consistency of 
care, value for money, convenience, 
accessibility, organizational 
environment, organization of care, 
service provision, duration of 
attendance, interruptions, patient 
safety, management continuity, 
informational continuity, consistency 
Organization of care 
	  	  
of team, clinical contact time, clinic 
waiting time, treatment process, 
relational continuity, informational 
continuity, management continuity 
Participants liked or wanted both treatment and the 
delivery of treatment to be individualised.  
Patients who felt that their exercises made sense to 
them and were well explained also felt that their 
individual needs were addressed, in contrast to 
those who felt that their exercises did not make 
sense or did not push them hard enough.  
Patients described the type of exercise as affecting 
compliance, only doing the exercises that fitted in 
with their lifestyle, suggesting the physiotherapists 
need to take this into account when prescribing 
exercise for chronic low back pain patients.  
Many placed importance on a thorough assessment, 
feeling that it enabled their treatment to better relate 
to their needs and emphazing the importance that 
patients seem to place on this aspect of 
Diagnostic and treatment expertise, 
individual treatment, content of 
treatment, flexibility in adapting care 




Patients needs to be listened to and involved in the 
treatment; so that it is seen as a consultive, rather 
than a prescriptive, process. (55) 
Participation in decision making, 
involvement in the process, 
consultive process, involvement in 
achieving patient’s collaboration 
Decision-making 
Patients felt low visual privacy to move to one 
room to another and when they were attended by 
therapists or performed exercise in a large room 
that was used by other people.  
They feel high service quality when having private 
rooms when they needed to change clothes for 
receiving therapy. (57) 
Standard of premises, facility design, 
ambient condition 
Physical environment HEALTH CARE 
SETTING FEATURE 
Positive influence on quality environment when the 
patients were supportive of each other in their 
efforts to improve health status. When this 
happened, they rated the environment as 
motivational (mutual help, similar stories and 
disability). (57) 
Social factors Social context 
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  Physical therapists’ perspectives towards exploiting contextual 
factors in clinical practice: findings from an italian national survey 
Abstract  
Background: Contextual factors (CFs) represent a potential therapeutic tool to boost 
physiotherapy outcomes, triggering placebo effects. Nevertheless, no evidence about 
the use of CFs among physical therapists is currently available. 
Objective: To investigate the perspective of Italian physical therapists specialized in 
Orthopaedic Manual Therapy (OMTs) towards CFs. 
Design: A cross-sectional online survey. 
Methods: A 17-item questionnaire and two clinical vignettes assessed the perspective 
of OMTs about the adoption of CFs in daily clinical practice. The target population 
was composed of 906 OMTs. An online survey was performed in 2016 using 
SurveyMonkey Software®. Data were analyzed by descriptive and inferential 
statistics. 
Results: A total of 558 volunteers (61.6% of the target OMT population) participated 
in the study. Half of the participants (52.0%) claimed to use CFs frequently in their 
practice. More of 50% of OMTs valued the therapeutic significance of CFs for 
different health problems as determined by a combined psychological and 
physiological effect. OMTs considered the use of CFs ethically acceptable when they 
exert beneficial therapeutic effects and their effectiveness has emerged in previous 
clinical experience (30.6%). They disagreed on the adoption of CFs when they are 
deceptive (14.1%). Moreover, OMTs did not communicate the adoption of CFs to 
patients (38.2%), and CFs were usually used in addition to other interventions to 
	  optimize clinical responses (19.9%). Psychological mechanisms, patient’s expectation 
and conditioning were believed to be the main components behind CFs (7.9%).  
Limitations: Considering that the data collected were self-reported and retrospective, 
recall and response biases may limit the internal and external validity of the findings. 
Conclusions: The use and beliefs of CFs among Italian OMTs depends on the 
specific type of CFs considered. The findings of this study suggest the need for an 


















Contextual factors (CFs) have been proposed in the scientific literature as an 
emerging topic (1). These are multidimensional aspects of the therapeutic encounter 
(provider, patient, patient-provider relationship, treatment and setting) (2) capable to 
enact psycho-neuro-immuno-endocrine responses that can trigger positive or negative 
clinical outcomes by placebo and nocebo effects (3). Placebo effects have been 
associated to the optimal use of CFs, whereas nocebo has been associated with a 
negative context surrounding the clinical encounter (4). Different psychological 
theories based upon expectations and learning processes have been established as the 
fundamentals mechanisms of CFs effects, whilst specific neurotransmitters such as 
endogenous cholecystokinin, opioid, endocannabinoid, vasopressin, and dopamine 
have been documented as orchestrating the neurobiology behind their clinical effect 
(5). 
Although the use of CFs as triggers of placebo and nocebo effects has been 
studied for many years in medicine discipline, only recently they have only recently 
been introduced in physical therapy discipline (6). Clinically, CFs are considered not 
eliminable components (7) of a specific physiotherapy treatment (8), thus capable of 
modulating symptoms. Available randomized controlled trials have reported the 
positive effect of CFs on musculoskeletal conditions such as low back pain (9-12), 
neck pain (13) and shoulder pain (14). Patients’ expectations with regard to a 
treatment (10, 13), the physical therapist’s verbal suggestions associated with 
treatment (9, 14), and the enhanced therapeutic alliance between the patient and the 
physical therapist (11, 12) all have been documented as improving outcomes in 
different domains such as pain, disability, expectation and satisfaction (15-17). 
	  Despite the increased interest concerning the use of CFs also in some clinical 
trials (9-14), no data have been published on physical therapists’ perspectives 
harnessing CFs in routine clinical practice. On the contrary, available surveys have 
investigated the use of placebos in specific groups of healthcare providers (18) 
documenting an overall use of them ranging from 17.0% to 80.0% among physicians 
(19-36), and from 51.0% to 100.0% among nurses (22, 37-39) in Canada (29, 32), 
Denmark (21), England (28, 31), France (38), Germany (23, 24, 36), India (34), Iran 
(37), Israel (22), Poland (27), Saudi Arabia (35), Switzerland (19), Turkey (39), the 
United Kingdom (20) and the United States (25, 26, 30, 33). 
Clinical implementation and perspectives about CFs use have been suggested as 
a priority field of investigation (18), in different professional healthcare groups, such 
as physical therapists (6). In fact, physical therapists establish a one-to-one 
relationship with the patient, following alongside the clinical pathway and, more 
directly, influencing his/her experience and degree of satisfaction (40). Among these 
professionals, physical therapists specialized in Orthopaedic Manual Therapy (OMTs) 
represent a professional group to be investigated because their clinical practice is 
widely pervaded by CFs (41). Therefore, we decided to explore within this area of 
medicine the frequency of use, beliefs, behaviors, attitudes, and knowledge with 
regard to CFs in a nationwide sample of Italian OMTs. 
 
Materials and Methods  
Design  
A quantitative web-based cross-sectional survey herein reported according to 
the Checklist for Reporting Results of Internet E-Surveys (CHERRIES) guidelines 
(42) was performed at the University of Genoa (Italy) between October and December 
	  2016. Ethical approval was obtained from the Liguria Clinical Experimental Ethics 
Committee (P.R.236REG2016, approved on 19/07/2016).  
 
Participants and setting  
A nationwide sample of Italian physical therapists specialized in OMTs was the 
target population identified from the complete email database of Master in 
Rehabilitation of Musculoskeletal Disorders (MRDM) of Genoa University (n=906). 
This advanced educational program captures almost the totality of the Italian physical 
therapists specialized as OMTs (43); moreover it represents the oldest academic post-
graduation program in manual therapy in Italy (44), based upon the standards 
established by the International Federation of Orthopaedic Manipulative Physical 
Therapists (45).  
Within the established population, we included those OMTs who: a) had a valid 
e-mail account, b) understood the Italian language; and c) were working as clinicians 
at the time of the survey. Considering previous surveys on placebos (19-21, 25, 26, 
36) that a likely response rate would range from 40.0% to 60.0%, we expected 
approximately 363 to 544 overall responses from the population of 906 OMTs. The 
application of these predicted values to the formula for estimating the sample size for 
a single population proportion with the population proportion set at 50.0%, which is 
the most conservative value to apply, produced a two-sided 95.0% confidence level 
within three to four percentage points of the true value and a relative standard error 
ranging from 2.7 to 4.1 (46). 
 
Questionnaire development and pre-testing  
	  A survey instrument, composed of questions and clinical vignettes, was 
developed using distinct and iterative steps (47). Items from the existing surveys on 
placebo were extracted from the literature (19-39). Moreover two clinical vignettes 
were derived and adapted from a recent survey on placebo (20).	  Clinical vignettes 
represent written case scenarios presenting fictitious patients: they are adopted for 
measuring health providers’ clinical behavior (48) by asking participants to report 
what their behavior would be (49).  
The initial list was composed of 17 questions and two clinical vignettes that 
were critically evaluated for face and content validity(47) by a panel of six experts 
with extensive experience in placebo and survey design (a physician, a psychologist, a 
nurse, and three physical therapists). These experts worked independently and then 
agreed upon the final list by proving feedback on content accuracy, wording clarity, 
and survey structure. Adjustments were progressively included by considering the 
feedback that emerged. When full agreement among experts was achieved, a 
preliminary version of the survey composed of 17 questions and two clinical vignettes 
was piloted in a convenience sample of 10 OMTs. The outcome of the pilot phase was 
satisfactory; therefore, no changes or comments were necessary. 
 
Questionnaire implementation  
A self-administered questionnaire (translated into English, S1 Appendix and in 
original language S2 Appendix) composed of three sections (A, B and C) was used. 
The socio-demographic variables were investigated by two open-ended questions (e.g. 
age) and five closed multiple-choice questions (e.g. gender, geographic region) in 
section A. Two clinical vignettes structured as closed multiple-choice questions were 
included in section B: 
	  a) the first vignette regarded the use of transcutaneous electrical nerve 
stimulation (TENS) in a patient with low back pain and high positive 
expectation towards this treatment based on previous encouraging experience. 
OMTs were asked to undertake a decision in this situation in which the use of 
TENS did not present contraindications and in absence of any evidence of 
efficacy;  
b) the second vignette was focused on an in-patient clinical case with shoulder 
pain positively responding when the active TENS was replaced by a sham 
TENS. Additionally, OMTs were asked to draw a conclusion about the 
efficacy and effectiveness of sham TENS. 
The last section (section C) lists 10 closed questions. Six questions were single-
choice questions exploring the knowledge of CFs, including the definition (e.g. ‘How 
would you define the therapeutic role of CFs?’), the frequency of CF use (answers 
from ‘never’ to ‘many times’) and the case-by-case frequency of CF use (Likert from 
0 ‘never’ to 4 ‘daily’, and ‘I was not aware of it was a CF capable to influence 
therapeutic outcome’). The section explored also participants’ CFs belief (Likert from 
0 ‘not at all’ to 4 ‘a lot of’) and the potential beneficial effects of CFs (e.g. ‘What are 
the potential effects of CFs in the following health problems?’). In the remaining 4 
questions multiple responses were allowed to describe the ethical implications 
perceived in using CFs (e.g. ‘The use of CFs for therapeutic purposes can be 
considered ethically acceptable when....’), communication implications about CFs 
(e.g. ‘How do you communicate to the patient the use of CFs at the end of 
treatment?’), the circumstances under which they are applied (e.g. ‘Under what 
circumstances would you use CFs?’), and the possible mechanisms of action (e.g. 
‘What mechanism of action can explain the effect of CFs?’). Overall, the term 
	  ‘contextual factor’ was preferred to ‘placebos’, as suggested in previous studies (26, 
50).  
 
Data collection procedure  
The Survey Monkey (Survey-Monkey, Palo Alto, California, 
www.surveymonkey.com) online survey tool was used. The survey was administered 
over an eight-week period between 14th October 2016 and 14th December 2016. After 
permission was obtained from MRDM of Genova University, all OMTs were 
contacted by using the blast email method (51). An email containing the survey and a 
brief note outlining (a) the aim of the study, (b) data handling (anonymity), (c) the 
informed consent statement, and (d) the invitation to complete the survey was 
delivered. Specifically, the statement within the email informed that by clicking the 
survey link the respondents were providing their consent to participate in the study 
(52).  
Two email reminders were sent two and four weeks after the initial contact to 
encourage those who did not participate in the survey. Ten to 15 minutes were needed 
to complete the survey, corresponding to the completion time found to optimize 
response rates in online surveys (53). Participation was voluntary and no incentives 
were offered to participants; there was the option to decline to answer specific 
questions or to leave the entire questionnaire blank (52). The order of questions was 
randomized. Participants were able to review or change responses using a back button 
until the end of the questionnaire.  
Data were downloaded and stored in an encrypted computer, and only the 
project manager could access to the information involved in all the stages of the 
study. Participants were ensured that their identities would not be disclosed to 
	  investigators. All data were de-identified (name and email address) to maintain 
confidentiality and data protection (52).  
 
Data Analysis  
Survey data were downloaded from the SurveyMonkey into Excel spreadsheets 
and reviewed for accuracy and missing values. A questionnaire was considered 
incomplete if there were more than 20.0% of missing data (54). For questions 
allowing only one choice, descriptive statistics (mean, standard deviation ± SD) were 
used for continuous variables by calculating also confidence intervals (CI) at 95%, 
while absolute frequencies and percentages were applied to dichotomous, nominal, 
and ordinal variables. The variables age and years of practice were transformed into 
ordinal variables considering a decade as variable levels for the analysis of 
correlations, as described below. For questions allowing more than one choice, the 
absolute frequency and percentages were calculated for every combination of 
responses given by each participant. For example, considering that the fields (n) asked 
in the domain ‘Ethic’ were four with dichotomous responses (r), we did not calculate 
the absolute frequency of the four possible fields but of their 16 combinations, given 
by the formula r∧n, to better describe the responses given by each participant.  
The presence of any relationship between the individual characteristics (section 
A of the survey) and the responses given (sections B and C of the survey) was 
investigated with the Cramer’s V which is a measure of strength and direction of 
association derived from the chi-square statistics. Only correlation values higher > 
0.60 were deemed acceptable and, therefore, here reported.  
The five response options for the domains of frequency of use (‘never’, ‘around 
once per year’, ‘around once per month’, ‘around once per week’, ‘daily’) and beliefs 
	  about CFs (‘not at all’, ‘few’, ‘enough’, ‘much’, ‘a lot of’) were converted into a five-
point Likert scale ranging from 0 (‘never’ and ‘not at all’) to 4 (‘daily’ and ‘very 
much’) in order to have an average distribution of the two domains and to analyze the 
relationship between the frequency of use and the associated beliefs about CFs using 
the Spearman’s rho. The R software was used for data analysis (55) with the packages 
psych (56) and ggplot2 (57). 
 
Results 
Participant’s characteristics  
Out of the 906 invited OMTs, a total of 571 responded (63.0%). Thirteen 
incomplete surveys were excluded from data analysis, leaving 558 questionnaires to 
be considered as valid (61.6%) for the analysis. The majority of OMTs (n=329; 
59.0%; 95%CI 54.7–63.0) were male, and their average age was 30.5 ± 6.5 years. 
Seventy-two percent of the participants (n=400; 95%CI 67.7–75.3) were living in the 
north of Italy. 
The participants reported an average of 6.8 ± 5.7 years of clinical experience. A 
high proportion was working 31–45 hours/week (n=316; 56.6%; 95%CI 52.4–60.8) as 
private practitioners (n=433; 77.6%; 95%CI 73.9–80.9) in the musculoskeletal field 
(n=472; 84.6%; 95%CI 81.3–87.4). The respondents’ demographics are described in 
Table 1. 
 
Definition of CF 
The majority of participants defined CFs as ‘an intervention without a specific 
effect for the condition being treated, but with a possible aspecific effect’ (n=407; 
72.9%; 95%CI 69.0–76.5). The remaining considered CFs as ‘an intervention that has 
	  a special effect through known physiological mechanisms’ (n=112; 20.1%; 95%CI 
16.9–23.7), ‘a sham treatment used as control tests for safety and efficacy of active 
treatment’ (n=20; 3.6%; 95%CI 2.3–5.6), and in minor frequency, as ‘a harmless or 
inert intervention’ (n=19; 3.4%; 95%CI 2.1–5.4). 
 
Clinical vignette 1  
Concerning the first vignette, the two most frequently chosen solutions were ‘to 
deliver TENS’ (n=169; 30.3%; 95%CI 26.5–34.3) and ‘to suggest the possibility of 
delivering the TENS if the clinical condition fails to improve’ (n=157; 28.1%; 95%CI 
24.5–32.1). The remaining responders selected the following answers: ‘to convince 
the patient of the futility of TENS” (n=104; 18.6%; 95%CI 15.5–22.2), ‘to advise a 
different treatment commonly used for low back pain’ (n=103; 18.5%; 95%CI 15.4–
22.0), and ‘to advise a follow-up appointment in the following days’ (n=21; 3.8%; 
95%CI 2.4–5.8). Only four OMTs (0.7%; 95%CI 0.2–1.9) chose ‘to tell the patient 
that low back pain would resolve itself in a few days’. 
 
Clinical vignette 2  
With regard to the second vignette, the most frequent answers were: ‘the 
positive attention of the healthcare team leads to decreased pain’ (n=114; 20.4%; 
95%CI 17.2– 24.1), ‘the pain as non-organic but psychological’ (n=71; 12.7%; 
95%CI 10.1– 15.8), ‘the patient as very suggestible’ (n=46; 8.6%; 95%CI 6.2–10.9), 
‘the natural decrease of pain intensity’ (n=44; 7.9%; 95%CI 5.8– 10.5) and their 
combinations (Fig 1). The least frequent answers were ‘the patient provides the 
expected response by the physical therapist’ (n=5; 0.9%; 95%CI 0.3-2.2) and this 
option combined with the others (Fig 1). 
	   
Frequency of use  
The frequency of use presented an average of 3.04 (95%CI 3.00–3.07) on a 
four-point Likert scale, indicating a higher adoption of CFs among OMTs. Fifty-two 
percent of OMTs (n=290; 95%CI 47.7–56.2) claimed to use the CFs ‘many times’ in 
their clinical practice. The remaining participants reported the use as ‘often’ (n=112; 
20.1%; 95%CI 16.9–23.7), ‘at least once’ (n=126; 22.6%; 95%CI 19.2–26.3), and 
‘never’ (n=30; 5.4%; 95%CI 3.7–7.7). Regarding the specific adoption of CFs, the 
most used CFs selected as ‘daily’ and ‘around once per week’ were (in descending 
order): the verbal communication (n=465; 83.3%; 95%CI 79.9-86.3), the patient-
centered approach (n= 451; 80.8%; 95%CI 77.3-84.0), the empathetic therapeutic 
alliance with the patient (n= 437; 78.3%; 95%CI 74.6-81.6), the positive attitudes and 
the optimistic behavior (n= 416; 74.5%; 95%CI 70.7-78.1), the physical contact with 
the patient (n= 414; 74.2%; 95%CI 70.3-77.7), the professional approach to the 
patient (n=385; 69.0%; 95%CI 65.0-72.8), the not verbal communication (n=374; 
67.0%; 95%CI 62.9-70.9), the creation of a comfortable setting (n= 327; 58.6%; 
95%CI 54.4-62.7), an overt therapy (n= 288; 51.6%; 95%CI 47.4-55.8), the patient’s 
expectations and preferences (n=277; 49.6%; 95%CI 45.4-53.9) and the previous 
experiences of the patient (n=197; 35.3%; 95%CI 31.4-39.4).  
The less used CFs, selected as ‘never’, was the professional reputation (n=188; 
33.7%; 95%CI 29.8-37.8). 
Three CFs presented opposite frequencies as ‘daily’ (the uniform: n=215; 
38.5%; 95%CI 34.5-42.7; an adequate environmental architecture: n=219; 39.2%; 
95%CI 35.2-43.4; an adequate design: n=207; 37.1%; 95%CI 33.1-41.3) and ‘never’ 
(the uniform: n=180; 32.3%; 95%CI 28.4-36.3; an adequate environmental 
	  architecture: n=147; 26.3%; 95%CI 22.8-30.2; an adequate design: n=167; 29.9%; 
95%CI 26.2-33.9).  A complete reporting of CF use is presented in Table 2. 
 
 Beliefs  
Concerning the beliefs, the average score was 2.79 (95%CI 2.77–2.82) out of 4, 
thus denoting a substantial level of conviction towards CFs among the OMTs.  
In detail, the most believed CFs selected as ‘much and ‘a lot of’ were (in 
descending order): the empathetic therapeutic alliance with the patient (n=332; 
59.5%; 95%CI 55.3-63.6), the patient-centered approach (n=312; 55.9%; 95%CI 
51.7-60.1), the physical contact with the patient (n=274; 49.1%; 95%CI 44.9-53.3), 
the verbal communication (n=266; 47.7%; 95%CI 43.5-51.9), the patient’s previous 
experience (n=244; 43.7%; 95%CI 39.6-48.0), the patient’s expectations and 
preferences (n=240; 43.0%; 95%CI 38.9-47.2), the professional approach with the 
patient (n=239; 42.8%; 95%CI 38.7-47.1), the positive attitudes and the optimistic 
behavior (n=238; 42.6%; 95%CI 38.5-46.9), the not verbal communication (n=236; 
42.3%; 38.2-46.5 95%CI), the comfortable setting (n=230; 41.2%; 95%CI 37.1-45.4) 
and the overt therapy (n=213; 38.2%; 95%CI 34.1-42.4). 
The least believed CF selected as ‘enough’ were (in descending order): the 
adequate design (n=236; 42.3%; 95%CI 38.2-46.5), the professional reputation 
(n=222; 39.8%; 95%CI 35.7-44.0) and the adequate environmental architecture 
(n=217; 38.9%; 95%CI 34.8-43.1). 
Moreover, the uniform divided the group between those who believed ‘enough’ 
(n=199; 35.7%; 95%CI 31.7-39.8) and those who believed ‘few’ (n=203; 36.4%; 
95%CI 32.4-40.5). An overall description of beliefs towards CFs is presented in Table 
3. 
	  	   	  
Therapeutic effect  1	  
‘Physiological and psychological’ effects were the most often therapeutic 2	  
effects chosen by OMTs in caring for the following health problems (in order): 3	  
chronic pain (n=436, 78.1%; 95%CI 74.4–81.4), insomnia (n=345; 61.8%; 95%CI 4	  
57.6–65.8) and acute pain (n=317, 56.8%; 95%CI 52.6–60.9); as well as in the case of 5	  
cognitive (n=317; 56.8%; 95%CI 52.6-60.9), rheumatologic (n=313; 56.1%; 95%CI 6	  
51.9– 60.2), gastrointestinal (n=307; 55%; 95%CI 50.8-59.2), emotional (n=303; 7	  
54.3%; 95%CI 50.1-58.5), sexual (n=295; 52.9%; 95%CI 48.6-57.1) and neurological 8	  
disorders (n=295; 52.9%; 95%CI 48.6-57.1). 9	  
Drug and medication addictions, immune/allergic and cardiovascular problems 10	  
were considered as sensitive to therapeutic effects due to ‘Physiological and 11	  
psychological’ (n=238; 42.6%; 95%CI 38.5-46.9; n=204; 36.6%; 95%CI 32.6-40.7; 12	  
n=253; 45.3%; 95%CI 41.2-49.6 respectively) and ‘Psychological’ (n=187; 33.5%; 13	  
95%CI 29.6-37.6; n=170; 30.5%; 95%CI 26.7-34.5; n=156; 28.0%; 95%CI 24.3- 14	  
31.9). However, about a quarter of OMTs reported that these clinical conditions have 15	  
‘No benefit’ from CFs (n=126; 22.6%; 95%CI 19.2-26.3; n=167; 29.9%; 95%CI 26.2- 16	  
33.9; n=129; 23.1%; 95%CI 19.7-26.9 respectively). 17	  
Finally, OMTs indicated the therapeutic effect for oncological problems as 18	  
predominantly ‘Psychological’ (n=274; 49.1%; 95%CI 44.9-53.3), while they 19	  
believed mainly in ‘No benefit’ for infectious problems (n=229; 41.0%; 95%CI 36.9- 20	  
45.3). An overall report of therapeutic effects is presented in Table 4. 21	  
 22	  
Ethical implications   23	  
Concerning the ethical use of CFs, the most frequent response was the 24	  
combination: ‘it exerts beneficial psychological effects’ and ‘clinical experience has 25	  
	  	   	  
shown the effectiveness’ (n=171; 30.6%; 95%CI 26.9-34.7). Moreover, both of these 26	  
answers particularly, resulted among the most often selected (Fig 2). The least 27	  
selected items were ‘the patient wants or expects this treatment’ (n=13; 2.3%; 95%CI 28	  
1.3-4.1), ‘the other therapies are over’ (n=8; 1.4%; 95%CI 0.7-2.9) and their 29	  
combinations (Fig 2). 30	  
With regard to the non-ethical adoption of CFs, the most frequently chosen item 31	  
was when ‘It is based on deception’ (n=79; 14.1%; 95%CI 11.4–17.4). Among the 32	  
answers mostly selected with the higher frequencies there were the six first 33	  
combinations of multiple items that encompassed more than 50% of our sample (Fig 34	  
3). 35	  
Differently, the least frequent selected answers were ‘it can create adverse 36	  
effects’ (n=20; 3.6%; 95%CI 2.3-5.6), ‘it	  undermines trust between patient and 37	  
physiotherapist’ (n=19; 3.4%; 95%CI 2.1-5.4), ‘the evidence is insufficient’ (n=11; 38	  
2.0%; 95%CI 1.0-3.6), ‘legal problems arise’ (n=4; 0.7%; 95%CI 0.2-1.9) and their 39	  
combinations (Fig 3). 40	  
 41	  
Communication  42	  
Participants reported higher frequency to ‘do not say anything’ (n=213; 38.2%; 43	  
95%CI 34.1– 42.4) when they were asked about communication and CFs. However, 44	  
they reported to communicate CFs adoption when ‘it is a treatment that can help and 45	  
will not hurt’ (n=114; 20.4%; 95%CI 17.2–24.1), ‘it is an effective treatment’ (n=36; 46	  
6.4%; 95%CI 4.6-8.9). Some combinations indicating the complexity of 47	  
communication regarding the CFs use also emerged, such as ‘do not say anything’ 48	  
plus ‘it is a treatment that can help and will not hurt’ and ‘it is a treatment that can 49	  
help and will not hurt’ plus ‘it is an effective treatment’ (Fig 4). 50	  
	  	   	  
The least frequent chosen items with regard to the communication implications 51	  
of CFs were: ‘it is a treatment that induces a psychological change’ (n=11; 2.0%; 52	  
95%CI 1.0-3.6), ‘it can help but you are not sure about its effect’ (n=3; 0.5%; 95%CI 53	  
0.1-1.7), ‘it is a treatment without a specific effect’ (n=2; 0.4%; 95%CI 0.1-1.4) and 54	  
the combinations with other responses (Fig 4). 55	  
 56	  
Circumstances of CFs application and mechanism of action  57	  
Regarding the circumstances of CFs application, the most frequent item was ‘as 58	  
an adjunct to other physical therapy interventions to optimize the clinical responses’ 59	  
(n=111; 19.9%; 95%CI 16.7–23.5) and the combinations ‘to calm the patient’ plus ‘as 60	  
an adjunct to other physical therapy interventions to optimize the clinical responses’ 61	  
(n=105; 18.8%; 95%CI 15.7-22.4). The least frequent answers were ‘to calm the 62	  
patient’ (n=18; 3.2%; 95%CI 2.0-5.1), ‘for non-specific problems’ (n=5; 0.9%; 63	  
95%CI 0.3-2.2), ‘as a result of unjustified and constant demands for physiotherapy 64	  
interventions’ (n=1; 0.2%; 95%CI 0.0-1.2), ‘when all other therapies are over’ (n=1; 65	  
0.2%; 95%CI 0.0-1.2), ‘as a diagnostic tool to differentiate between psychological 66	  
and physiological problems’ (n=1; 0.2%; 95%CI 0.0-1.2), ‘to control pain’ (n=1; 67	  
0.2%; 95%CI 0.0-1.2) and their combinations (Fig 5).  68	  
Concerning the mechanism of action behind CFs, OMTs selected heterogeneous 69	  
responses. The most frequent option was the combination ‘the patient’s expectation’ 70	  
plus ‘conditioning’ and ‘psychological factors’ (n=44; 7.9%; 95%CI 5.8–10.5) as 71	  
reported in Fig 6. 72	  
 73	  
Correlation between variables  74	  
	  	   	  
The correlation between the frequency of use and the beliefs of each CF was 75	  
poor with a Spearman’s rho ≤ 0.4 for the following items (in descending order): 76	  
physical contact with the patient (rho=0.39), overt therapy (rho=0.39), patient’s 77	  
previous experience (rho=0.38), professional reputation (rho=0.37), professional 78	  
approach to the patient (rho=0.36), patient-centered approach (rho=0.36), verbal 79	  
communication (rho=0.33), empathetic therapeutic alliance with the patient 80	  
(rho=0.32), adequate design (rho=0.32), adequate environmental architecture 81	  
(rho=0.29), and comfortable setting (rho=0.26). Positive weak associations with 82	  
Spearman’s rho >0.40 were found for the following items: uniform (rho=0.48), 83	  
patient’s expectation and preference (rho=0.44), positive attitudes and optimistic 84	  
behavior (rho=0.43), and non-verbal communication (rho=0.40). No significant 85	  
correlations were found between demographic characteristics and responses in all 86	  
domains. 87	  	   88	  
Discussion 89	  
To the best of our knowledge, this is the first study evaluating awareness 90	  
regarding CFs among physical therapists specialized in OMTs. The findings suggest 91	  
that the use and the belief about the effectiveness of CFs are related to the specific 92	  
type of CFs under consideration. Their adoption is in general decided based on 93	  
clinical circumstance and perception of ethical as a component of the treatment 94	  
capable of enhancing the effect of the physiotherapy intervention. The underlying 95	  
mechanism of CFs action is still thought to be a combination of psychological and 96	  
physiological effects. 97	  
Although previous studies have not been conducted in the field, some 98	  
considerations are possible when comparing our results with a similar survey 99	  
	  	   	  
performed among other healthcare professions (19-39). In accordance with previous 100	  
surveys among physicians (25, 28, 29, 32), almost 70.0% of OMTs defined CFs as an 101	  
intervention without a specific effect, but with a possible non-specific effect. These 102	  
findings reveal that physical therapists conceptualize the context around the treatment 103	  
as an incidental element that can occur during treatment (58) instead of a powerful 104	  
therapeutic tool capable of influencing patients’ outcome (59), thus reflecting a lack 105	  
of knowledge in the field (6).  106	  
As emerged from clinical vignette 1, only 40% of Italian OMTs refused TENS 107	  
or offered an alternative treatment in accordance with the national guidelines for acute 108	  
low back pain (60). Instead, a 60% of participants valued patients’ expectations 109	  
during the choice of treatment immediately or after a few days, which have been 110	  
recognized as a CFs capable of increasing the likelihood of clinical success (10, 13). 111	  
Globally, these findings suggest that both external evidence and patient’s expectations 112	  
influence the OMTs’ decision-making, thus embracing the principles of evidence- 113	  
based practice in physiotherapy (61). 114	  
Various responses in term of frequency emerged from clinical vignette 2. 115	  
Around two out ten OMTs identified the positive healthcare attention as an element 116	  
capable of reducing pain, remarking the importance of the humanity in clinical 117	  
practice (11). Others participants reported instead that the decrease of symptom could 118	  
be explained considering the pain as non-organic but psychological, the patient’s 119	  
suggestibility, the natural course of pathology and their combinations. The 120	  
psychological nature of some symptoms should be taken into consideration as a 121	  
source of some unexplained musculoskeletal disorders (62). The suggestibility also 122	  
represents a psychological trait capable of enhancing placebo effects, thus influencing 123	  
	  	   	  
the patient’s conditions (63); moreover, the natural course of pathology (e.g. 124	  
spontaneous fluctuations of symptoms) can mask the therapeutic effects of CFs (64). 125	  
At overall levels, around seven out ten OMTs reported a high frequency of 126	  
application of CFs in their daily practice, in line with previous studies among 127	  
physicians (19-34) and nurses (22, 37-39). Globally, the professional reputation 128	  
resulted in the least adopted CFs, identifying it as an undiscovered variable enclosed 129	  
behind the complex concept of professional identity in physiotherapy discipline (65). 130	  
The dichotomy frequency of use (‘daily’ vs ‘never’) reported in some CFs (e.g. 131	  
uniform, adequate design and adequate environmental architecture) was unexpected. 132	  
Speculating, the uniform (e.g. white coat) is often imposed in workplaces, thus 133	  
becoming a CFs not always chosen independently by a physical therapist to influence 134	  
patient’s perception (66). Moreover, the design (e.g. colors of the room) and the 135	  
environmental architecture (e.g. windows and skylights) are not modifiable 136	  
infrastructural elements as compared to music, fragrances or temperature (67). 137	  
According to physicians’ (21, 22, 25, 27-35) and nurses’ (22, 37, 38) 138	  
perspectives, our participating OMTs strongly believed in the actual therapeutic value 139	  
of CFs. Also in this case, the least believed CFs concerned specific elements of a 140	  
physical therapist (e.g. professional reputation, uniform) and of healthcare setting 141	  
(e.g. architecture and design) and this may be associated with a lack of knowledge. In 142	  
fact these specific CFs have not been included in the national academic curriculum as 143	  
compared to other elements (e.g. verbal and not verbal communication) (68) and this 144	  
can have threatened their knowledge. As already documented, the clinician’s 145	  
leadership and the healthcare environment represent all emerging elements of 146	  
personal branding (69) and marketing position (70) capable of influencing also the 147	  
therapeutic outcome.  148	  
	  	   	  
Regarding the therapeutic effect of CFs, OMTs believed in psychological and 149	  
physiological effects for most of the health problems (e.g. pain conditions). This trend 150	  
is similar to that reported previously by nurses and physicians who believed in 151	  
predominantly subjective or a mixture of subjective and objective effects (21, 25, 27, 152	  
29, 32-35, 37), depending upon the specific health problems considered (18). 153	  
Moreover, OMTs reported a variety of responses for some specific clinical conditions: 154	  
‘psychological and physiological effects’ combined with ‘psychological’ and ‘no 155	  
benefit’ (e.g. drug and medication addiction, immune/allergic and cardiovascular); as 156	  
well as mainly ‘psychological’ (e.g. oncological problems) and ‘no benefit’ (e.g. 157	  
infectious problems), thus reflecting a possible lack of direct clinical experience in 158	  
managing these conditions (18). 159	  
Concerning the ethical implications of CFs, OMTs considered their use 160	  
acceptable to enhance positive psychological effects when the clinical experience has 161	  
shown their effectiveness. However, when CFs are based upon deception, they should 162	  
be avoided, thus remarking the importance of an ethical application of CFs in the 163	  
patient-physical therapist encounter (71). As reported in previous surveys (18),  164	  
nurses (22, 37) and physicians (19-22, 24-29, 31-35) were also in favor towards the 165	  
use of placebos, and they rarely considered placebos as not allowed or as a treatment 166	  
that is never permissible.  167	  
Furthermore, as previously documented (19, 20, 22, 24-26, 29, 32-35, 37, 39), 168	  
our participants were not used to communicate the adoption of CFs to their patients or 169	  
to inform them that the context is an effective addition to the treatment, capable of 170	  
helping without hurting. The need to disclose to the patient the use of a placebo 171	  
intervention during the informed consent process is still under debate among 172	  
clinicians and researchers (72); however, open-label adoption of a placebo is capable 173	  
	  	   	  
of positively influencing therapeutic outcomes in chronic low back pain (73) and it is 174	  
appreciated by the patients (74). 175	  
As clinical indications, OMTs attributed to CFs a therapeutic role in calming 176	  
patients and as an adjunctive strategy to physical therapy interventions, thus 177	  
remarking the value of the contextual component in influencing patient’s therapeutic 178	  
outcomes (6, 59). Instead, reasons reported among other health professions are 179	  
variable (18) where physician (19, 21, 22, 25, 32) (20, 24, 27, 31, 33-35) and nurses 180	  
(22, 37) embraced placebos predominantly to gain therapeutic advantage, to calm the 181	  
patient, to satisfy the patient’s request, to avoid conflicts, to distinguish organic from 182	  
psychogenic problems, to supplement the therapy, to control pain, to treat non- 183	  
specific symptoms, or use when all other interventions have been ineffective. 184	  
Moreover, OMTs presented a multifaceted point of views concerning the 185	  
mechanisms of action, reporting as most frequent the combination of patient’s 186	  
expectations, conditioning and psychological factors. This heterogeneity can reflect a 187	  
lack of knowledge toward the topic as already reported by other healthcare providers 188	  
(22, 24, 25, 27, 28, 31, 32, 34, 35), thus suggesting the need of educational efforts on 189	  
CFs and on placebo effects (6).  190	  
 191	  
Strengths and weaknesses of the study 192	  
A high response rate was achieved (61.6%) as compared to previous studies on 193	  
placebos (from 40.0% to 60.0%) (19-21, 25, 26), confirming the willingness of Italian 194	  
OMTs to participate in the web-based cross-sectional survey (43). It was surveyed a 195	  
specific group of Italian physical therapists with OMT specializations (n= 906) who 196	  
are educated to manage mainly musculoskeletal disorders in the private healthcare 197	  
	  	   	  
sector (75). Therefore, their responses may differ from those of non-specialized 198	  
physical therapists or from those of other physical therapy specialists (33, 75). 199	  
A survey instrument was adopted instead of focus groups or interviews to 200	  
ensure data were collected at the national level, thus reflecting the perspectives of the 201	  
target population (76). The questionnaire was composed of different items (e.g. close- 202	  
ended questions) to increase the likelihood to capture the complexity of the 203	  
phenomena under study (77). Moreover, clinical vignettes were used despite the fact 204	  
their validity has been recently questioned (78-80). 205	  
Given that data were self-reported and retrospective in nature, recall bias can 206	  
threaten the validity of the findings (20). Despite the assurance of anonymity, some 207	  
participants may have misreported their use of CFs (25).  208	  
 209	  
Conclusions 210	  
Implications for clinicians, policymakers and researchers 211	  
A wide use of CFs in physical therapy practice has emerged among Italian 212	  
OMTs. To ensure appropriate competence, awareness, and the ethical use of the 213	  
context, this issue should be included in physical therapy graduate and postgraduate 214	  
study programs and in professional lifelong learning courses. The research on CFs in 215	  
physical therapy has to be considered in its early stages. Therefore, further 216	  
quantitative studies evaluating knowledge, uses, and aptitudes on CFs among non- 217	  
specialized physical therapists across different countries, are strongly recommended. 218	  
Moreover, studies comparing CFs beliefs, perspectives, and use among healthcare 219	  
workers are also suggested. To develop a more comprehensive understanding of the 220	  
phenomena, there is also a need to investigate patients’ perceptions towards CFs in 221	  
	  	   	  
physical therapy practice as well as clinicians’ subjective experience of placebo and 222	  
nocebo effects. 223	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 428	  
Table 1. Participant characteristics (n=558) 429	  
Demographic Values   95%CI 
Gender 
Male, n (%) 







Years, average (SD) 30.5 (6.5) 30.0-31.1 
Italian Region 
North, n (%)  
Centre, n (%)   









Years of practice, average (SD) 6.8 (5.7) 6.3-7.3 
Workplace, n (%) 
Private practice 
Hospital 










































N, number of participants; %, percentage; SD, standard deviation;	  95%CI, 95% confidence interval; >, 430	  
more 431	  
	  	   	  
Table 2. Contextual factors use in clinical practice (n=558) 432	  
Contextual factors itemsa Likert Score  
average   
(95%CI) 
4 
n (%);  
95%CI 
3 
n (%);  
95%CI 
2 
n (%);  
95%CI 
1 
n (%);  
95%CI 
0 
n (%);  
95%CI 
Unaware 
n (%);  
95%CI 




90 (16.1);  
13.2-19.5 
98 (17.6);  
14.5-21.0 
104 (18.6);  
15.5-22.2 
42 (7.5);  
5.5-10.1  




A: Uniform (e.g. white coat) 2.2  
(2.0-2.3) 
215 (38.5);  
34.5-42.7 
47 (8.4);  
6.3-11.1 
33 (5.9);  
4.2-8.3 
30 (5.4);  
3.7-5-7 




A: Positive attitudes and optimistic behavior (e.g. 
towards a patient’s dysfunctions) 
3.5  
(3.4-3.6) 
416 (74.5);  
70.7-78.1 
80 (14.3);  
11.6-17.6 
19 (3.4);  
2.1-5.4 
9 (1.6);  
0.8-3.1 




B: Patient’s expectation and preference (e.g. towards 







55 (9.9);  
7.6-12.7 
15 (2.7);  
1.6-4.5  




















C: Verbal communication (e.g. positive messages 















C: Not verbal communication (e.g. posture, gestures, 
eye contact, facial expressions) 
3.4  
(3.3-3.5) 












C: Empathetic therapeutic alliance with the patient 





69 (12.4);  
9.8-15.4 








D: Overt therapy (e.g. possibility for the patient to see 3.0  288 (51.6); 128 (22.9); 50 (9.0); 17 (3.0); 59 (10.6); 16 (2.9); 
	  	   	  
the therapy using a mirror) (2.9-3.2) 47.4-55.8 19.6-26.7 6.8-11.7 1.8-4.9 8.2-13.5 1.7-4.7 
































D: Physical contact with the patient (e.g. touch to 































E: Adequate environmental architecture (e.g. 































%, percentage; n, number of participants; 95%CI, 95% confidence interval; 0, never; 1, around once per year; 2, around once per month; 3, 433	  
around once per week; 4, daily; A: physical therapist domain; B: patient domain; C: physical therapist - patient relationship domain; D: therapy 434	  
domain; E: healthcare setting domain. 435	  
a The items were reported from: Testa M, Rossettini G. Enhance placebo, avoid nocebo: How contextual factors affect physiotherapy outcomes. 436	  
Man Ther. 2016;24:65-74.  437	  
 438	  
	  	   	  
Table 3. Beliefs regarding contextual factors (n=558) 439	  
Contextual factors itemsa Likert Score  
average   
(95%CI) 
4 
n (%);  
95%CI 
3 
n (%);  
95%CI 
2 
n (%);  
95%CI 
1 
n (%);  
95%CI 
0 
n (%);  
95%CI 
Unknown 
n (%);  
95%CI 






























A: Positive attitudes and optimistic behavior (e.g. 















B: Patient’s expectation and preference (e.g. 































C: Verbal communication (e.g. positive messages 















C: Not verbal communication (e.g. posture, gestures, 















C: Empathetic therapeutic alliance with the patient 















D: Overt therapy (e.g. possibility for the patient to 2.6  102 (18.3); 213 (38.2); 161 (28.8); 38 (6.8); 20 (3.6); 24 (4.3); 
	  	   	  
see the therapy using a mirror) (2.5-2.7) 15.2-21.8 34.1-42.4 25.2-32.8 4.9-9.3 2.3-5.6 2.8-6.4 
D: Patient-centered approach (e.g. shared-decision 































D: Physical contact with the patient (e.g. touch to 































E: Adequate environmental architecture (e.g. 































%, percentage; n, number of participants; 95%CI, 95% confidence interval; 0, not at all; 1, few; 2, enough; 3, much; 4, a lot of; A: physical 440	  
therapist domain; B: patient domain; C: physical therapist - patient relationship domain; D: therapy domain; E: healthcare setting domain. 441	  
a The items were reported from: Testa M, Rossettini G. Enhance placebo, avoid nocebo: How contextual factors affect physiotherapy outcomes. 442	  
Man Ther. 2016;24:65-74.  443	  
 444	  
 445	  
	  	   	  
Table 4. Therapeutic effect(s) of contextual factors (n=558) 446	  
Clinical conditions Psychological and Physiological 
n (%); 95%CI 
Physiological  
n (%); 95%CI 
Psychological 
n (%); 95%CI 
No benefit 
n (%); 95%CI 
Chronic pain 436 (78.1); 74.4-81.4 12 (2.1); 1.2-3.8 104 (18.6); 15.5-22.2 6 (1.1); 0.4-2.4 
Insomnia 345 (61.8); 57.6-65.8 4 (0.7); 0.2-1.9 167 (29.9); 26.2-33.9 42 (7.5); 5.5-10.1 
Acute pain 317 (56.8); 52.6-­‐60.9 26 (4.7); 3.1-6.8 164 (29.4); 25.7-33.4 51 (9.1); 6.9-11.9 
Cognitive disorder 317 (56.8); 52.6-60.9 8 (1.4); 0.7-2.9 230 (41.2); 37.1-45.4 3 (0.5); 0.1-1.7 
Rheumatologic problem 313 (56.1); 51.9-60.2 19 (3.4); 2.1-5.4 170 (30.5); 26.7-34.5 56 (10.3); 7.7-12.9 
Gastrointestinal problem 307 (55); 50.8-59.2 21 (3.8); 2.4-5.8 112 (20.1); 16.9-23.7 118 (21.1); 17.9-24.8 
Emotional disorder 303 (54.3); 50.1-58.5 10 (1.8); 0.9-3.4 232 (41.6); 37.5-45.8 13 (2.3); 1.3-4.1 
Sexual problem 295 (52.9); 48.6-57.1 9 (1.6); 0.8-3.1 151 (27.1); 23.5-31.0 103 (18.5); 15.4-22.0 
Neurological problem 289 (51.8); 47.6-56.0 10 (1.8); 0.9-3.4 155 (27.8); 24.1-31.7 104 (18.6); 15.5-22.2 
Cardiovascular problem 253 (45.3); 41.2-49.6 20 (3.6); 2.3-5.6 156 (28.0); 24.3-31.9 129 (23.1); 19.7-26.9 
Drug and medication addiction 238 (42.6); 38.5-46.9 7 (1.2); 0.5-2.7 187 (33.5); 29.6-37.6 126 (22.6); 19.2-26.3 
Immune/allergic problem 204 (36.6); 32.6-40.7  17 (3.0); 1.8-4.9 170 (30.5); 26.7-34.5 167 (29.9); 26.2-33.9 
Oncological problem 195 (34.9); 31.0-39.1 7 (1.2); 0.5-2.7 274 (49.1); 44.9-53.3 82 (14.7); 11.9-17.8 
Infectious problem 123 (22.0); 18.7-25.8 17 (3.0); 1.8-4.9 189 (33.9); 30.0-38.0 229 (41.0); 36.9-45.3 
• %, percentage; n, number of participant; 95%CI, 95% confidence interval 447	  
!
!
Fig 1. Percentages of responses for clinical vignette 2.  ""#!
""$
A: the pain as non-organic but psychological, B: the patient as very suggestible, C: the "%&!
natural decrease of pain intensity, D: the patient provides the expected response by the "%'!
physical therapist, E: the positive attention of the healthcare team leads to decreased "%(!
pain. "%)!
 "%"!




A: it exerts beneficial psychological effects, B: the other therapies are over, C: The "%+!
patient wants or expects this treatment, D: Clinical experience has shown the "%#!
effectiveness.  "%$!
 "*&!
Fig 3. Percentages of responses for not-ethical use of contextual factors.  "*'!
 "*(!
A: it is based on deception, B: it!undermines trust between patient and physical "*)!
therapist, C: the evidence is insufficient, D: legal problems arise, E: it can create "*"!
adverse effects. "*%!
 "**!





A: it is a treatment that can help and will not hurt, B: it is an effective treatment, C: it "+&!
is a treatment without a specific effect, D: it is a treatment that induces a "+'!
psychological change, E: it can help but you are not sure about its effect, F: do not say "+(!
anything.  "+)!
 "+"!





A: as a result of unjustified and constant demands for physiotherapy interventions, B: "+#!
to calm the patient, C: when all other therapies are over, D: as an adjunct to other "+$!
physical therapy interventions to optimize the clinical responses, E: for non-specific "#&!
problems, F: to stop the patient’s complaints, G: as a diagnostic tool to differentiate "#'!
between psychological and physiological problems, H: to control pain, I: to gain time "#(!
 "#)!
 "#"!
Fig 6. Percentages of responses for contextual factors mechanism of action.  "#%!
 "#*!
A: patient’s expectation, B: conditioning, C: suggestibility, D: natural history of "#+!
disease, E: psychological factors, F: unexplained, G: physiological/biological factors, "##!






S1 Appendix. The questionnaire: “Knowledge about contextual factors among 494	  
Italian physical therapists specialized in manual therapy (OMTs).” 495	  
 496	  
Welcome to this survey! 497	  
Dear colleague thank you for taking part in this survey. 498	  
 499	  
This survey aims to clarify the use of contextual factors in enhancing the therapeutic 500	  
outcome in physiotherapy. 501	  
 502	  
The contextual factors consist of a series of relational or environmental situations that 503	  
may affect the perception of patients’ suffer and functional impairment. Examples of 504	  
the main contextual factors are: the words and posture used by the physical therapist, 505	  
the smells, the sounds and the decor of the therapeutic setting to enhance the 506	  
effectiveness of physiotherapy.  507	  
We consider important to study them in their spread within physiotherapy practice. 508	  
 509	  
Kindly answer the following questions based on your personal clinical experience. 510	  
The compilation of the entire questionnaire is voluntary and requires 10 to 15 511	  
minutes. Your answers are completely anonymous and will only be used for the 512	  
purposes of this research.  513	  
 514	  
By clicking on the link to the survey, you provide your consent to participate in the 515	  
study. Whenever you complete the page, click on "Next" to save your answer. If you 516	  
decide to abandon the survey, select "Exit". 517	  
 518	  
	  	  
Socio-demographic characteristics 519	  
What is your gender? [select] 520	  
¨ Male 521	  
¨ Female 522	  
 523	  
How old are you? [complete] 524	  
………. 525	  
 526	  
How long have you licensed as physical therapist? [complete] 527	  
………. 528	  
 529	  
In which region of Italy do you work? [select] 530	  
¨ North 531	  
¨ Center 532	  
¨ South 533	  
 534	  
What is your clinical workplace? [select] 535	  
¨ Hospital 536	  
¨ Residential care (nursing home, RSA) 537	  
¨ Private practice 538	  
 539	  
What is your field of intervention? [select]  540	  
¨ Geriatric 541	  
¨ Neurological  542	  
¨ Musculoskeletal 543	  
	  	  
¨ Hearth, Respiratory, Pediatric 544	  
 545	  
How many hours do you work for each week? [select]  546	  
¨ 0-15 547	  
¨ 16-30 548	  
¨ 31-45 549	  
¨ 46-60 550	  
¨ > 60 551	  
 552	  
Clinical vignettes 553	  
Clinical vignette 1 554	  
A man of 40 years, freelancer, visits your clinic complaining low back pain. He 555	  
requests a TENS therapy to return to work more quickly. Based on clinical 556	  
examination, you don’t find contraindications for the use of TENS, but you know that 557	  
in this case there is no indication to use this therapy. The patient insists to require 558	  
TENS, on the grounds that this therapy helped him in the past during a previous 559	  
episode of low back pain. 560	  
 561	  
What would you do in this situation? [select] 562	  
¨ deliver TENS 563	  
¨ suggest the possibility of delivering the TENS if the clinical condition fails to 564	  
improve 565	  
¨ try to convince the patient of the futility of TENS 566	  
¨ advise a different treatment commonly used for low back pain 567	  
¨ advise a follow-up appointment on the following days 568	  
	  	  
¨ tell the patient that low back pain would resolve itself in a few days 569	  
 570	  
Clinical vignette 2 571	  
In a hospital, a patient with important shoulder pain receives TENS therapy several 572	  
times a day on demand. For frequent requests occasionally therapy is replaced with 573	  
sham T.E.N.S. (with power-off). The patient reports that in each case the TENS 574	  
(whether active or sham) improve the clinical condition. 575	  
 576	  
What conclusion can be drawn about the effectiveness of TENS sham? [More 577	  
answers are possible] 578	  
¨ the positive attention of the healthcare team leads to decreased pain  579	  
¨ the pain is non-organic but psychological  580	  
¨ the patient is very suggestible  581	  
¨ the natural decrease of pain intensity  582	  
¨ the patient provides the expected response by the physical therapist 583	  
 584	  
Frequency of use (1/2) 585	  
How often in your career do you INTENTIONALLY used the contextual factors to 586	  
enhance the result of physiotherapy? [select] 587	  
¨ many times 588	  
¨ often 589	  
¨ at least once 590	  
¨ never 591	  
 592	  
	  	  
Frequency of use (2/2) 593	  
Indicate how often do have you INTENTIONALLY used the following contextual factors with the patient to enhance the physiotherapy 594	  












Never I did not aware 






Professional reputation       
Uniform       
Positive attitudes and optimistic behavior        
Patient’s expectation and preference       
Patient’s previous experience       
Verbal communication       
Not verbal communication       
Empathetic therapeutic alliance with the 
patient 
      
Overt therapy       
Patient-centered approach       
Professional approach to patient       
Physical contact with the patient       
Comfortable setting       
Adequate environmental architecture       




How do you BELIEVE that your therapeutic outcome can be influenced by ...? [select] 598	  
 Very 
Much 
Much Enough Few None I don’t know 
Professional reputation       
Uniform       
Positive attitudes and optimistic behavior        
Patient’s expectation and preference       
Patient’s previous experience       
Verbal communication       
Not verbal communication       
Empathetic therapeutic alliance with the 
patient 
      
Overt therapy       
Patient-centered approach       
Professional approach to patient       
Physical contact with the patient       
Comfortable setting       
Adequate environmental architecture       
Adequate design       
 599	  
 600	  
	  Ethical issues 
The use of contextual factors for therapeutic purposes can be considered 
ETHICALLY ACCEPTABLE when ... [you can select more than one answer] 
¨ it exerts beneficial psychological effects  
¨ the other therapies are over  
¨ the patient wants or expects this treatment  
¨ clinical experience has shown the effectiveness  
 
The use of contextual factors for therapeutic purposes can be considered 
ETHICALLY NOT ACCEPTABLE when ... [you can select more than one answer] 
¨ it is based on deception  
¨ it	  undermines trust between patient and physical therapist  
¨ the evidence is insufficient  
¨ legal problems arise  
¨ it can create adverse effects 
 
Communication and application 
How do you COMMUNICATE to the patient the use of contextual factors at the 
end of treatment? The notified its ... [you can select multiple possibilities] 
¨ it is a treatment that can help and will not hurt  
¨ it is an effective treatment  
¨ do not say anything  
¨ it is a treatment without a specific effect  
¨ it is a treatment that induces a psychological change 
¨ it can help but you are not sure about its effect. 
	  Under what CIRCUMSTANCES would you use contextual factors? [you can select 
multiple possibilities] 
¨ as a result of unjustified and constant demands for physiotherapy interventions 
¨ to calm the patient 
¨ when all other therapies are over 
¨ as an adjunct to other physical therapy interventions to optimize the clinical 
responses 
¨ for non-specific problems 
¨ to stop the patient’s complaints 
¨ as a diagnostic tool to differentiate between psychological and physiological 
problems 
¨ to control pain 
¨ to gain time 
 
Mechanism of action, therapeutic effect and definition 
What MECHANISMS OF ACTION can explain the effect of contextual factors? 
[you can select multiple possibilities] 
¨ patient’s expectation 
¨ conditioning 
¨ suggestibility 
¨ natural history of disease 
¨ psychological factors 
¨ unexplained 
¨ physiological/biological factors 
¨ spiritual energies 
	  ¨ mind-body connections 
 
What are, in your opinion, the POTENTIAL EFFECTS of contextual factors in the 
following health problems? [select] 





acute pain     
chronic pain     
cognitive disorder     
emotional disorder     
gastrointestinal disorder     
sexual disorder     
drug and medication 
addiction 
    
neurological disorder     
rheumatologic disorder     
immune/allergic disorder     
oncological disorder     
cardiovascular disorder     
infectious     
insomnia     
 
How would you define, in the light of this survey, the therapeutic role of contextual 
factors? [select] 
¨ an intervention without a specific effect for the condition being treated, but 
with a possible aspecific effect  
¨ an intervention that has a special effect through known physiological 
mechanisms  
¨ sham treatment used as control tests for safety and efficacy of active treatment 
¨ a harmless or inert intervention 
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Manual therapy RCTs: should we control placebo in placebo control? 
 
Dear Editor, 
We have read with interest the paper by Bautista-Aguirre and colleagues recently 
published in the European Journal of Physical and Rehabilitation Medicine (1). 
The authors in their randomized controlled trial (RCT) have compared, in patients 
with chronic mechanical neck pain, the efficacy of the high-velocity low-amplitude 
thrust technique directed to the cervical or the thoracic spine with a placebo control. 
The placebo intervention consisted in a sham-manual contact applied over the lateral 
sides of the cranium, with a “five-finger hold” and with no movement or therapeutic 
intention. Interestingly, their findings have revealed a lack of clinically relevant 
differences on neural mechanosensitivity of upper limb nerve trunks and grip strength 
between groups, thus suggesting a role of placebo in the modulation of outcomes. This 
valuable study offers the research community a starting point of reflection about three 
main features associated with placebo intervention when adopted as control in manual 
therapy and stimulates considerations of possible strategies to go beyond the limits. 
Firstly, conceptualising the placebo control as inactive, inert or false could be not 
adequate. Despite the lack of a specific therapeutic action, placebo control can elicit real 
psychobiological responses. These responses, that are the result of well-known 
mechanisms, involving neurotransmitters (endogenous opioids, dopamine, 
cannabinoids, oxytocin and vasopressin) and key brain areas (the dorsolateral prefrontal 
cortex, the rostral anterior cingulate cortex, the periaqueductal grey and the spinal cord), 
are able to influence the patient’s symptoms, such as pain, anxiety and motor 
performance (2). 
	  	  
Secondly, continuing to discretionarily choose a placebo control could hide a 
pitfall. Although up-to-date systematic review recognized the use of heterogeneous 
typology of placebo control in manual therapy such as hands-on techniques (e.g. light 
touch, gentle touch), physical modalities (e.g. ultrasound, laser) and mixed procedures 
(3), researchers should choose a sham comparator as much as possible indistinguishable 
from the active treatment. Aspects like patient and provider positioning and contact, 
movement induced on the patient’s body, mechanical thrusting applied to the patient 
and sound of cavitation should be carefully balanced between experimental and control 
groups (4). 
Thirdly, considering the clinical modifications induced in patients as exclusively 
dependent on the so-called “intervention” (both inactive or active), and neglecting the 
contextual factors surrounding the setting of the intervention could be a fault. Indeed, 
every intervention is administered in a psychosocial arena that is composed also by 
contextual factors, such as therapeutic signs and rituals, the encounter between patient 
and provider, the verbal and non-verbal interaction, the behaviour and appearance of 
provider and the expectation of patient. Placebo control includes a contact between 
provider and patient, it is administered in an environment created for the active 
intervention and is, therefore, similarly influenced by contextual factors (5). 
The designing of the administration of a placebo control in RCTs on manual 
therapy efficacy is far more complex than administration of placebo control in RCT 
assessing drugs efficacy (3). Manual treatment presents specific and contextual elements 
intimately encapsulated that interact with each other, and are difficult to separate when 
planning a RCT (4). From a research perspective, to neglect the contextual factors 
component of the placebo control and its capacity to influence the therapeutic outcome 
could bias the results, underestimating or overestimating the differences between the 
	  	  
treatment and placebo conditions and reducing the possibility to highlight the real 
weight of the specific intervention (5) (figure 1). 
To manage these challenges when designing an RCT on manual therapy, 
investigators could:  
a) balance the contextual factors across the intervention and control groups (4). For 
example, the modality of administration, the feature of the healthcare settings, the 
behaviour and presence of the clinicians, the verbal instruction given to the patient. 
The social interaction of patients and the amount of contact time should be 
controlled as much as possible to be structurally equivalent and comparable in order 
to offer similar context between experimental and control groups (3). 
b) improve the details of a sham procedure in the control group (4). For example, the 
sham dosage (i.e., duration, session, period); the sham procedures (i.e., protocol- 
based or personalised, type of approach); and sham operator (type of practitioner, 
number of operators, operator’s years of experience, training for practitioner, 
operator background, supervision/tutoring) should be reported similarly between 
experimental and control groups (5). 
 Placebo control in physical and rehabilitation medicine continues to represent an 
intriguing topic still debated from both, theoretical and practical perspective. Even more 
than in other research fields, manual therapy researchers should change their mind about 
placebo as inert treatment, start to consider placebo as therapeutically active treatment 
and take care of all the aspects that determine its influence on clinical outcomes, such as 
contextual factors. We think that time has come to reconsider the design of RCTs in 
physiotherapy and manual therapy to better measure the power of our therapeutic 
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A) Balanced use of contextual factors. When contextual factors were adequate controlled among 
experimental and control groups, is it possible to observe the specific action of the experimental therapy.  
B): Unbalanced use of contextual factors. When contextual factors were overbalanced among 










Every chapter of this thesis contains a thorough discussion concerning the specific 
topic investigated. In this last section some critical points, which emerged from the 
discussions of each chapter, are analysed, offering some suggestions that may be helpful 
for future developments and implementation of the contextual factors model in clinical 
practice and research in physical therapy. 
 
Implication for physical therapy discipline  
 As demonstrated in this PhD project, the contextual factors may represent useful 
therapeutic tools capable, in their entirety, of affecting the physical therapy discipline. 
From a clinical perspective, the use of the contextual factors with the best evidence-
based therapy represents an opportunity to enhance placebo effects and to avoid nocebo 
effects, influencing the whole therapeutic outcome in full compliance with ethical code 
and conduct (1, 2). The contextual factors help clinicians to interpret the patients’ 
clinical picture and to unravel the conundrum of underlying complaints, thus explaining 
some unexpected outcomes and variability of symptoms (3, 4). Moreover, physical 
therapists who consider the context as an influencer of therapeutic outcome can 
critically evaluate their therapeutic solutions and also accept potentiality and limits of 
their profession (5).   
 From a policy perspective, contextual factors represent important elements to be 
considered to understand the complexity of modern health systems (6). At multiple 
levels, stakeholders, organizations and governments should take into account the 
context around the healthcare as an element that can affect effectiveness and quality of 
	  	  
care, to encourage its assessment and analysis in clinical settings (7). For example, the 
context around the treatment can impact the overall patients’ satisfaction and their 
perceptions of their health care experiences, so as to enhance the attractiveness of a 
specific healthcare service, guiding the patient to choose, return to and recommend it, 
and to improve the compliance towards treatments and follow-up (8). Moreover, the 
investigation of the dynamic interactions among health, personal, organizational and 
contextual variables can help to identify problems, to improve healthcare processes, to 
define appropriate policies and to allocate resources (9, 10). 
 From an academic perspective, contextual factors (e.g. patient-clinician 
relationship) embody useful elements, the awareness and the practice of which have to 
be strengthened in the teaching programs and activities during the university training, in 
order to prepare the students for a better management of the psychosocial component of 
disease during internships (11). In medical education, contextual factors help student to 
consider the therapeutic outcome as a product of the interactions between clinicians, 
patients and setting as a complex, not predictable and nonlinear system that evolves 
over time (12). In addition, recent findings have proposed the contextual factors as 
capable to impact the clinician’s clinical reasoning performance during diagnostic and 
therapeutic process (13-15), thus offering to mentors and teachers a further didactic 
topic for the improvement of students’ clinical competences (16). 
 
Implication for future studies 
The results of the present PhD project represent a starting point for future 
researches in physical therapy, part of which has already been initiated in the scientific 
world. The possibility to study the contextual factors, placebo and nocebo effects allows 
	  	  
the scientific community to measure their impact on different outcomes and in different 
musculoskeletal conditions, through primary studies. 
 A first line of research aims to identify the best placebo comparator for different 
manual therapy treatments. Various studies tried to develop (17, 18) and validate (19-
21) a sham placebo procedure, however many complications challenged this research, 
due to the difficulty of controlling the subjects’ blinding, the expectations and the a 
priori inertness of the sham procedure (22-24). Recently a novel sham procedure had 
been validated (25) and applied in clinical setting in patients with migraine (26) and 
cervicogenic headache (27), thus opening the possibility of investigations, the results of 
which are expected in the following 3 years. 
A second line of research should analyse the active mechanism of action of 
contextual factors. Despite the creation of an adequate trial design remains a challenge 
in placebo and nocebo research (28, 29), randomized clinical trials are planned in the 
next years to measure the impact of contextual factors on different therapeutic outcomes 
in various musculoskeletal conditions (30). This research approach could be developed 
through the comparison of the same physical therapy treatment performed in a neutral 
and enriched context, to measure the change of subjective (e.g. pain and disability) and 
objective (e.g. strength) outcomes (31, 32). 
A third line of research can explore the patient’s point of view concerning the 
contextual factors. Indeed, survey (33-35) and qualitative interview (36-39) have been 
adopted to study the patient’s perspective regarding the ethics and the acceptability of 
placebo treatments. To date, no studies of that kind have been performed in Italy, thus 
opening a window of opportunity for similar investigations there. Furthermore, an item 
bank of contextual factors has been proposed to assess the healthcare experience and 
attitudes from the patient's perspective (40). This recent finding offers a starting point 
	  	  
for the creation of a questionnaire, to classify the patients on the basis of their 
preferences about contextual factors, to guide clinicians on enriching the physical 
therapy treatment with a specific contextual element. 
 
Strength and limitations of the PhD project  
The use of different study designs represents the strength of this PhD project. The 
contextual factors have been investigated using a clear and defined methodology as 
reported in chapter III (systematic review of qualitative studies using a metasynthesis 
and metasummary approach) and chapter IV (national online survey), thus reducing the 
possible source of bias and improving the overall quality of the project (41, 42). 
Moreover, the topic has been discussed using a multidisciplinary broad-spectrum 
analysis ranging from clinical to research points of view, helping the reader to 
understand the topic from different perspectives and increasing the PhD student’s 
reflective process (43). 
The creation of the conceptual model of contextual factors through non 
systematic-review methods for physiotherapy outcomes (chapter I), for musculoskeletal 
pain (chapter II), and for clinical trial research (chapter V) could represent a possible 
weakness of this PhD project. However, narrative review, debate and letter to the editor 
have been considered an accepted method for discussion (42) and have been previously 
adopted as a model in placebo, nocebo and contextual factors research (44-47).  
 
Conclusion 
The aim of this PhD project has been to investigate the relevance of contextual 
factors as triggers of placebo, nocebo effects and their impact on therapeutic outcome in 
	  	  
physical therapy. This goal has been achieved through different study designs, in order 
to present the contextual factors as a general conceptual model for physical therapy 
practice.  
Three main findings emerged:  
1) The contextual factors affect the different physical therapy outcomes such as pain 
and patients’ satisfaction;  
2) Italian physiotherapists deliberately use contextual factors in their daily practice, 
and believe they have therapeutic effects;  
3) The contextual factors represent elements to be carefully considered while 
designing clinical trials. 
In summary, the research on contextual factors as triggers of placebo and nocebo 
effects is at an early stage, and it represents a vast area for further investigation. 
This translational approach includes an opportunity of growth for the whole 
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In the Appendix, different corollary papers, conducted during the three years of   
this PhD are presented. The contextual factors model was adapted in the nursing field. 
After this, the knowledge, attitude and behaviour of Italian nurses regarding contextual 
factors were examined. Finally, the context effect was investigated in motor 
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The impact of contextual factors on nursing outcomes and the role of 
placebo/nocebo responses: a discussion paper 	  
Abstract 
Placebo and nocebo responses represent one of the most fascinating topics in the 
healthcare field. The placebo response (from Latin “I shall please”) is a beneficial 
outcome(s) triggered by a positive context. The opposite is the nocebo response (from 
Latin “I shall harm”), which indicates an undesirable outcome(s) triggered by a negative 
context. Both are complex and distinct psycho-neurobiological phenomena in which 
behavioural and neurophysiological changes arise subsequent to an interaction between 
the patient and the healthcare context. Placebo and nocebo concepts have been recently 
introduced in the nursing discipline, generating a wide debate on ethical issues; 
however, nursing implications of education, clinical practice, nursing administration 
and research regarding contextual factors triggering nocebo and placebo effects, have 
not been debated to date. Therefore, the aims of this discussion paper were: (a) to 
briefly introduce the placebo and nocebo mechanisms and responses, (b) to elucidate the 
contextual factors capable of triggering placebo and nocebo responses in the nursing 
field, and (c) to debate implications of contextual factors at the nursing education, 









Placebo and nocebo responses represent one of the most fascinating topics in the 
healthcare field. They constitute two multifaceted phenomena in which psycho-
neurobiological modifications arise after an interaction between the patient and the 
context. While the placebo response (from Latin placēbō, “I shall please”) represents a 
beneficial outcome(s) produced by a positive context (1), the nocebo response (from 
Latin nocēbō, “I shall harm”) expresses an undesirable outcome(s) produced by a 
negative context (2).  
In the medical literature, the concept of placebo has been debated since 1941 (3), 
specifically in the field of medication administration, and was introduced as a Medical 
Subject Heading (MeSH) in 1990. On the other hand, the concept of nocebo was 
introduced by Kennedy in 1961 and recognised as a MeSH only in 2014. In the nursing 
discipline, while placebo was introduced in 1966 (4), nocebo was formally introduced 
in the literature only eight years ago (5). 
Moreover, both concepts have generated a wide debate mainly regarding ethical 
issues (6, 7) despite that they have been proposed as promising clinical tools useful in 
modulating nursing outcomes (8, 9). According to the most recent review in the field, 
primary studies on nocebo effects have not been summarised to date (8, 9).  
In recent years, the investigation of placebo and nocebo responses have been 
included the evaluation of the context supporting the patient in achieving (or not) the 
desired health outcomes (10). As a consequence, the misleading interpretation of 
placebo as inert treatment given to comfort or please the patient have been overcome; 
differently, the modern conceptualization of the placebo and nocebo responses as the 
psychosocial context that accompanies any healthcare intervention, be it active or sham, 
have been embraced (11-13). 
	  	  
The context is composed by the “whole atmosphere around the therapy” (14) 
created by the health-care team, technologies and settings. Recently, specific contextual 
factors have been proposed in the literature as potential triggers of placebo and nocebo 
responses (11, 15). As suggested by Di Blasi, Harkness, Ernst, Georgiou, and Kleijnen 
(16) these factors are embodied at different levels: a) provider and patient features, b) 
patient-provider relationship (e.g. empathy), c) intervention (e.g. colour and shape of a 
medication), and d) healthcare setting (e.g. home or hospital, room layout). These 
factors constitute the therapeutic ritual and healing symbols surrounding the encounter 
capable of triggering placebo and nocebo responses, impacting the patient’s physiology 
and psychology and, ultimately, influencing the expected clinical outcome (17, 18).  
Since a boost of placebo and prevention of nocebo would be valuable for nursing 
practice, this discussion paper aimed to: (a) briefly introduce the placebo and nocebo 
mechanisms and responses, (b) elucidate the contextual factors capable of triggering 
placebo and nocebo responses in the nursing field, and (c) debate implications at the 
nursing education, practice, organisational and research levels. 
 
Placebo and nocebo mechanisms and responses 
Placebo and nocebo responses have been used as a model to investigate the 
human body systems, analysing their interaction with different systems, mechanisms, 
diseases and therapeutic interventions (19). Specifically, placebo and nocebo responses 
have been studied in mood, cardiovascular, respiratory, gastrointestinal, motor, immune 
and endocrine systems (20-22). However, pain represents the most investigated 
symptom of placebo and nocebo responses (2, 23) as reported in Figure 1. The factors 
explaining placebo and nocebo responses, have been identified at the individual levels 
and at the context levels. 
	  	  
 
Individual and psychological factors 
At the individual level, early stages of the research aimed at evaluating the role of 
some genetic variants were established as relevant in placebo and nocebo responses but 
the available findings are not conclusive (24). Preliminary evidence regarding that goal-
seeking, self-efficacy/esteem, the locus of control, optimism, fun seeking, sensation 
seeking, neuroticism, suggestibility, beliefs and body consciousness, can all act as trait 
predictors of placebo responses (25), differently, anxiety, panic disorder or pessimism 
can exacerbate nocebo responses (9). However, more evidence is available regarding 
the role of psychological determinants such as expectations and learning (26, 27).  
An expectation represents a conscious element through which the patient expects 
a beneficial or harmful outcome based upon the evaluation of contextual factors such as 
verbal instructions (e.g. communication associated with interventions provided by the 
nurse) or past experiences (e.g. previous interaction with a nurse) (26). The expectations 
are capable of creating modifications through the influence of the reward mechanism 
and anxiety and can be further influenced by emotional and cognitive factors, such as 
self-efficacy, self-reinforcing feedback, memory, attention and motivation (19, 20, 28). 
Learning encompasses associative, social and reinforced expectation mechanisms 
(27). Associative learning emerges when a conditioned neutral stimulus such as a 
contextual factor (e.g. the colour of a medication) is associated with an unconditioned 
stimulus (e.g. the active molecules contained in the medication), and it is capable of 
modulating the symptom even when the active principle is not administered (29). Social 
learning occurs, for example, when a patient following a specific treatment learns to 
modulate symptoms by appreciating the responses reported by other patients (27). 
Moreover, in accordance with Colloca (27) expectations and learning represent an 
	  	  




From a neurobiological perspective, placebo and nocebo responses have been 
documented to be developed by a specific neurochemistry and neural network (21). 
Placebo and nocebo interact with the brain modulatory systems at a neurochemical 
level, through the release of specific neurotransmitters (21). For instance, considering 
pain outcome as a model, the endogenous opioids, dopamine, cannabinoids, oxytocin 
and vasopressin are involved in the reduction of pain (e.g. placebo analgesia) whenever 
the patient interact with positive contextual factors (1, 30). Opposite, cholecystokinin, 
dopamine, opioid deactivation and cyclooxygenase-prostaglandins activation are 
implicated in the amplification of pain (e.g. nocebo hyperalgesia) during healthcare-
patient encounter surrounded by negative contextual factors (2, 30). 
Furthermore, recent advances in neuroimaging techniques, such as functional 
magnetic resonance imaging (fMRI) and positron emission tomography (PET), suggest 
an involvement of specific neural correlates during placebo and nocebo responses of 
pain (21). The positive and negative use of contextual factors are capable of acting or 
de-acting the four key brain regions commonly associated with the descending pain 
processing pathway: the dorsolateral prefrontal cortex, the rostral anterior cingulate 
cortex, the periaqueductal grey and the dorsal horn of spine (30, 31) Nevertheless, other 
classical pain-matrix areas have been reported to change in their activity during placebo 
or nocebo responses such as thalamus, insula, somatosensory cortex, and mid-cingulate 
regions (12, 13).  
 
	  	  
The trigger role of contextual factors  
Contextual factors have been documented as triggering placebo and nocebo 
responses. Specifically, all clinical interventions have been defined as composed by two 
inseparable elements: (a) the first is the intervention itself (e.g. the medication, the 
treatments) mainly based upon biological elements, while the (b) second is based upon 
the context (1). The context is not a vacuum but it represents a powerful healing space 
enriched by emotional, cognitive, affective, social and relational factors, and is capable 
of interacting with the patient’s clinical condition (12). These contextual factors convey 
a hidden meaning, detected and actively analysed by the patient, which are essential for 
the perception of care and the interpretation of the therapeutic intervention (29). When 
these factors are filtered by the patient’s perspective, they are translated into a complex 
cascade of psycho-neuroimmunoendocrine events capable of generating placebo/nocebo 
responses and eliciting expectations, memories and emotions that in turn can influence 
the patient’s health-related outcome (12, 29). 
To date the contextual factors relevant in triggering placebo and nocebo responses 
have been identified by Di Blasi, Harkness, Ernst, Georgiou, and Kleijnen (16) and 
recently translated by Testa and Rossettini (15) in the physiotherapist field and by 
Rossettini, Carlino and Testa (11) in musculoskeletal pain. These contextual factors, 
which are capable of influencing the clinical outcomes, have been identified as: 
professional reputation, appearance, beliefs and behaviours of healthcare providers; 
expectations, preferences, previous experience, clinical conditions, gender and age of 
the patient; verbal and non-verbal elements of communication characterising the 
patient-healthcare provider relationship; the environment, architecture and internal 
design of the healthcare setting; specific aspects of treatment such as a clear diagnosis, 
	  	  
an overt therapy, observational learning and patient-centred approach, a global process 
of care and the therapeutic touch. 
 
Nursing outcomes can be modulated by contextual factors 
Nursing outcomes are considered those changes subjectively or objectively 
reported by patients or by their caregivers and/or family members, as a result of the 
nursing care received. Safety and effectiveness outcomes have been categorised and 
specific indicators have been established (32). Among safety outcomes, falls, pressure 
sores, hospital acquired infections (e.g. pneumonia, surgical site infections) and 
medication errors leading to mortality have been described (32). Among effectiveness 
outcomes, activity daily living independence, as well as patient or family self-
management competence, coping, comfort and satisfaction with nursing care have been 
established and included in several national and international quality indicators and 
research projects (32).  
With the goal of preventing negative outcomes as those associated to safety, and 
achieving positive outcomes as those associated with effectiveness, clinical nurses 
develop the plan of care after identifying actual or at-risk problems. On the basis of 
patient and caregiver preferences, values and resources, clinical nurses identify the 
nursing interventions required. These interventions should be based upon the evidence 
available and can be composed of simple interventions (patient mobilisation), bundle 
interventions (such as the prevention of infections associated with care) or complex 
interventions (such as those performed for improving independence in nursing homes or 
in mental health care). All of these interventions can be performed by the same nurse 
(as in the case of a family nurse or primary nurse) or by a team (as in the case of 
hospital nursing care).  
	  	  
Although evidence emerging from research can suggest the likelihood of 
preventing a certain negative outcome, or achieving a positive outcome thanks to an 
intervention, there is a need to consider the “uncertainty principle” (10). Paraphrasing 
Colloca and Benedetti (10) it is a challenge to measure with a certain degree of accuracy 
the contribution of each intervention (e.g. the effect of an educational session) on 
outcomes because the intervention itself is influenced by contextual factors. Effects 
determined by interventions have been conceptualized as the sum of the contextual 
factors effect plus the active intervention effect plus the interaction of the contextual 
factors and active intervention effects (33). The contextual factors surrounding the 
patient has the power to interact with the intervention, modulating its effect and 
outcomes (12, 30, 31). Positive contextual factors can increase the effectiveness of the 
nursing intervention, while negative contextual factors can decrease it (22). Thus, the 
contextual factors embody a non-eliminable component of nursing care capable of 
influencing the overall patients’ outcomes (34) such as (a) the positive patient’s 
experience with care (e.g. satisfaction, involvement, perception of quality, 
empowerment, adherence and compliance to treatments, motivation, willingness, hope, 
safety); (b) the occurrence of adverse events (e.g. patient mortality, medication errors, 
restraint use and hospital-acquired infections); and (c) symptoms (e.g. pain, discomfort, 
anxiety, nausea, stress, fatigue, social, psychological, physical and spiritual wellness) 
(35-85).   
To our knowledge, no attempt has been established to develop conceptual models 
aimed at summarising the contextual factors relevant for placebo and nocebo responses 
among the nursing discipline. Thus, the conceptual models available in the field and 
developed by Di Blasi, Harkness, Ernst, Georgiou, and Kleijnen (16), Testa and 
Rossettini (15) and by Rossettini, Carlino and Testa (11) have been considered and 
	  	  
translated in the nursing field by categorising contextual factors in: a) nurse and patient 
features, b) the patient-nurse relationship, c) intervention features, and d) the 
characteristics of the healthcare setting, as reported in Figure 2. Table 1 reports a 
summary of contextual factors triggering placebo and nocebo responses that clinical 
nurses should consider in their daily care. 
 
Nurse features 
Nurses embody a specific “effect” because they convey information to the patient 
through appearance and behaviour that communicate the essence of nursing care (35). 
As the first impact, a nurse’s uniform is capable of influencing the perception of nursing 
professionalism and competence by patients (36, 37).  
The professional qualifications, expertise, competences and technical skills of 
nurses can influence patient satisfaction and compliance with care (38-41). Moreover, 
personal qualities such as leadership, attitudes and beliefs are components capable of 
influencing patient satisfaction and the occurrence of adverse events such as patient 
mortality, medication errors, restraint use and hospital- acquired infections (42). Other 
personal qualities include honesty, openness, trustworthiness, empathy, compassion, 
confidentiality and commitment to providing the best care. Authenticity, assertiveness, 
humility and the ability to provide holistic care have also been associated with patient 
satisfaction and perception of quality with nursing care (43, 44). Moreover, awareness 
of unvoiced needs by encouraging patients to share their concerns, have also been 
documented as capable of influencing outcomes. When caring for patients and 
caregivers, demonstrating care, tolerance and respect, accepting patient preferences and 
decisions, and providing information regarding illness and health processes all influence 
nursing outcomes (38-41, 43, 44). 
	  	  
On the other hand, failure to anticipate or recognise patient needs, depersonalising 
the patient by referring to him or her by the medical diagnosis or bed number, 
neglecting care responsibilities, in which patients feel abandoned, vulnerable, ashamed, 
ignored or insecure can negatively affect nursing outcomes by increasing the occurrence 
of adverse events (38, 43, 45-47). 
 
Patient features 
The patient's previous experiences, preferences, and expectations are significant 
elements capable of influencing both placebo and nocebo responses.  
The expectations regarding an intervention can influence the patient's 
involvement, satisfaction and experience as well as the outcomes regarding pain control 
(48-50). Positive expectations, desires and hopes may increase nursing outcomes (48, 
49), while, as reported recently by Woo (50) negative expectations of discomfort during 
wound dressing changes have been associated with an increased occurrence of pain 
(also known as nocebo hyperalgesia), wound exudate and occurrence of necrotic tissues.  
Moreover, previous experience of care and preferences can also influence 
outcomes. According to a recent systematic review, the likelihood of a nocebo response 
is increased when prior negative knowledge or expectations exist. In addition, pre-
existing psychological traits (e.g. anxiety) may exacerbate the nocebo influence (9). 
Finally, the socio-demographic backgrounds of patients such as age and gender 
have also been documented as nursing outcome triggers. Elderly patients have been 
reported to be more satisfied with nursing care; moreover, men have been documented 
to report a higher level of satisfaction with nursing care compared to women, similarly 
to patients with lower education levels (51). Differently, the nocebo effect has been 
reported more often among women (9).  
	  	  
 
The patient-nurse relationship  
A patient-centred communication based upon verbal and non-verbal strategies 
positively influences the clinical encounter between the nurse and the patient, 
improving satisfaction, empowerment, adherence to care treatments and symptom 
resolution (52, 53). Differently, as documented recently by Doyle, Hungerford and 
Cruickshank (54) poor patient outcomes occur when the nurse’s behaviour is callous 
and lacks empathy.  
Verbal communication is emphasised by open-ended and affective questions and 
the ability to listen actively, as well as by techniques aimed at increasing understanding 
of the patient’s concerns such as communicating with empathy, paraphrasing, and 
following-up cues (5, 55). Verbal communication used by nurses during medication 
administration has been documented to influence the patient’s satisfaction and 
symptoms: pain is influenced positively by verbal suggestion of amelioration and 
negatively by verbal sentences of aggravation (55-57).  
Non-verbal communication is also considered a key factor influencing nursing 
outcomes. Additionally, the nurse’s ability to interpret non-verbal body language 
expressions of emotion and/or distress may affect patient satisfaction (55). Tailoring 
non-verbal communication to patients’ sensory deficits is also crucial: deaf patients 
report an increased sense of vulnerability, a risk of delayed recognition of their 
symptoms and needs and in receiving appropriate interventions (58). 
 
Intervention features 
Several elements of nursing interventions can affect patient outcome(s). Showing 
or telling a patient that an intervention is being applied can stimulate placebo responses 
	  	  
(59). Moreover, presenting information about side effects of treatment in form of 
probability instead of a mere list, as well as balancing positive and negative information 
during care, can reduce the nocebo responses (60).  
Creating a therapeutic context in which patients can share their experiences with 
other patients or can watch videos where patients report their positive experience with 
the same intervention may increase the likelihood of positive effects of the treatment 
(61). Similarly, reducing exposure to patients experiencing side effects of the 
medication can reduce nocebo (60). In addition, in the field of educational interventions, 
offering in-group sessions by nurses instead of individual interventions can trigger some 
effects (62): according to the literature available, patients who receive education 
sessions in a group have increased motivation, willingness, compliance and hope, and 
also interact with other participants (63). 
The patient-centred approach is also capable of modulating nursing care effects 
(64). Tailoring nursing interventions by considering patient preferences and needs, 
empowering patients in self-care management and ensuring continuity along care 
transitions, as well as offering visits by the same nurse, can all positively influence 
nursing outcomes such as patient’s satisfaction, compliance and experience with care 
(38-41, 43, 65-68). On the other hand, higher workloads, long waiting times, the use of 
medical and sophisticated language, or the adoption of nurse-centred approaches with a 
lack of patient understanding and proximity can hamper patient satisfaction (38, 40, 43, 
45, 66, 67). In addition, the above-mentioned factors may reduce consistency between 
patients and nurses regarding the care plan, thus threatening its quality (69). 
The comfort touch adopted by nurses has also been recognised as a contextual 
factor. Touch represents the basis of social interaction conveying information about the 
emotional and mental state of individuals involved in the relationship (70). In nursing 
	  	  
care, touching has been documented as a useful intervention that alleviates pain, 
anxiety, nausea and fatigue, thus increasing the quality of life (71-75). While touching 
patients, nurses communicate empathy, caring, affection, concern and security, thus 
facilitating the achievement of the expected outcomes (70).  
 
Healthcare setting features 
Sensory cues, structural aspects, decorations and ornaments are the most 
influential elements of the healing environment that should be considered when 
planning and designing the care settings (76, 77).  
In general, clear indication of health-care settings can improve healthcare 
accessibility (78). Specifically, environments with natural lighting (e.g. full spectrum 
lighting), low noise levels (e.g. adoption of sound-absorbing ceilings or 
earplugs/earmuffs) and relaxing and soft sound (e.g. music, bird songs, rain showers, 
ocean waves) have been documented as greatly appreciated by patients (79-81). Also 
the adoption of pleasant aromas and an adequate temperature and microclimate (e.g. 
filters, airflow control and ventilation systems) all generate a positive therapeutic setting 
(82). 
Moreover, environments that integrate windows and skylights, with comfortable 
and private settings (e.g. single-bed or private patient rooms) have also been 
documented as greatly appreciated by patients (78). Nature artwork, such as flowers or 
green vegetation in nursing homes, can have a calming effect (78, 82). The adoption of 
healing gardens close to wards (e.g. plants, water) and social spaces (e.g. lounge, day 
rooms and waiting rooms) have been documented as increasing connections between 
patients and their caregivers, thus reducing stress and promoting wellbeing (82). Colour 
	  	  
frames based on calming tones also mitigate patient involvement in nursing care, 
however the meaning of colour is culturally based and can differ between patients (78).  
Finally, combining positive distractors have been documented as modulating pain, 
stress, anxiety and safety, promoting social, psychological, physical and spiritual 
wellness (83). However, uncomfortable, frightening, oppressive, claustrophobic and 
dirty rooms have been associated with patient dissatisfaction and negative outcomes 
(84, 85). 
 
Implications for the nursing discipline 
While the placebo has a longer history in the nursing literature, the recent 
introduction of the nocebo concept suggests that these concepts require complete 
consideration at different levels of the nursing discipline, e.g. from education to clinical 
practice, nursing administration and research. Because of the relationship with patient 
clinical outcome, it is necessary to identify future directions for inquiry and application 
starting with a critical evaluation of current nursing practices. 
 
Nursing education 
Although the concept of caring as acquired during nursing education embodies 
several of the above-mentioned factors (86), these are not always clearly described in 
nursing programs (87). The nursing curriculum should consider the relevance of 
contextual factors by including these in their programs. Specifically, if these factors are 
ignored, that may communicate to students and faculty members that they are irrelevant 
in nursing care.  
Students at different levels of education (from bachelor’s and master’s nursing 
degrees) with different degrees of nursing competence should be coached to analyse and 
	  	  
consider the relevance of contextual factors in triggering nursing outcomes. They 
should be accompanied to progressively increase their awareness of their own attitudes 
and traits. In addition, they should be accompanied to develop complex competences in 
assessing patient and caregiver needs and preferences, also taking into consideration 
cultural patterns.  
Students should have the opportunity to reflect on how their personal qualities 
evolve by reflecting on clinical experiences. On the other hand, supervisors at both the 
faculty and clinical levels should consider student aptitudes and qualities (such as 
openness and honesty) as specific traits on which students need to receive feedback 
aimed at promoting their growth. Students should also have the opportunity to reflect 
with experienced nurses on unexpected negative patient outcomes, by identifying the 
relevant contribution of some contextual factors in addition to other well-known 
mechanisms such as the nurse-to-patient ratio or physiopathology mechanisms. 
Moreover, the clinical context in which students undertake their clinical 
experience should be qualitatively adequate. Contextual elements triggering placebo 
and nocebo responses may also have a role in student learning outcomes, preventing or 
facilitating their achievements, an area that has not attracted the attention of researchers 
to date. 
 
Nursing clinical practice 
How clinical nurses consider the contextual factors triggering nocebo/placebo 
responses in their daily practice has been not documented to date. However, in those 
contexts in which nurses work in groups as in the hospital, the inter-nurse variability 
with regard to the consideration of contextual factors may offset the positive effects 
obtained or reinforce negative ones. Patients switching from one nursing team to 
	  	  
another at the end of shifts, or transiting from one context to another (the medical unit to 
rehabilitation unit), can experience uncertainty or confusion even if nursing 
interventions are similar. These effects can be different due to different contextual 
factors.  
Moreover, experienced clinical nurses may identify other factors not clearly 
included in the available frameworks (88) by their clinical wisdom and expertise, as 
well as their close relationship with patients, and may develop an in-depth knowledge of 
other factors that may modulate the relationship between nursing care and patient 
outcomes. Therefore, it is ideal to ensure continuity in care by providing the same nurse 
(e.g. primary nursing models). When this is not possible, it is suggested that care plans 
contain documentation regarding relevant contextual factors and their clinical effects, 
aiming at ensuring consistency across shifts and contexts in order to increase the 
likelihood of a positive nursing outcome. 
Clinical nurses should also be supported in developing and maintaining their 
competences through continuing education strategies that should not only concern 
interventions, but also the context in which they are implemented. Moreover, with 
regard to the ethical implications of the contextual factors, clinical nurses have been 
documented to consider placebo responses as real, with therapeutic benefits, and 
permissible within the ethical borders in daily practice (89). Therefore, the elicitation of 
placebo and the avoidance of nocebo responses by contextual factors have been 
reported as ethical (11, 15). In fact, the conscious adoption of contextual factors 
symbolises a useful chance to improve evidence-based nursing care without threatening 
the principle of non-maleficence, the patient autonomy and informed consent. Therefore 
this approach is profound different with that replacing the required treatment with a 
potentially ineffective treatment (20, 22, 90). 
	  	  
_ENREF_23  
Nursing care organization 
The ward atmosphere and environment have received increased attention in recent 
years as mediators of the quality of nursing care. Examples may be detected in recent 
studies where the organisational support perceived by clinical nurses may modulate 
patient outcomes by increasing or decreasing their occurrence (91, 92). Differently, in 
light of nocebo/placebo mechanisms, contextual factors may directly influence patients 
and promote (or hamper) the achievement of expected outcomes. Therefore, the role of 
the environment should be considered not only as affecting the performance of the 
nursing workforce, but also as triggering patient outcomes with direct effects. 
Nurse leaders should be prepared to continually assess, design and promote 
interventions to improve the quality of the environment while working with other 
leaders both at the hospital and at the residential levels. There is also a need to develop 
and validate instruments capable of measuring the quality of factors implied in 
nocebo/placebo mechanisms, aiming at monitoring the amelioration of the contextual 
factors over time. 
Any form of nursing care standardisation, addressing patients’ needs without 
considering preferences, expectations and unique needs, should be detected early and 
prevented. Specifically, some models of nursing care delivery (e.g. functional models), 
should be immediately replaced with person-centred models where evidence-based 
approaches, capable of identifying the best interventions within those documented in the 
literature, are implemented in an appropriate environment, capable of maximising the 




While placebo and nocebo responses are well documented, there has been 
minimal research in the nursing field (8, 9). 
Designing and implementing a trial for placebo and nocebo investigation 
represents a challenge (33) and several confounding factors should be controlled. The 
history of disease, the influence of uncontrolled biases, unidentified co-interventions 
and adverse side effects can all modulate nursing care outcomes (93). Research on 
placebo and nocebo should adopt placebo ethically as an enhancing strategy associated 
with the best evidence-based available interventions to prevent nocebo and improve 
nursing outcomes (20, 90). Moreover, research on placebo and nocebo responses should 
be moved on contextual factors effect (11, 15). Limiting the influence of the contextual 
factors around the intervention can help to identify the specific effect of the intervention 
itself. On the other hand, boosting the context around an active intervention can disclose 
the role of contextual factors in modulating clinical outcomes (59). 
Different lines of research can be designed and promoted in specialist areas (e.g. 
critical care nursing, oncology care, mental health or chronic care) or in general areas, at 
national and international levels, also considering the cultural differences that may 
affect placebo and nocebo effects. Firstly, there is a need to explore the knowledge and 
expertise on placebo and nocebo responses both among undergraduates and registered 
nurses, aiming at assessing their awareness in the field and promoting improvements to 
increase their awareness. There is also a need to discover the effect of single and/or 
combined contextual factors affecting nursing care outcomes, possibly through 
incremental study designs to weigh the effect of each component. Lastly, exploring 
patient perceptions regarding the contextual elements capable of positively or 
negatively influencing expected nursing outcomes, as well as researching psychological 
	  	  
and genetic traits of placebo and nocebo responders given the documented variability 
across patients (15), are recommended.  
 
Limitations 
This discussion paper is affected by several limitations. First, the model selected 
(11, 15, 16) for summarizing the role of the contextual factors was not preliminarily 
validated for its consistency in the nursing discipline. However, some elements are not 
tied to individual disciplines but are common frameworks for all health disciplines. 
Second, examples of primary studies and data provided in supporting each element of 
the model were not selected by using a systematic approach (e.g. a systematic review of 
the literature) and not criticized in depth given that the priority was to offer a brief 
overview. Third, contextual factors have been categorized into a conceptual model by 
describing each factor involved; interpretations with regard the relationships between 
factors and placebo require further critical analysis and discussion. Fourth, in this 
discussion paper we emphasize the need of continuing scrutiny and reflection on daily 
practice aiming at potentiating positive and at preventing negative outcomes by 
modulating the contextual factors. However, reflective professional processes are 
important above the placebo and nocebo effects, given that allow nurses, and all 
clinicians, to continuing understand and learn how their behavior, and attitudes and the 
environment of care contribute to improve patients’ experience. Finally, according to 
the aims of the study, the use placebos as controls in clinical trials was not considered in 




To our knowledge, this is the first paper discussing the implications of 
nocebo/placebo mechanisms in the nursing field. Paradoxically, Florence Nightingale, 
in defining the role of the nursing over 100 years ago, was the first theorist who 
expressed nursing as “the act of utilizing the environment of the patient to assist him in 
his recovery (Nightingale, 1860)”. Contextual factors have a trigger effect on nursing 
outcomes. Therefore, besides appropriate evidence-based interventions, nurse educators, 
clinicians, leaders and researchers, in their different fields of competence, should pay 
specific attention to contextual factors in order to develop their awareness, unveil their 
mechanisms of action by considering them in their implementation in daily practice. 
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Table 1. Contextual factors increasing placebo responses and contrasting nocebo 
responses: a summary for clinical practice (adapted by Testa and Rossettini 2016) 
Nurse and patient features 
Develop qualification, knowledge, competence and expertise; 
Adopt a professional uniform;  
Be genuine, respectful, tolerant, honest and trustworthy during nursing care; 
Provide clear information, prompts and explanations of patients’ problem(s); 
Explore each patient’s disease and illness, expectations, preferences, desires, hopes and 
previous experience; 
Stimulate enquires and answers to patient requests by offering advice and reassurance; 
Consider patient’s gender, age and educational background 
Patient-nurse relationship  
Be warm, confident, compassionate, assertive and open with patient; 
Adopt empathetic speech pattern, language mutuality, open-ended and affective questions;  
Adopt a patient-centered communication style and active listening;  
Offer positive messages associated with nursing intervention implementation; 
Make eye contact, smile, adopt facial expressiveness of concern, assistance and 
engagement; 
Use affirmative head nodding, gestures and postures orientated towards the patient; 
Interpret the patient’s non-verbal body language expressions of emotion and distress.  
Intervention features 
Demonstrate and communicate to the patient that the intervention is going to be delivered; 
Stimulate patient to discuss with other patients who have undertaken similar interventions 
with positive results; 
Adopt a holistic approach, tailoring interventions to patient preferences and values; 
Ensure continuity by offering nursing care by the same nurse (e.g. primary nursing model); 
Offer easy accessibility, adequate time and continuity of nursing care; 
Inform, facilitate, help, assist, comprehend and take care of patients through the adoption of 
touch.   
Health-care setting features  
Ensure indications to facilitate nursing care accessibility; 
Offer a pleasant caring environment by decorating with artwork and ornaments; 
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ABSTRACT  
Background: The placebo phenomenon has been studied in nursing discipline while 
the nocebo effect remains unexplored. Recently a set of contextual factors functioning 
as potential triggers of placebo and nocebo effects has been described; however, their 
use in daily nursing clinical practice have never been reported. 
Objectives: To describe beliefs and daily use of the contextual factors aiming at 
increasing the placebo effects and at preventing nocebo effects in nursing practice.  
Design: A national web-based cross-sectional survey on 2016. 
Settings: National nurses’ associations specialized on medical, diabetic, geriatric and 
neuroscience care. 
Participants: A national wide sample of Italian nurses appertaining to four national 
associations. There were included those nurses who: a) had a valid e-mail account, 
and b) were working as clinicians at the time of the survey. 
Methods: A questionnaire self-administered through SurveyMonkey Software® 
developed upon the literature and conceptual frameworks available on contextual 
factors. There were explored: 1) contextual factors definition; 2) beliefs (from 0 ‘not 
at all’ to 4 ‘a lot of’), 3) their case-by-case frequency of use (from 0 ‘never’ to 4 
‘daily’); 4) the circumstances under which they are applied in daily care, 5) the 
clinical conditions where participants have perceived their potential beneficial effects, 
6) the ethical implications in using the contextual factors, and 7) the communication 
to the patient about their use.  
	  	  
Results: Out of 1,411 eligible nurses, a total of 455 responded (32.2%) and 425 
questionnaires (30.1%) were valid for the analysis. The majority of participants 
(n=211; 49.6%) defined the contextual factors as ‘an intervention without a specific 
effect for the condition being treated, but with a possible aspecific effect’. They have 
reported to belief on the contextual factors (2.91; 95%CI 2.88–2.94) and to use them 
> 2 times/month mainly in addition to a nursing intervention to optimize clinical 
outcomes’ (n=79; 18.6%). The psychological and physiological therapeutic effects 
have been perceived mainly in chronic pain (n=259, 60.9%), insomnia (n=243; 
57.2%), and emotional disorders (n=230; 54.1%). Contextual factors have been 
reported as ethically acceptable when ‘It exerts beneficial psychological effects’ 
(n=148; 34.8%). Around a quarter of nurses have reported to ‘Say anything’ to the 
patient when the contextual factors are used.  
Conclusions: Behind those evidence-based interventions appropriate to the 
condition(s) of the patient, clinical nurses believe and use other factors aimed at 












What is already known about the topic? 
Placebo unlike nocebo has been largely studied in the nursing discipline and it reflects 
all benefits in a patient’s health ascribable to the symbolic impact of medical 
treatment/nursing intervention or the setting. 
A set of contextual factors have been identified to function as triggers of 
placebo/nocebo responses capable of increasing the positive outcomes or to 
preventing those negative by enacting different psychological and neurobiological 
mechanisms. 
 
 What this paper adds:  
Nurses are aware on CFs in their capability of increasing the placebo effects and in 
preventing the nocebo effects of nursing interventions. 
They belief in the value of the CFs which are implemented around two times/month in 
several different clinical conditions where psychological and physiological 
mechanism explain their effectiveness.  
Nurses are not use to communicate the implementation of CFs to the patients, 
therefore their use remain silent. Moreover, nurses consider the use of CFs as 










In recent years placebo has been largely studied in the nursing discipline (1, 2), 
while less often nocebo effects have been considered to date (3). Specifically, placebo 
(Latin “I shall please”) represents “all benefit in a patient’s health ascribable to the 
symbolic impact of medical treatment/nursing intervention or the setting” (4); 
differently, nocebo (Latin “I shall harm”) describes the “ill effect caused by the 
suggestion or belief that something is harmful” and reflects new or worsened 
symptoms occurring during a medical treatment or a nursing intervention (4).  
Several researchers (5, 6) have studied the rationale mechanisms explaining the 
occurrence of placebo or nocebo effects in certain circumstances and recently a set of 
contextual factors (CFs) functioning as a mediators or triggers of placebo/nocebo 
responses capable of influencing the clinical outcomes, has been described (7, 8). The 
CFs have been documented to enhance the clinical outcomes of evidence-based 
interventions, by enacting various psychological and neurobiological mechanisms 
increasing placebo and preventing or reducing nocebo effects (4). For example, 
clinical nurses can improve patient’s symptoms and well-being through the activation 
of some CFs capable of stimulating placebo responses e.g., by creating a comfortable 
environment or by using the therapeutic approach; on the contrary, some CFs can 
trigger nocebo effects, stimulating adverse effects of interventions (4) e.g., by 
negatively use verbal or non-verbal body language (9) when, nurses are work to 
increased work pressure and therefore less work-engaged and burned-out (10). 
Recently the term ‘CFs’ has been preferred instead to ‘placebo’ (11) specifically 
while conducting research  aiming at preventing bias in responses (12, 13). 
In accordance to the available conceptual frameworks (7, 8, 14) the CFs 
relevant for placebo and nocebo responses have been recognized in health-care 
	  	  
professional features (professional reputation, appearance [e.g., uniform], positive 
attitudes and optimistic behaviour); patient’s features (expectations, preferences, 
previous experience, clinical conditions, gender and age); health-care-patient 
relationship (verbal, non-verbal communication, empathetic therapeutic alliance); 
specific aspects of the interventions (over therapy, patient-centered approach, 
professional approach, and therapeutic touch); and in the healthcare setting 
(comfortable setting, environment, architecture and internal design). Translating the 
framework in the clinical practice, the manner in which health-care professionals 
implement an intervention (e.g., by manifesting an optimistic approach), the patients 
‘expectations (e.g., to ameliorate the symptoms), as well as the verbal, non-verbal 
communication and the patient-centered approach enacted by professionals and the 
environment feature where the process happens, can trigger positive or negative 
outcomes.  
In the nursing discipline, available studies have been measured mainly the 
perceived effectiveness of placebo medication among rheumatology, hemodialysis 
and non-hemodialysis nurses (1, 15, 16) as well as the general aptitudes of head 
nurses (17) and clinical nurses (2) regarding the adoption of placebo, by involving 
monocentric cross-sectional surveys. Therefore, no large-scale data with regard to the 
daily use of different CFs by nurses have been reported to date as well as their process 
of implementation, e.g., in which clinical conditions they are mostly effective, to the 
patient’s information and ethical implications. Moreover, while some CFs can be 
considered as background of each intervention (e.g., comforting environment), others 
are themselves evidence-based interventions in nursing discipline: for example, 
therapeutic touch, patient-center care and developing an empathic relationship with 
the patient (18) are all considered themselves evidence-based nursing interventions. 
	  	  
Therefore, understanding whether these interventions are used by nurses to 
enhance the effects of other interventions or not in their daily practice, is essential in 
order of: a) describing the awareness of nurses in daily use of factors modulating 
placebo/nocebo responses; b) understanding research implications e.g., the need to 
describe and evaluate also the use of these factors when the effectiveness of other 
nursing interventions are tested; and c) reflecting on nursing education and 
managerial implications. Therefore, with the intent to describe beliefs and daily use of 
CFs as triggers factors of placebo/nocebo effects in daily practice, a national study 




A web-based cross-sectional survey herein reported according to the Checklist 
for Reporting Results of Internet E-Surveys (CHERRIES) guidelines (19) and 
STrengthening the Reporting of OBservational studies in Epidemiology (STROBE) 
(20) was performed after having obtained the ethical approval from the Liguria 
Clinical Experimental Ethics Committee (P.R.236REG2016, July 7, 2016). 
 
Participants and setting 
A nationwide sample of Italian nurses was the target population identified from 
the email database of nurses’ associations specialized on medical (A.N.I.M.O. -
Associazione Nazionale Infermieri Medicina Ospedaliera; n=931), diabetic (O.S.D.I. - 
Operatori Sanitari di Diabetologia Italiani; n=910), geriatric (G.R.G. - Gruppo di 
Ricerca Geriatrica; n=123), and neuroscience care (A.N.I.N. - Associazione Nazionale 
Infermieri di Neuroscienze; n=50).  
	  	  
Within the target population, there were included those nurses who: a) had a 
valid e-mail account, and b) were working as clinicians at the time of the survey. 
Taking into consideration previous surveys in the field (12, 21-25) where the response 
rate was from 30% to 60%, there were expected approximately 423 to 847 responses 
from the population of 1,411 nurses. The application of these predicted values to the 
formula for estimating the sample size for a single population proportion with the 
population proportion set at 50.0%, which is the most conservative value to apply, 
produced a two-sided 95% confidence level within two to four percentage points of 
the true value and a relative standard error ranging from 2.17 to 4.08 (26). 
 
Questionnaire development  
A survey instrument was developed using distinct and iterative steps (27). Items 
from existing surveys on placebo were extracted from the literature (2, 12, 15-17, 21-
25, 28-38). The initial list was composed of 17 items that were critically evaluated for 
face and content validity (27) by a panel of six experts with extensive experience in 
placebo and survey design (nurses, physicians, psychologists and physical therapists). 
These experts worked independently and then agreed upon the final list of items by 
proving feedback on content accuracy, wording clarity, and survey structure. Those 
questions regarding the beliefs and the use of CFs were organized according to the 
available framework (7, 14)_ENREF_26 thus evaluating each specific aspect (e.g., 
verbal communication). Adjustments were progressively included by considering the 
feedback emerged. When full agreement among experts was achieved, a preliminary 
version of the survey composed of 14 items was pilot tested in a convenience sample 
of 10 registered nurses (RNs).  
	  	  
Thus, a self-administered questionnaire (translated in English, available as 
Supplementary File 1 composed by two sections (A-B) was used: the first was aimed 
at investigating the socio-demographic variables by two open-ended questions 
(experience as a nurse, gender) and five closed multiple-choice questions (e.g. nursing 
education) (seven items).  
The section B was composed by seven closed multiple-choice questions 
exploring: 1) CFs definition; 2) participants’ beliefs regarding each CF (from 0 ‘not at 
all’ to 4 ‘a lot of’), 3) the case-by-case frequency of use of each CF (Likert from 0 
‘never’ to 4 ‘daily’); 4) the circumstances under which they are applied, 5) the clinical 
conditions where participants have perceived the potential beneficial effect of CFs, 6) 
the ethical implications perceived in using CFs, and 7) the communication to the 
patient about CFs use.  
 
Data collection procedure 
The Survey Monkey (Survey-Monkey, Palo Alto, California, 
www.surveymonkey.com) online survey tool was used. The survey was administered 
over an eight-week period between September 2016 and November 2016. After 
permission was obtained from the Nurses Associations, all nurses were contacted 
using the blast email method (39). An email containing the survey and a brief note 
outlining the aim of the study, data handling (anonymity), the informed consent 
statement, and the invitation to complete the survey, was delivered (39). Two 
reminder emails were sent two and four weeks after the initial contact to encourage 
those who did not participate to complete the survey (40).  
Ten to 15 minutes were needed to complete the survey, in line with the 
completion time documented as optimizing response rates in online surveys (41). 
	  	  
Participation was voluntary and no incentives were offered to participants; there was 
the option to decline to answer specific questions or to leave the entire questionnaire 
blank (40). The order of questions was randomized. Participants were able to review 
or change responses using a back button until the end of the questionnaire.  
Data were downloaded and stored in an encrypted computer, and only the 
project manager could access the information at all study stages. All data were de-




A questionnaire was considered incomplete if there were more than 20% of 
missing. Descriptive statistics were used to calculate frequencies, percentages, 
averages and confidence of intervals (CI) at 95%. Specifically, in the case of CFs 
frequency of use and beliefs, the five response categories were collapsed into three 
categories (‘very often’ and ‘never’; ‘very much’ and ‘nothing’, respectively) leaving 
unaltered the central categories (‘occasionally’ and ‘enough’). For those questions 
allowing more than one choice, the absolute frequency and percentages were 
calculated for every combination of responses given by each participant, e.g. to better 
describe the responses given by each participant in the item regarding ‘Ethics’ we did 
not calculate the absolute frequency of the four possible responses (r) but their 16 
combinations, given by the formula r∧n.  
In those response options of CFs frequency of use (from “never” to “daily”) and 
beliefs (from “not at all” to “a lot of”) there were then converted in continuous 
variable aiming at describing the averages and the correlations by using the 
Spearman’s (rho, ρ). Relationship between the individual characteristics and the 
	  	  
responses given was investigated with the Eta squared and the Cramer’s V according 
to the variable nature (continuous and nominal). The R software was used for data 
analysis (42) with the packages “psych” and “ggplot2”. 
 
Results 
Participant’s characteristics  
There were invited to participate 2,014 Italian nurses; 603 of them were 
bounced because their addresses were unknown or not up-to-date, thus leaving a 
sample of 1,411 nurses that it was set as 100%. A total of 455 responded (32.2%); 
among these 30 RNs provided incomplete surveys, leaving 425 (30.1%) 
questionnaires valid for the analysis. 
The majority of RNs (361; 84.9%; 95%CI 81.1-88.1) were female, and their 
average age was 46.6 years (95%CI 45.7-47.4). Fifty-nine percent (n=251; 95%CI 
54.2-63.7) were living and working in the north of Italy. 
The majority of participants were educated at the bachelor levels (n=194; 
45.6%; 95%CI) and reported an average of 23.7 years (95%CI 22.7-24.7) of clinical 
experience; at the moment of the survey the majority were working in the hospital 
(n=348; 81.8%; 95%CI 77.8-85.4) and belonged to Medical Nurses Association 
(n=263; 61.8%; 95%CI 57.1-66.5) as reported in Table 1. 
 
Definition of CFs  
The majority of participants defined CFs as ‘an intervention without a specific 
effect for the condition being treated, but with a possible aspecific effect’ (n=211; 
49.6%; 95%CI 44.8–54.5). The remaining considered CFs as ‘an intervention that has 
a special effect through known physiological mechanisms’ (n=138; 32.5%; 95%CI 
	  	  
28.1–37.2), ‘a sham treatment used as control tests for safety and efficacy of active 
treatment’ (n=46; 10.8%; 95%CI 8.1–14.3), and in minor frequency, as ‘a harmless or 
inert intervention’ (n=30; 7.1%; 95%CI 4.9–10.0). 
 
Beliefs  
 Participants have reported a substantial level of conviction towards CFs 
(average 2.91; 95%CI 2.88–2.94). As reported in Table 2, the highest trusted factor 
was the ‘verbal communication’ (n=353; 83.1%, 95%CI 79.1-86.4) and the ‘patient-
centered approach’ (n=353; 83.1%; 95%CI 79.1-86.4%) while those lowest factors 
were, in order, the ‘professional reputation’ (n=199; 46.8%; 95%CI 42.0-51.7), the 
‘uniform’ (n=196; 46.1%; 95%CI 41.3-50.9), the adequate ‘architecture’ (=157, 
36.9%; 95%CI 32.4-41.7) and ‘environmental design’ (n=124, 29.2%; 95%CI 24.9-
33.7). 
 
Frequency of use 
As reported in Table 3, RNs have reported to use the CFs more than 2 
times/month (average 2.56; 95%CI 2.52–2.60). The majority (n=180; 42%; 95%CI 
37.6–47.2) has reported to use the CFs ‘many times’ in their clinical practice while 
the remaining ‘often’ (n=92; 21.7%; 95%CI 17.9–25.93) and ‘at least once’ (n=50; 
11.7%; 95%CI 8.9–15.3). A total of 103 RNs has instead reported to use CFs ‘never’ 
(24.2%; 95%CI 20.3–28.7); specifically, there were reported ‘never’ use an ‘adequate 
design’ (n=183; 43.1%; 95%CI 38.3-47.9), an ‘adequate environmental architecture’ 
(n=156; 36.7%; 95%CI 32.2-41.5), the ‘professional reputation’ (n=159; 37.4%; 
95%CI 32.8-42.2), the ‘uniform’ (n=150; 35.3%; 95%CI 30.8-40.1), and a 
‘comfortable setting’ (n=127; 29.8%; 95%CI 25.6-34.5). 
	  	  
 
Circumstances of application  
As reported in Figure 1, participants were divided among those providing a 
unique reason such as ‘in ad addition to a nursing intervention to optimize clinical 
outcomes’ (n=79; 18.6%; 95%CI 15.1-22.7%) and ‘to calm the patient’ (n=22; 5.18% 
95%CI 3.35-7.85) and more options, mostly combining ‘to calm the patient’ and ‘in 
addition to a nursing intervention to optimize clinical outcomes’ (n=63; 14.8%; 
95%CI 11.6-18.6), followed by ‘to calm the patient’, ‘in addition to a nursing 




Nurses have reported ‘no effects’ in some clinical conditions such as infections 
(n=181; 42.6%; 95%CI 37.9-47.5), immunological problems and allergies (n=158; 
37.2%; 95%CI 32.6-41.9), and in drug/medication addictions (n=134; 31.5%; 95%CI 
27.2-36.2). Moreover, the therapeutic effects of CFs has been identified mainly as 
‘psychological and physiological’ in chronic pain (n=259, 60.9%; 95%CI 56.1-65.6), 
insomnia (n=243; 57.2%; 95%CI 52.3-61.9), emotional (n=230; 54.1%; 95%CI 49.3-
58.9), acute pain (n=202, 47.5%; 95%CI 42.7-52.4), oncological (n=190; 44.7%; 
95%CI 39.9-49.6), cardiovascular (n=187; 44.0%; 95%CI 39.2-48.8), neurological 
(n=182; 42.8%; 95%CI 38.1-47.7) and in rheumatologic problems (n=179; 42.1%; 
95%CI 37.4-46.9) (Supplementary File 2). 
Differently, participants have reported only ‘psychological’ effects in cognitive 
disorders (n=177; 41.6%; 95%CI 36.9-46.5) and sexual conditions (n=136; 32.0%; 
	  	  
95%CI 27.6-36.7) while only ‘physiological’ effects were reported more often in 
gastrointestinal problems (n=86; 202; 95%CI 16.6-24.4).  
 
Ethical implications  
Participants have reported that CF use is ethically acceptable when ‘It exerts 
beneficial psychological effects’ (n=148; 34.8%; 95%CI 30.3-39.6), ‘It exerts 
beneficial psychological effects’ and the ‘Clinical experience has shown the 
effectiveness’ (n=81; 19.1%; 95%CI 15.5-23.2) as well as when ‘It exerts beneficial 
psychological effects’ and ‘The patient desire or expects this intervention (n=46; 
10.8%; 95%CI 8.1-14.3) as reported in Figure 2.  
However, participants have considered non-ethical when CFs use ‘It is based on 
deception’, ‘Threatens trust between the patient and the nurse’ (n=66; 15.5%; 95%CI 
12.3-19.4), or simply ‘Threatens trust between the patient and the nurse’ (n=63; 
14.8%; 95%CI 11.7-18.6), ‘It is based on deception’ (n=49; 11.5%; 95%CI 8.7-15.0) 
or ‘It is based on deception’, ‘Threatens trust between the patient and the nurse’ and 




The 24.2% of nurses reported to ‘Say anything’ to the patient (n=103; 95%CI 
20.3-28.7); another 20.7% (n=88; 95%CI 17.0-24.9) informed the patients that CFs 
‘Is a treatment that can help and will not hurt’; the 15.5% communicated to the 
patients that the CFs ‘Is an effective treatment’ (n=66; 95%CI 12.3-19.4) and in 
similar proportion (n=65; 15.3%; 95%CI 12.1–19.2) is used to communicate that ‘The 




A moderate correlation (ρ=0.47) emerged between overall beliefs and the 
overall frequency of use; specifically, moderate positive associations (Supplementary 
Figure 1) were found between the frequency and the use of ‘patient’s expectation and 
preference’ (ρ=0.57), ‘uniform’ (ρ=0.56), ‘professional reputation’ (ρ=0.51), ‘patient-
centered approach’ (ρ=0.46), ‘non-verbal communication’ (ρ=0.45), ‘positive 
attitudes and optimistic behavior’ (ρ=0.44), ‘physical contact with the patient’ 
(ρ=0.44), ‘verbal communication’ (ρ=0.44), ‘patient’s previous experience’ (ρ=0.42), 
and ‘over therapy’ (ρ=0.41). Correlations were not emerged between individual 
characteristics of participants and responses in all domains of the questionnaire. 
 
Discussion 
To our best knowledge this is the first national study aimed at examining the 
attitudes of nurses towards the implementation of CFs to promote placebo effects and 
minimize nocebo effects in daily practice.  
CFs are considered interventions capable of enhancing the effectiveness of other 
nursing interventions. Findings reflect those emerged in previous nurse (2, 15-17) and 
physician surveys (31, 35) suggesting that nurses are aware not only of the use of 
placebos in clinical settings, but also they value factors that can optimize clinical 
outcomes.  
 Nurses have reported to take in consideration CFs, on average from ‘enough’ to 
‘much’, specifically with regard to (in order) verbal and non-verbal communication, 
patient-centered approach, psychical contact and the empathetic therapeutic alliance 
which represent all core concepts of caring (43). An inferior degree of trust has been 
	  	  
reported, in order, on professional reputation, uniform, adequate environment and 
design, which represent factors capable of increasing care humanization as 
emphasized recently in the literature (44) thus likelihood not included yet in 
undergraduate and continuing education programs. However, health care 
professional’s reputation and environment (23) represent important CFs and 
milestones of personal branding as “introspective process by which you define 
yourself professionally” capable of influencing clinical outcomes and to increase 
professional realization and reputation (45). 
The adoption of CFs in the clinical practice occurs more often than two times 
per month, with a consistent variation across factors: for example, higher use has been 
reported during verbal and non-verbal communication, positive attitudes and 
optimistic behavior, and in professional approach with patients in line with the nurses’ 
beliefs. On the contrary, nurses have reported to use less often (around at least one per 
year) the adequate setting design, the environmental architectures and the professional 
reputation which have been also reported as those factors ‘never’ used. Italian nurses 
are used to work mainly at the National Health Service public sector, where the 
architecture features are in general old (46) and unmodifiable; in addition, the 
professional reputation as a single nurse is not used given that nurses work as a team 
and patients cannot decide to be cared for by a specific nurse. Therefore, the adoption 
of these CFs is more challenging for NHS nurses, and exploring their value among 
those nurses working in the private sector is suggested.  
Nurses have reported to apply CFs in different circumstances mainly in addition 
to nursing interventions required by the clinical condition to obtain therapeutic 
effects, such as to relaxing or controlling pain, as already documented among nurses 
(2, 15-17) and physicians (17, 21-23, 35). On the contrary, the CFs adoption is rarely 
	  	  
used when patients required continuously unjustifiable interventions, to prevent their 
complaints or when evidence-based interventions are ineffective, thus suggesting that 
CFs are not used alone in high demanding and in high complex patients. Moreover, 
CFs are never used to gain time (e.g., waiting for physician consultation) indicating 
that no other factors (e.g. organizational factors) than those strictly clinical play a role 
in the decision to stimulate placebo and to avoid nocebo effects. 
From the experience of participants, different clinical conditions can be 
benefited by CFs. Above all, emotional disorders, chronic pain, cognitive disorders, 
insomnia and acute pain. With regard to pain, previous studies have already 
documented nurses’ attitudes towards the use placebo of medication (1, 15, 16); while 
the adoption of other strategies aimed at reducing pain have never been documented 
before. The remaining clinical conditions, suggest that nurses have experienced 
positive effects in the majority of health issues with the exception of infections, 
immune problems/allergies, drug/medication addictions, and sexual problems. The 
specificity mission of the nursing associations approached can explain these findings 
considered that nurses included do not dealt on a daily basis these clinical conditions. 
Moreover, the therapeutic effects of CFs have identified mainly among ‘psychological 
and physiological’ thus suggesting a mixed effect in the majority of health conditions; 
also in previous studies subjective mechanisms or a mix of subjective and objective 
mechanisms (2, 17, 30) have been reported. 
Nurses considered the use of CFs as ethically acceptable when the benefits are 
evident from the side of patients and the nurses: in other words, when the intervention 
is not harmful. In performing this evaluation, the amount of clinical experience of 
nurses (e.g., newly graduates or experts), as well as their capability to detect 
psychological benefits or to diagnose patients desires or expectations can play a great 
	  	  
role in defining the ethical acceptability of the intervention. Otherwise, the use of CFs 
has been considered non-ethical when negative effects at different levels can emerge 
as documented in previous studies (2, 17) confirming that caring is based upon non-
maleficence (2, 47).  
Around a quarter of nurses have reported to do not inform the patient on the CF 
use, thus jeopardizing the principles of the autonomy (48); the remaining are used to 
communicate in general the benefits, as previously documented (21, 34). The lack of 
information can denote a paternalistic approach towards patients that has been 
documented among Italian health care professionals (49). Moreover, the informed 
consent can influence the effects of the CFs implementation and, therefore, their 
clinical outcomes (50) perceived by nurses that can turn in increased or decreased use 
of CFs. However, it can be difficult for nurses to inform patients regarding the use of 
some specific CFs, e.g. the empathetic relationship, because they are embodied in the 
concept of caring (47). Furthermore, while no individual factors (e.g., age, gender, 
education) were correlated both with beliefs and CFs use, a moderate correlation 
emerged between beliefs and the occurrence of some specific factors. Some CFs (e.g. 
professional approach) are fundamentals elements of caring (47) and, therefore, 
routinely adopted in daily nursing care. 
 
Strengths and weaknesses of the study 
Although the study novelty, several limitations affect its findings.  
Firstly, the RNs involved appertained to four different national associations 
developing nursing care in specific groups of patients whom reflect the main issues of 
the Italian population (51); however, they cannot reflect the entire population of RNs 
composed by 441,000 nurses (52). Secondly, in developing the questionnaire, not all 
	  	  
factors included in the available frameworks (e.g., patient age, gender) (14) have been 
considered. Thirdly, although the participant rate was in line with previous studies 
(12, 21-25), only those interested on the topic may have answered to the survey, thus 
introducing a selection bias. Social desirability (53) or memory bias with regarding 
some specific items (e.g., the frequency of use of CFs in daily practice) can have all 
affected the findings. Finally, although the participants’ profile was in line with that 
documented at the Italian level where nurses have been documented predominantly to 
be female, in the middle age, educated mainly in university settings, and working in 
hospitals (54) the sample of responders may not be representative of the overall 
Italian nurse population therefore limiting the generalizability of the results. 
 
Educational, research and managerial implications 
 The CFs valued by nurses and experienced as effective are based upon the 
internal quality of the nurse and the quality of the relationship between the nurse and 
the patient. These qualities require a large personal investment: therefore, nurses 
should be supported in developing these qualities since their nursing graduation. With 
regard to those neglected CFs, e.g. the quality of the setting where the care is offered, 
increasing awareness among nurses since nursing education and after, during their 
clinical experience. 
 From the point of view of the research and managerial implications, according 
to the current debate, nursing practice is considered of poor quality when missed 
nursing care or unfinished nursing interventions occur and this can increase the 
likelihood of adverse events (55). In this light, different tools are used of measuring 
the process of nursing care and whether or not interventions are missed or undone, as 
well as if some implicit rationing of nursing care occur. However, an evidence-based 
	  	  
intervention can be implemented in the expected time and manner, but not 
accompanied by appropriate CFs, which can reduce its effectiveness.  
 Moreover, research has already defined how important are the organizational 
environments and the nursing leadership styles in supporting nurses to be engaged and 
committed (10); in a poor environment, nurses can be constrained in enacting their 
compassionate care, thus paradoxically apply all interventions required by patients by 
neglecting other factors (e.g., verbal communication) that can trigger negative 
outcomes. Therefore, future research and nurse managers actions focused on safety 
and adverse effects, should also consider the role of CFs as modulators.  
Finally, in designing studies aimed at measuring the effectiveness of nursing 
interventions, assessing the presence of CFs, for example measuring beliefs or the 
frequency of their use at the baseline, can help to (a) compare the homogeneity of 
different contexts, (b) identify groups to compare, or (c) define the contribution of 
factor(s) other than the intervention under study in the expected outcomes. 
 
Conclusion  
 Nurses are aware of the CFs as elements to increase the placebo effects and 
prevent the occurrence of nocebo effects in concomitance with nursing interventions. 
Nurses belief in the value of the CFs which are implemented around two times per 
month in several different clinical conditions where psychological and physiological 
mechanisms might explain their effectiveness. Nurses are not used to communicate 
the implementation of CFs to the patients, therefore their adoption remain as part of 
the optimization of the routine clinical practice. Moreover, nurses consider the use of 
CFs as ethically acceptable when capable of producing benefits for the patient. 
	  	  
 Nurses like and use mainly verbal and non-verbal communication, patient-
centered approaches, psychical contact and the empathetic therapeutic alliance; 
differently, those who dislike contextual factors are concerned about professional 
reputation, uniform, adequate environment and design.  
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Table 1. Participant characteristics (n=425) 
Legend: N, number of participants; %, percentage; SD, standard deviation;	  95%CI, 95% confidence 
interval; E-learn, e-learning; MNS, master of nursing science; Post grad dip, post graduated diploma

























Nursing Education  
Bachelor  
Bachelor + E-learn 
Bachelor + MNS  
Bachelor + MNS + E-learn  
Bachelor + MSN + Post grad dip  
Bachelor + MSN + Post grad dip + E-
learn 
Bachelor + Post grad dip 



































Nursing Association  
Medical Nurses  
Diabetic care Nurses 
Geriatric Nurses  












Table 2. Beliefs regarding contextual factors as reported by participants (n=425) 




n (%); 95%CI 
Enough 
n (%); 95%CI 
Nothing 
n (%); 95%CI 
Unknown 





Professional reputation 2.35 (2.24-2.46) 191 (44.9); 40.2-49.8 199 (46.8); 42.0-51.7 17 (4.0); 2.4-6.4 18 (4.2); 2.6-6.7 
Uniform  2.01 (1.89-2.12) 164 (38.6); 33.9-43.4 196 (46.1); 41.3-50.9 55 (12.9); 9.9-16.6 10 (2.4); 1.2-4.4 





Patient’s expectation and preference 3.06 (2.97-3.15) 311 (73.2); 68.7-77.3 108 (25.4); 21.4-29.8 3 (0.7); 0.2-2.2 3 (0.7); 0.2-2.2 

















Verbal communication 3.30 (3.22-3.39) 353 (83.1); 79.1-86.4 62 (14.6); 11.4-18.4 2 (0.5); 0.1-1.8 8 (1.8); 0.4-2.9 
Not verbal communication  3.29 (3.20-3.38) 351 (82.6); 78.6-86.0 62 (14.6); 11.4-18.4 3 (0.7); 0.2-2.2 9 (2.1); 1.0-4.1 








Over therapy 3.02 (2.92-3.13) 307 (72.2); 67.7-76.4 74 (17.4); 14.0-21.4 20 (4.7); 2.9-7.3 24 (5.6); 3.7-8.4 
Patient-centered approach 3.32 (3.22-3.42) 353 (83.1); 79.1-86.4 49 (11.5); 8.7-15.1 9 (2.1); 1.0-4.1 14 (3.3); 1.8-5.6 
Professional approach with patient 3.15 (3.06-3.24) 324 (76.24); 71.8-80.1 68 (16.0); 12.7-19.9 5 (1.2); 0.4-2.9 28 (6.6); 4.5-9.5 











Comfortable setting 2.68 (2.56-2.79) 279 (65.65); 60.9-70.1 88 (20.7); 17.0-24.9 44 (10.4); 7.7-13.7 14 (3.3); 1.8-5.6 
Adequate environmental architecture 2.52 (2.41-2.63) 244 (57.41); 52.6-62.1 124 (29.2); 24.9-33.8 42 (9.8); 7.3-13.2 15 (3.5); 2.1-5.8 
Adequate design 2.32 (2.21-2.44) 205 (48.24); 43.4-53.1 157 (36.9); 32.4-41.8 48 (11.3); 8.5-14.8 15 (3.5); 2.1-5.8 
Legend: %, percentage; n, number of participants; 95%CI, 95% confidence interval 




Table 3. Contextual factors use in clinical practice as reported by participants (n=425) 




n (%); 95%CI 
Enough 
n (%); 95%CI 
Nothing 
n (%); 95%CI 
Unknown 





Professional reputation 1.95 (1.76-2.14) 174 (40.9); 36.3-45.8 35 (8.2); 5.8-11.4 159 (37.4); 32.8-42.2 57 (13.4); 10.4-17.1 
Uniform  2.21 (2.03-2.39) 218 (51.3); 46.4-56.1 31 (7.3); 5.1-10.3 150 (35.3); 30.8-40.1 26 (6.1); 4.1-8.9 





Patient’s expectation and preference 2.76 (2.60-2.92) 306 (72.0); 67.4-76.2 14 (3.3); 1.8-5.6 103 (24.3); 20.3-28.6 2 (0.5); 0.1-1.8 

















Verbal communication 2.96 (2.80-3.12) 317 (74.6); 70.1-78.6 5 (1.2); 0.4-2.9 101 (23.7); 19.8-28.2 2 (0.5); 0.1-1.8 
Not verbal communication  2.91 (2.75-3.08) 316 (74.4); 69.8-78.4 5 (1.2); 0.4-2.9 102 (24.0); 20.1-28.4 2 (0.5); 0.1-1.8 








Over therapy 2.64 (2.49-2.80) 287 (67.5); 62.8-71.9 28 (6.6); 4.5-9.5 104 (24.5); 20.5-28.9 6 (1.4); 0.6-3.2 
Patient-centered approach 2.86 (2.70-3.02) 306 (72.0); 67.4-76.2 14 (3.3); 1.8-5.6 102 (24.0); 20.1-28.4 3 (0.7); 0.2-2.2 
Professional approach with patient 2.91 (2.75-3.08) 313 (73.7); 69.1-77.7 6 (1.4); 0.6-3.20 102 (24.0); 20.1-28.4 4 (0.9); 0.3-2.6 











Comfortable setting 2.38 (2.22-2.55) 258 (60.7); 55.8-65.4 30 (7.1); 4.9-10.0 127 (29.8); 25.6-34.5 10 (2.4); 1.20-4.43 
Adequate environmental architecture 1.99 (1.82-2.16) 202 (47.5); 42.7-52.4 45 (10.6); 7.9-14.0 156 (36.7); 32.2-41.5 22 (5.2); 3.35-7.85 
Adequate design 1.57 (1.41-1.76) 145 (34.1); 29.7-38.8 74 (17.4); 14.0-21.4 183 (43.1); 38.3-47.1 23 (5.4); 3.54-8.13 
Legend: %, percentage; n, number of participants; 95%CI, 95% confidence interval 
† Likert scale: 0, never; 1, at least once per year; 2, at least once per month; 3, at least once per week; 4, daily.
!
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Figure 1. Contextual Factors circumstances of application  
 
A: ‘As a result of unjustified and continuing demand of nursing interventions by the patient’, B: ‘To 
calm the patient’, C: ‘when all other interventions are over’, D: ‘As an adjunct to other nursing 
intervention to optimize clinical outcomes’, E: ‘For non-specific problems, F: ‘To stop the patient’s 
complaints’, G: ‘As a diagnostic tool to differentiate between psychological and physiological 


















Figure 2. Contextual factors use and ethical implications  
 
CFs use is ethical when. A: ‘It exerts beneficial psychological effects’, B: ‘Other interventions are 
over’, C: ‘The patient desire or expects this intervention, D: ‘My clinical experience has shown the 
effectiveness’.  
CFs use is not-ethical when. E: ‘It is based on deception’, F: ‘Threatens trust between the patient and 
the nurse’, G: ‘The evidences available are insufficient’, H: ‘Some legal problems can arise’, I: ‘It can 






Supplementary file 1. The questionnaire: “Knowledge about contextual factors 
among Italian nurses.” 
 
Welcome to this survey! 
Dear colleague thank you for take part in this survey. 
 
This survey aims to clarify the use of contextual factors in enhancing the therapeutic 
outcome in nursing care. 
 
The contextual factors consist of a series of relational or environmental situations that 
may affect the perception of patients’ suffer and functional impairment. Examples of 
the main contextual factors are: the words and posture used by the nurse, the smells, 
the sounds and the decor of the therapeutic setting to enhance the effectiveness of 
nursing care.  
We consider important to study them in their spread within nursing care. 
 
Kindly answer the following questions based on your personal clinical experience. 
The compilation of the entire questionnaire takes a maximum of 10 minutes. Your 
answers are completely anonymous and will only be used for the purposes of this 
research.  
 
Whenever you complete the page, click on "Next" to save your answer. If you decide 
to abandon the survey, select "Exit". 
 
Socio-demographic characteristics 




How old are you? [complete] 
………. 
 









What is your clinical workplace? [select] 
¨ Hospital 
¨ Nursing home  
¨ Community care 
¨ Other ……………. 
 
What is your reference association? [select]  
¨ A.N.I.N. (Associazione Nazionale Infermieri Neuroscienze) 
¨ A.N.I.M.O. (Associazione Nazionale Infermieri Medicina Ospedaliera) 
¨ G.R.G (Gruppo di Ricerca Geriatrica) 
¨ O.S.D.I. (Operatori Sanitari di Diabetologia Italiani) 
 
Which training path did you experience? [you can select more than one answer] 
¨ Bachelor of nursing 
¨ Master of nursing science  




How would you define the therapeutic role of contextual factors? [select] 
¨ an intervention without a specific effect for the condition being treated, but 
with a possible aspecific effect  
¨ an intervention that has a special effect through known physiological 
mechanisms  
¨ sham treatment used as control tests for safety and efficacy of active treatment 





How do you BELIEVE that your therapeutic outcome can be influenced by ...? [select] 
 Very 
Much 
Much Enough Few None I don’t know 
Professional reputation       
Uniform       
Positive attitudes and optimistic behaviour        
Patient’s expectation and preference       
Patient’s previous experience       
Verbal communication       
Not verbal communication       
Empathetic therapeutic alliance with 
patient 
      
Over therapy       
Patient-centered approach       
Professional approach with patient       
Physical contact with patient       
Comfortable setting       
Adequate environmental architecture       






Frequency of use (1/2) 
How often in your career do you INTENTIONALLY used the contextual factors to 
enhance the result of nursing care? [select] 
¨ many times 
¨ often 




Frequency of use (2/2) 













Never I did not think it 
was a contextual 




Professional reputation       
Uniform       
Positive attitudes and optimistic behaviour        
Patient’s expectation and preference       
Patient’s previous experience       
Verbal communication       
Not verbal communication       
Empathetic therapeutic alliance with 
patient 
      
Over therapy       
Patient-centered approach       
Professional approach with patient       
Physical contact with patient       
Comfortable setting       
Adequate environmental architecture       




Under what CIRCUMSTANCES would you use contextual factors? [you can select 
multiple possibilities] 
¨ as a result of unjustified and constant demands for nursing interventions 
¨ to calm the patient 
¨ when all other therapies are over 
¨ as an adjunct to other nursing interventions to optimize the clinical responses 
¨ for non-specific problems 
¨ to stop the patient’s complaints 
¨ as a diagnostic tool to differentiate between psychological and physiological 
problems 
¨ to control pain 
¨ to gain time 
 
Therapeutic effect  
What are, in your opinion, the POTENTIAL EFFECTS of contextual factors in the 
following health problems? [select] 





acute pain     
chronic pain     
cognitive disorder     
emotional disorder     
gastrointestinal disorder     
sexual disorder     
drug and medication 
addiction 
    
neurological disorder     
rheumatologic disorder     
immune and allergic 
disorder 
    
oncological disorder     
cardiovascular disorder     
infectious     







How do you COMMUNICATE to the patient the use of contextual factors at the 
end of treatment? The notified its ... [you can select multiple possibilities] 
¨ it is a treatment that can help and will not hurt  
¨ it is an effective treatment  
¨ do not say anything  
¨ it is a treatment without a specific effect  
¨ it is a treatment that induces a psychological change 
¨ it can help but you are not sure about its effect. 
 
Ethical issues 
The use of contextual factors for therapeutic purposes can be considered 
ETHICALLY ACCEPTABLE when ... [you can select more than one answer] 
¨ it exerts beneficial psychological effects  
¨ the other therapies are over  
¨ the patient wants or expects this treatment  
¨ clinical experience has shown the effectiveness  
 
The use of contextual factors for therapeutic purposes can be considered 
ETHICALLY NOT ACCEPTABLE when ... [you can select more than one answer] 
¨ it is based on deception  
¨ it	  undermines trust between patient and nurse  
¨ the evidences are insufficient  
¨ legal problems arise  
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The placebo effect in motor performance is differently modulated by 
external and internal focus of attention. 
 
Abstract  
Background: The placebo effect is a beneficial outcome that follows the application 
of an inert treatment. It can influence not only perception (like pain), but also 
behaviour, for example by improving motor performance. Motor control can be 
modulated in many ways. One of the most powerful is the focus of attention. In this 
context, directing attention to the movements of the body (internal focus) or to the 
goal of the action (external focus) can have different effect on motor performance. 
The aim of our study was to investigate whether attentional focus and placebo 
procedures interact in modulating motor performance.  
Methods: 60 healthy subjects (25 women; mean age, 23.2 ± 3.3 years) were 
randomized in 4 groups: placebo group with internal focus of attention (PI), placebo 
group with external focus of attention (PE), control group with internal focus of 
attention (CI) and control group with external focus of attention (CE). Subjects 
performed a motor task by pressing a piston as strongly as possible with the right 
index finger. The PE and CE groups were instructed to “concentrate on the piston’s 
movement”; the PI and CI groups were instructed to “concentrate on the finger’s 
movement”. The PE/PI groups were verbally informed that treatment with peripheral 
low-frequency transcutaneous electrical nerve stimulation (TENS) applied on the first 
dorsal interosseus would induce force enhancement. These groups were also 
conditioned after TENS application, with a surreptitious amplification of the visual 
feedback signalling the force level; the CE/CI groups instead, were told that TENS 
was not effective and they did not undergo the conditioning phase. 
	  	  
Results: The PE and PI groups believed that TENS had been effective and expected 
to perform better compared with the CE and CI groups. Moreover, the PI group 
presented higher force levels than the PE group, suggesting that the placebo effect in 
motor performance can be enhanced with an internal focus of attention. 
Conclusion: These findings show for the first time that the placebo effect in motor 
performance can be influenced by the subject’s attentional focus. 	  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
